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Abstract 
T cell development in the thymus produces multiple lineages of cells, 
including conventional naïve CD4+ and CD8+ T cells, regulatory T cells, and 
innate T cells. Innate T cells encompass γδ T cells, invariant natural killer (iNKT) 
cells, mucosal-associated invariant T (MAIT) cells, and H2-M3-restricted cells 
(Berg, 2007). Although they are a minor subset of all thymocytes, innate T cells 
develop in the thymus and share characteristics of the innate and adaptive 
immune systems (Berg, 2007). These lymphocytes undergo antigen receptor 
rearrangement and are able to exert their effector function immediately upon ex 
vivo stimulation (Berg, 2007). However, in several strains of mice harboring 
mutations in T cell signaling proteins or transcriptional regulators, conventional 
CD8+ T cells develop as innate cells that share characteristics with memory T 
cells (Atherly et al., 2006b; Broussard et al., 2006; Fukuyama et al., 2009; 
Gordon et al., 2011; Verykokakis et al., 2010b; Weinreich et al., 2010).  
One of these signaling proteins, inducible T cell kinase (Itk) is a 
nonreceptor protein tyrosine kinase that signals downstream of the T cell 
receptor (TCR) (Berg et al., 2005). Upon TCR activation, Itk is activated and 
recruited to the TCR signaling complex, where Itk interacts with Src homology 2 
(SH2) domain-containing leukocyte phosphoprotein of 76 kDa (SLP-76), linker for 
activation of T cells (LAT), and phospholipase C γ1 (PLCγ1) (Berg et al., 2005). 
Thus, in Itk-deficient mice, TCR signaling is disrupted, which results in mature 
CD4- CD8+ (CD8SP) thymocytes that are CD44high, CD62Lhigh, CD122+, and 
CXCR3+ and that express high levels of the transcription factor, Eomesodermin 
viii
(Eomes) (Atherly et al., 2006b; Broussard et al., 2006; Weinreich et al., 2010). 
Recently, it was determined that the development of these innate CD8SP 
thymocytes in itk-/- mice is dependent on IL-4 produced in the thymic environment 
by a poorly characterized subset of CD3+ thymocytes expressing the 
transcriptional regulator, promyelocytic leukemia zinc finger (PLZF) (Gordon et 
al., 2011; Verykokakis et al., 2010b; Weinreich et al., 2010).  
Here we show that a sizeable proportion of mature CD4+ CD8- (CD4SP) 
thymocytes in itk-/- mice also develop as Eomesodermin+ innate T cells. These 
Eomes+ innate CD4+ T cells are CD44high, CD62Lhigh, CD122+, and CXCR3+ 
(Atherly et al., 2006b; Broussard et al., 2006; Dubois et al., 2006; Weinreich et 
al., 2010). Surprisingly, neither CD4SP nor CD8SP innate thymocytes in itk-/- 
mice are dependent on γδ T cells for their development as was previously 
hypothesized (Alonzo and Sant'Angelo, 2011). Instead, both subsets of innate itk-
/- T cells require the presence of a novel PLZF-expressing, SAP-dependent 
thymocyte population that is essential for the conversion of conventional CD4+ 
and CD8+ T cells into Eomesodermin-expressing innate T cells with a memory 
phenotype. This novel subset of PLZF-expressing SAP-dependent innate T cells 
preferentially home to the spleen and mesenteric lymph nodes and have a 
restricted TCR repertoire. Thus, we have christened this subset as CD4+ PLZF+ 
MAIT-like cells.  
We have characterized multiple subsets of innate T cells that expand in 
the absence of Itk. Therefore, we were interested in how innate T cells respond 
to infection. Although Itk KO mice have defects in cytolytic function and cytokine 
ix
production during an acute infection, these mice are able to clear viral infections 
(Atherly et al., 2006a; Bachmann et al., 1997). Hence, we hypothesized that Itk-
deficient memory CD8+ T cells would be able to provide protection upon a 
challenge infection. Conversely, we found this not to be true although Itk-deficient 
memory CD8+ T cells were present in similar frequencies and cell numbers as 
WT memory CD8+ T cells at 42 days post-infection. Furthermore, Itk-deficient 
memory CD8+ T cells were able to produce IFNγ and exert cytolytic function upon 
stimulation. Although the function of Itk-deficient memory CD8+ T cells appeared 
to be intact, we found that these cells were unable to expand in response to a 
challenge infection. Remarkably, conventional memory CD8+ T cells lacking Itk 
were able to expand and form protective memory responses upon challenge. 
Thus, the inability of Eomes+ innate CD8+ T cells to form protective memory 
responses does not appear to be intrinsic to cells deficient in Itk.  
This thesis is divided into six major chapters. The first chapter will provide 
an introduction to T cell development and the role of Itk in T cell development. 
Additionally, it will introduce a variety of innate T cell subsets that will be 
discussed throughout this thesis and will provide an overview of CD4+ and CD8+ 
T cell differentiation during infection. This section will explain the role of Itk in 
CD4+ helper T cell differentiation and describe how Itk-deficient CD8+ T cells 
respond to acute infection. The introduction will also discuss the generation of 
conventional memory CD8+ T cells. The second chapter will provide the details of 
the experimental procedures used in this thesis. The third chapter will describe 
the characterization and development of Eomes+ innate CD4+ T cells that 
xdevelop in the absence of Itk. Additionally, this chapter will address the subset of 
PLZF+ innate T cells that induce the expression of Eomes in innate T cells. The 
fourth chapter will further characterize and explore the development of itk-/- CD4+ 
PLZF+ MAIT-like T cells. The fifth chapter will examine the role of Eomes+ innate 
CD8+ T cells in protective memory responses. Chapters three through five will 
display work that is in preparation to be submitted to a peer-reviewed journal. 
The sixth chapter will discuss the results of this thesis and their implications.  
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3Chapter I: Introduction  
T cells are a vital component of the immune system. They induce class 
switching of B cells during a humoral response and induce death of cells infected 
with an intracellular pathogen. In the absence of the T cell response, 
immunodeficiency occurs. Conventionally, T cells have an polyclonal repertoire 
that consists of αβ chains as components of their T cell receptor (TCR) with the 
coreceptors CD8 or CD4; however, unconventional, innate-like subsets of T cells 
(hereafter referred to as ‘innate T cells’) have been described that are 
characterized by having a restricted TCR repertoire (Berg, 2007).  Examples of 
innate T cells include, but are not limited to, γδ T cells, invariant natural killer T 
(iNKT) cells, mucosal-associated invariant T (MAIT) cells, CD8αα intraepithelial T 
cells, and H2-M3 restricted T cells (Berg, 2007; Veillette et al., 2007). Other 
characteristics that distinguish conventional versus innate T cells include surface 
marker expression, the need for priming after stimulation, and the signaling 
pathways utilized during development (Berg, 2007; Veillette et al., 2007). 
Conventional αβ T cells exhibit a naïve phenotype by having low 
expression of CD44 and little to no expression of CD122 or NK cell markers, 
such as NK1.1 (Berg, 2007) (Figure 1.1A). Innate T cells differ by expressing 
high levels of CD44, CD122, and NK cell markers, which are all indicative of an 
activated or memory phenotype (Berg, 2007) (Figure 1.1B). In addition to the cell 
surface phenotype, conventional αβ T cells are primed and require differentiation 
following antigen-mediated activation to exert their effector function, such as 
cytokine secretion or cytolytic function (Figure 1.1A); in contrast, innate T cells 
4are able to perform their effector functions immediately upon stimulation (Berg, 
2007) (Figure 1.1B). These differences in phenotype and function may be the 
result of differential requirements for development. Most subsets of innate T cells 
require IL-15 and/or the signaling lymphocytic activation molecule (SLAM) 
signaling pathways for their development, function, and/or survival (Atherly et al., 
2006a; Horai et al., 2007; Verykokakis et al., 2010b). However, IL-15 and SLAM 
signaling pathways are dispensable for the development of conventional αβ T 
cells (Berg, 2007). 
Role of T Cell Receptor Signaling in T Cell Development 
Despite these distinctive differences in conventional versus innate T cells, 
unconventional T cells are thought to undergo some of the same developmental 
processes as conventional αβ T cells. Conventional and innate T cell precursors 
enter the thymus upon migration from the bone marrow and are characterized as 
double negative (DN) cells that lack expression of CD4, CD8, and CD3. The DN 
subset is divided into stages one through four via expression of CD44 and CD25 
where DN1 cells are CD44high CD25-, DN2 cells are CD44high CD25+, DN3 cells 
are CD44low CD25+, and DN4 cells are CD44low CD25- (Naito et al., 2011). The 
bifurcation of αβ and γδ T cell lineages occurs around the DN2 stage of T cell 
development (Lauritsen et al., 2006) (Figure 1.2).  
Although the mechanism of this bifurcation of lineages is not entirely 
elucidated, it is thought that strength of TCR signaling may be involved, such as 
stronger TCR signals induce γδ T cell development while weaker TCR signals 
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Figure 1.1: Innate-like T cells versus Conventional T cells. (A) Conventional 
T cells have a naïve phenotype (CD44low CD122- NK1.1-). Upon activation, 
conventional cells require priming prior to exerting effector functions. (B) Innate-
like T cells have an activated or memory phenotype (CD44high CD122+ NK1.1+) 
and are able to exert effector functions immediately upon activation. 
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Figure 1.2: T Cell Development. Double-negative thymocytes enter the thymus. 
αβ and γδ T cells diverge at this point in development, and αβ T cells undergo β 
selection prior to up regulation CD4 and CD8 co-receptors to become double-
positive thymocytes. After DP thymocytes undergo positive and negative 
selection, these thymocytes mature into T regulatory, iNKT, CD4, or CD8 T cells. 
TCR signaling strength can play a role in lineage differentiation.  
 
7induce αβ T cell development (Lauritsen et al., 2006). Additionally, IL-7 has been 
determined to be involved in this αβ versus γδ lineage bifurcation where cells 
expressing high levels of the IL-7Rα (CD127) differentiate into γδ T cells while 
thymocytes having lower expression levels of IL-7Rα develop into αβ T cells 
(Kang et al., 2001). Although the signals driving γδ T cell differentiation remain to 
be resolved, Sox13 has been shown to be required for the development of this 
innate T cell subset (Melichar et al., 2007). In the absence of this transcription 
factor,  γδ T cells have impaired development (Melichar et al., 2007). Further, 
inducing expression of Sox13 via an lck proximal promoter, these transgenic 
mice were able to induce expression of γδ T cell specific genes and inhibit the 
development of αβ T cells (Melichar et al., 2007).  
After the divergence of γδ T cells and during the DN3 to DN4 transition, αβ 
T cells undergo selection of their β chain via signaling of the pre-TCR complex, 
which consists of the TCRβ chain, the pre-Tα chain, CD3ε, CD3γ, and TCRζ. 
These signals induce allelic exclusion of the β chain and promote the survival, 
proliferation, and differentiation of DN thymocytes to the double-positive (DP) 
stage of development (Michie and Zúñiga-Pflücker, 2002). During this DP stage, 
thymocytes express both CD4 and CD8 coreceptors and undergo selection of 
their TCRα chain (Figure 1.2).  
Once αβ T cells have reached the DP stage of development and their 
TCRα chain has been rearranged, these cells undergo positive and negative 
selection. During these selection processes, the strength of the TCR signal is 
8critical for the decision of a cell to continue to mature or to die (Starr et al., 2003) 
(Figure 1.3). αβ T cells that do not receive TCR signals at this stage die from 
neglect, and αβ T cells that react too strongly undergo apoptosis in order to 
prevent autoimmunity in the periphery (Starr et al., 2003; Sugawara et al., 1998; 
Werlen et al., 2000). For example, peptide studies have determined that only the 
weakest agonists can induce the positive selection of H2-M3-restricted or OT-I 
transgenic T cells (Berg et al., 2000; Chiu et al., 1999; Hogquist and Bonnevier, 
1998). Conversely, strong agonists of these T cells induce death (Berg et al., 
2000; Chiu et al., 1999; Hogquist and Bonnevier, 1998). However, it has been 
shown more recently that some types of unconventional T cells actually require 
strong TCR signals in order to develop. These unconventional cells include CD4+ 
CD25+ FOXP3+ natural T regulatory (nTreg) and iNKT cells (Moran et al., 2011) 
(Figure 1.2).  
During positive and negative selection another critical juncture of 
development occurs. This juncture is the bifurcation of CD4+ versus CD8+ αβ T 
cells. Again, TCR signaling strength has been shown to play a role in this lineage 
choice (Singer et al., 2008; Starr et al., 2003) (Figure 1.2). During this stage, 
CD4+ T cell development is driven by stronger TCR signaling while CD8+ T cells 
develop from weaker TCR signals (Singer et al., 2008; Starr et al., 2003). For 
example, inhibition of extracellular signaling kinase (Erk) downstream of TCR 
signaling, promotes CD8+ T cell development while diminishing the development 
of CD4+ T cells (Sharp et al., 1997). Thus, the strength of the TCR signal plays a 
major role in T cell development and lineage differentiation, and 
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Figure 1.3: Positive and Negative Selection. DP thymocytes undergo positive 
and negative selection via TCR signaling. If a developing thymocyte receives 
strong TCR signaling, that cell undergoes negative selection and is deleted. If the 
cell receives no signaling, it dies from neglect. If a thymocyte receives weaker 
signaling, the T cell is positively selected.  
 
10
this role of TCR signaling may be important in the lineage decision of becoming a 
conventional or an innate T cell. 
Role of Tec Kinases in TCR Signaling and T Cell Development 
Inducible T cell kinase (Itk) and resting lymphocyte kinase (Rlk) are 
downstream of TCR signaling (Berg et al., 2005). They are members of the Tec 
family of non-receptor protein tyrosine kinases that is predominantly found in 
hematopoietic cells (Berg et al., 2005). This family consists of five members, 
Bruton’s tyrosine kinase (Btk), Itk, Rlk, tyrosine kinase expressed in 
hepatocellular carcinoma (Tec), and bone marrow tyrosine kinase in 
chromosome x (Bmx) (Berg et al., 2005). These kinases are structurally similar 
and contain a kinase domain, an SH2 domain, an SH3 domain, a Tec homology 
domain consisting of a Btk homology domain and a proline-rich region, and a 
pleckstrin homology domain. An exception to this structure is Rlk, which has a 
cysteine-string motif in place of the pleckstrin homology domain. This cysteine-
string is palmitoylated, and this palmitoylation results in Rlk being constitutively 
localized at the cell membrane (Berg et al., 2005) (Figure 1.4).  
Btk is a major component downstream of B cell receptor (BCR) signaling. 
To demonstrate the importance of Btk in B cells, humans deficient in Btk have 
defective B cell development resulting in X-linked agammaglobulinemia (XLA) 
(Vetrie et al., 1993). Similar defects are seen in xid mice that contain mutations 
within Btk although these mice have a less severe phenotype than XLA patients 
(Rawlings et al., 1993; Thomas et al., 1993). Additionally, Btk is expressed in 
11
 
 
Figure 1.4: Tec Family of Nonreceptor Protein Tyrosine Kinases. The Tec 
family of nonreceptor protein tyrosine kinases consists of five family members, 
Btk, Itk, Rlk, Tec, and Bmx. These proteins have a kinase domain, an SH2 
domain, an SH3 domain, a Tec homology domain consisting of a proline-rich 
region (PRR) and a Btk homology domain, and a pleckstrin homology domain. 
Rlk differs from other members of this family by having a cysteine string rather 
than a pleckstin homology domain.  
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mast cells and acts as a positive regulator of FcεR1 signaling in mast cells 
(Felices et al., 2007). Thus, mast cells deficient in Btk have defects in cytokine 
production and activation (Felices et al., 2007). Mast cells also express Itk, Rlk, 
and Tec (Felices et al., 2007). Intriguingly, data from our lab and others indicate 
a negative role for Itk in mast cell signaling by showing that Itk-deficient mast 
cells secrete increased amounts of cytokine upon stimulation (Iyer and August, 
2008). Further, Itk-deficient mast cells appear to have increased phospholipase 
Cγ1 (PLCγ1) phosphorylation (Iyer and August, 2008). These results are 
noteworthy since Itk has a positive role in αβ T cell receptor (TCR) signaling 
(Berg et al., 2005).  
Itk, Rlk, and Tec are expressed in αβ T cells, and all three kinases appear 
to have a positive role in TCR signaling (Berg et al., 2005). Itk phosphorylates 
PLCγ1 upon activation, and consequently, in the absence of Itk or both Rlk and 
Itk, PLCγ1 activation is decreased, leading to diminished Ca2+ flux and reduced 
mitogen-associated protein kinase (MAPK) activation (Berg et al., 2005) (Figure 
1.5). These decreases in TCR signaling result in defective nuclear factor for 
activated T cells (NFAT) and activator protein-1 (AP-1) activation. As a 
consequence, Itk and Rlk/Itk-deficient T cells produce little IL-2 and have 
reduced proliferation following activation (Berg et al., 2005). Interestingly, there 
appears to be a hierarchy in the importance of these kinases in T cells as follows: 
Itk > Rlk > Tec.  
Due to the defects in TCR signaling in Tec kinase-deficient mice, it was 
surprising that T cells developed in their absence. To determine if Itk had any 
13
 
 
 
Figure 1.5: TCR Signaling. Itk, Rlk, and Tec are downstream of the TCR. Upon 
TCR activation, leukocyte-specific protein tyrosine kinase (Lck) and zeta-chain-
associated protein kinase 70 (ZAP-70) activate Itk, which is recruited to the TCR 
signaling complex via SLP-76. Itk activates PLCγ1, which leads to calcium flux 
and PKC and MAPK activation. This results in gene transcription via AP-1 and 
NFAT in an activated T cell (Berg et al., 2005).  
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role in T cell development, our lab and others examined this issue in more detail. 
The two stages of T cell development where Itk potentially plays a role are at the 
DN stage during β selection and at the DP stage during positive and negative 
selection after α chain rearrangement. Our lab has previously described how the 
absence of Itk and Rlk/Itk affects β selection during T cell development (Lucas et 
al., 2007). We found that Itk, Rlk, and Tec are all expressed during the DN 
stages of T cell development; yet, Itk has the highest expression during all four 
stages (Lucas et al., 2007). Although we did not observe a block during the DN1 
and DN2 stages of development, there does appear to be a proliferation defect 
during the DN to DP transition (Lucas et al., 2007). After β selection, thymocytes 
undergo multiple rounds of proliferation as they transition to the DP stage. In Itk 
and Rlk/Itk-deficient thymocytes, this proliferative burst is slightly blunted (Lucas 
et al., 2007). Further, Itk-deficient thymocytes were not as effective as wild-type 
(WT) thymocytes at repopulating the DP and single-positive (SP) subsets during 
competitive repopulation assays (Lucas et al., 2007). Although this role may be 
small, these data indicate that Tec kinases do have a role in the transition of 
thymocytes from the DN to the DP stage of development. 
Although there are subtle effects of Itk and Rlk/Itk deficiency at the DN 
stage of T cell development, the role of Tec kinases in αβ T cell development is 
more obvious at the DP stage. Though lineage commitment of conventional αβ 
CD4+ or CD8+ T cells appears unchanged in the absence of Itk, there are 
alterations in positive and negative selection. For instance, when the major 
histocompatibility complex (MHC) class I restricted HY TCR transgenic line was 
15
crossed with Itk, Rlk or Rlk/Itk-deficient T cells, positive selection of HY+ CD8+ T 
cells in transgenic female mice was inhibited in the absence of Itk or Rlk/Itk 
(Schaeffer et al., 2000). Further, when HY male mice were examined, CD8+ T 
cells survived negative selection in the absence of Itk and Rlk/Itk by escaping 
death-inducing signals (Schaeffer et al., 2000).  
Our lab also examined positive selection in the absence of Itk using the 
MHC class II restricted TCR transgenic lines AND, 5C.C7 and 2B4. These TCRs 
are specific for same MHC/peptide antigen, moth cytochrome c (88-103), but 
have different avidities for their selecting ligand. Thus, these TCRs have different 
efficiencies of positive selection. Our lab found that T cells with the weakest 
avidity to moth cytochrome c, the 2B4 transgenic T cells, had a reduced T cell 
population in Itk-deficient mice when compared to WT mice (Lucas et al., 2002). 
Conversely, T cells with the highest avidity to moth cytochrome c, the AND 
transgenics, had comparable T cell populations when comparing Itk-deficient and 
WT mice (Lucas et al., 2002). Additionally, when the positive selection stage was 
examined via CD69, TCR, and HSA expression, it was discovered that Itk-
deficient thymocytes have a delay in positive selection (Lucas et al., 2002). 
Further, the marker for strength of TCR engagement, CD5, had lower expression 
on Itk-deficient T cells when compared to WT T cells (Lucas et al., 2002). Thus, 
the absence of Tec kinases in the TCR signaling cascade can influence positive 
and negative selection.  
In this thesis, I will examine the role of Itk in the development of innate αβ 
T cells. As Itk and Rlk have been shown to influence positive and negative 
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selection (Lucas et al., 2002; Schaeffer et al., 2000), Itk has the potential to play 
a role in the lineage decision to become an innate versus a conventional T cell. 
Previously, our lab and others have determined that CD8+ T cells deficient in Tec 
kinases have an innate phenotype (Atherly et al., 2006b; Broussard et al., 2006; 
Dubois et al., 2006; Hu et al., 2007; Weinreich et al., 2010). In this thesis, I will 
demonstrate that a CD4+ T cell population exists with characteristics similar to 
Itk-deficient CD8+ T cells. I will also investigate the mechanisms behind the 
development of Itk-deficient Eomesodermin+ (Eomes+) innate T cells. These 
mechanisms include MHC molecules required for the selection of innate T cells 
and the extrinsic factors required for the development of innate T cells. Our lab 
and others have seen defects in iNKT cell development and function (Au-Yeung 
and Fowell, 2007; Felices and Berg, 2008; Qi et al., 2012), and we have also 
observed that the γδ T cell population is affected by lack of Tec kinases (Felices 
et al., 2009; Qi et al., 2009; Yin et al., 2013). These subsets may contribute to the 
development of Eomes+ innate T cells by producing extrinsic factors, such as 
cytokines, that are required for the development of Eomes+ innate T cells 
(Verykokakis et al., 2010b; Weinreich et al., 2010). Additionally, there is a role for 
SLAM family signaling in the development of many innate T cells (Chung et al., 
2005; Horai et al., 2007; Nichols et al., 2005; Pasquier et al., 2005; Verykokakis 
et al., 2010b). Thus, it appears that the signals controlling lineage selection and 
fate may be more complicated than previously thought, with a combination of 
different signals affecting the outcome of T cell development. Additionally, I will 
examine the role of these innate cells during viral infections. Specifically, I will be 
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utilizing the lymphocytic choriomeningitis virus (LCMV) model to study the ability 
of Eomes+ innate CD8+ T cells to form protective memory responses. This model 
has been used to characterize the differentiation of conventional CD8+ T cells 
into memory cells. It is well documented that conventional αβ CD8+ T cells leave 
a pool of memory cells after a primary infection (Williams and Bevan, 2007). 
These memory T cells are able to respond more robustly and rapidly to a 
challenge infection (Williams and Bevan, 2007). We utilize the LCMV model to 
determine if Eomes+ innate CD8+ T cells can also form a memory pool that will 
have a more robust response upon a challenge infection. I will also use a P14 
TCR transgenic that is specific for the LCMV glycoprotein (GP33-41) to examine 
the role of Itk in memory differentiation of conventional T cells. 
This introduction is separated into two major sections. The first section will 
describe the innate T cells subsets that are discussed in this thesis. The second 
section will describe the requirements for and the differentiation of conventional 
memory CD8+ T cells. This section will also discuss the known roles of innate 
cells during acute infections. 
1. Development of Innate T Cell Subsets 
A. Eomesodermin+ CD8+ innate T cells 
 As described briefly above, conventional CD8+ T cells require the 
expression of class Ia MHC molecules on the thymic epithelium for their selection 
and development (Berg, 2007; Singer et al., 2008). Upon positive selection of a 
conventional CD8+ T cell, these cells undergo final maturation stages in the 
thymus to become naïve (CD44low CD62Lhigh) T cells before exiting the thymus 
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(Berg, 2007). Conversely, innate CD8+ T cells only require expression of class Ib 
MHC molecules on hematopoietic cells in the thymus for their development 
(Berg, 2007; Urdahl et al., 2002). Upon selection of innate CD8+ T cells, these 
cells maintain high levels of CD44 and CD62L as they exit the thymus, rendering 
them with a memory phenotype (Berg, 2007). Interestingly, in the absence of Itk 
and Rlk/Itk, the majority of CD8+ T cells have this innate phenotype and also 
express high levels of the T-box transcription factor, Eomes (Atherly et al., 
2006b; Nayar et al., 2012; Weinreich et al., 2010). Eomes functions similar to T-
bet, which is required for Th1 differentiation of CD4+ T cells (Szabo et al., 2002). 
Eomes and T-bet are both expressed in conventional CD8+ T cells and can 
regulate CD122 and IFNγ expression in CD8+ T cells (Intlekofer et al., 2005; 
Pearce et al., 2003). Additionally, Eomes can be induced by IL-4 and type I 
interferons (IFNs) (Marshall et al., 2010; Nayar et al., 2012; Oliver et al., 2012). 
However, unlike T-bet, Eomes is suppressed by IL-12 (Takemoto et al., 2006). 
This demonstrates that these T-box transcription factors can be differentially 
regulated in conventional CD8+ T cells.   
In addition to high Eomes expression, innate CD8+ T cells have high 
expression of the IL-2Rβ (CD122), of NK1.1, and of CXCR3 (Atherly et al., 
2006b; Broussard et al., 2006; Gordon et al., 2011; Nayar et al., 2012; 
Verykokakis et al., 2010b; Weinreich et al., 2010; 2009). Further these cells can 
produce IFNγ upon ex vivo stimulation (Atherly et al., 2006b; Broussard et al., 
2006; Gordon et al., 2011; Verykokakis et al., 2010b). Since IL-2Rβ is highly 
expressed on itk-/- innate Eomes+ CD8+ T cells, it is not surprising that the 
19
absence of IL-15 abrogated the survival of these innate T cells (Atherly et al., 
2006b). Intriguingly, this Eomes+ innate phenotype is not only found in the 
absence of Itk. It has also been discovered in the absence of the transcription 
factors Krüppel-like factor 2 (KLF2) and inhibitor of DNA binding 3 (Id3), the 
histone/protein acetyltransferase cAMP response element-binding protein 
(CREB) binding protein (CBP), and the TCR signaling mutant Src homomology 
2-domain-containing leukocyte phosphoprotein of 76 kDa (SLP-76)Y145F 
(Fukuyama et al., 2009; Gordon et al., 2011; Verykokakis et al., 2010b; 
Weinreich et al., 2009; 2010). 
PLZF+ CD3+ T cells produce IL-4 that converts conventional CD8+ T cells into 
Eomesodermin+ innate T cells 
Initially, it was thought that this Eomes+ innate phenotype of Itk-deficient 
CD8+ T cells was an intrinsic defect by use of fetal thymic organ cultures 
(FTOCs) and of bone marrow chimeras (Broussard et al., 2006). However, it was 
determined that this phenotype is partially due to reduced TCR signal strength 
combined with an increase in IL-4 signaling. In unequal mixed bone marrow 
chimeras, if KLF2, Itk, or Id3 deficient bone marrow is the majority (~85-95%) and 
WT bone marrow is the minority (~5-15%), the WT CD8+ T cells developing in 
these mixed chimeras express high levels of CD44, CD62L, CD122, and CXCR3 
(Verykokakis et al., 2010b; Weinreich et al., 2009; 2010). Further, culturing WT 
CD8+ T cell in vitro can induce Eomes expression via IL-4 signaling (Oliver et al., 
2012). Yet, our lab has determined via in vitro experiments that both weakened 
TCR signaling combined with IL-4 will optimally induce Eomes expression (Nayar 
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et al., 2012). In this experiment WT CD8+ T cells were cultured with the small 
molecule Itk inhibitor 10n in the presence of IL-4 (Nayar et al., 2012). Only in the 
weakest TCR signaling combined with IL-4 signaling was Eomes upregulated to 
optimal levels (Nayar et al., 2012). Thus, it was determined that an extracellular 
component combined with suboptimal TCR signaling was required for this innate 
Eomes+ T cell phenotype. 
Another interesting extracellular component occurring in the absence of Itk 
is an increase in hyper-immunoglobulinE (IgE) (Felices et al., 2009; Qi et al., 
2009). This hyper-IgE syndrome is due to an increase in IL-4 in the environment, 
which is produced by an increase in Itk-deficient γδ T cells (Felices et al., 2009; 
Qi et al., 2009). Additionally, innate Eomes+ T cells express high levels of the IL-
4Rα (CD124) (Weinreich et al., 2010). IL-4Rα is regulated by IL-4 signaling via 
STAT6 (Perona-Wright et al., 2010), therefore, IL-4 seemed a likely candidate to 
have an extracellular effect on developing innate CD8+ T cells. When KLF2 or Itk 
KO mice were crossed to IL-4Rα KO mice, the presence of innate Eomes+ CD8+ 
T cells was abrogated (Weinreich et al., 2010). Additionally, Id3 deficient mice 
were crossed to IL-4 deficient mice, which resulted in the absence of Eomes+ 
innate T cells (Verykokakis et al., 2010b). 
Recently, the transcriptional regulator promyelocytic leukemia zinc finger 
(PLZF) has been identified as a master regulator of iNKT cell development 
(Kovalovsky et al., 2008; Savage et al., 2008). This transcription factor is highly 
expressed during stage one and two of iNKT cell development, but expression of 
PLZF decreases as iNKT cells mature (Kovalovsky et al., 2008; Savage et al., 
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2011). PLZF is a broad-complex, tramtrack, bric à brac (BTB) or poxvirus (POZ) 
and zinc-finger (BTB/POZ-ZF) transcriptional regulator that allows iNKT cells to 
produce both IL-4 and IFNγ during development. This finding was determined by 
expressing PLZF under the CD4 promoter. PLZF transgenic cells were able to 
produce ample amounts of IL-4 and IFNγ (Raberger et al., 2008; Savage et al., 
2008). Hence, it was hypothesized that there is an increase in PLZF expressing 
cells in these various mutant mice (Itk KO, KLF2 KO, Id3 KO, CBP KO, and SLP-
76Y145F) that would promote increasd production of IL-4. This increase in IL-4 in 
the thymic environment would induce Eomes expression in CD8+ T cells.  
Plzflu/lu mice have a spontaneous mutation in PLZF that results in a 
nonsense codon that nullifies PLZF expression. KLF2, Itk, or Id3 KO or SLP-
76Y145F mice were crossed to these PLZF mutant mice, and indeed, the 
development of Eomes+ innate T cells was abolished (Gordon et al., 2011; 
Verykokakis et al., 2010b; Weinreich et al., 2010). Therefore, it was determined 
that PLZF+ CD3+ cells expand in the absence of Itk, KLF2, and Id3 and in the 
SLP-76Y145F signaling mutant and that these PLZF+ CD3+ cells produce abundant 
amounts of IL-4 (Gordon et al., 2011; Verykokakis et al., 2010b; Weinreich et al., 
2010). This increase in IL-4 is the extrinsic factor converting conventional αβ T 
cells into Eomes+ innate T cells (Figure 1.6). However, weakened TCR signaling 
and increased IL-4 in the environment should occur in order to induce optimal 
Eomes expression in innate T cells (Nayar et al., 2012).  
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Figure 1.6: Model of Innate versus Conventional CD8+ T cell Development. 
In WT mice, TCR signaling is intact and there is little IL-4 in the thymic 
environment. This leads to the inhibition of Eomes and the development of 
conventional T cells. In the absence of Itk, TCR signal strength is reduced. 
Additionally, we see an expansion in a CD3+ PLZF+ T cell population that 
produces IL-4. This combination leads to the development of Eomes+ innate 
CD8+ T cells.  
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Role of SLAM associated protein (SAP) in the development of Eomesodermin+ 
innate T cells 
 In the absence of the adaptor protein, SAP, Itk KO and Id3 KO Eomes+ 
innate T cells fail to develop (Horai et al., 2007; Verykokakis et al., 2010b). 
Originally, it was thought that SAP had a role in SLAM-family receptor signaling 
within the CD8+ T cells. However, in experiments performed with Id3 KO and 
SAP KO unequal mixed bone chimeras, it was determined that SAP expression, 
and thus SLAM-family receptor signaling, is not required for innate cells to 
express Eomes (Verykokakis et al., 2010b). However, in the absence of SAP, 
PLZF+ CD3+ thymocytes are diminished (Verykokakis et al., 2010b). 
Consequently, and similarly to iNKT cells, SAP is necessary for the development 
of PLZF+ CD3+ cells that convert conventional cells into Eomes+ innate T cells 
(Verykokakis et al., 2010b). Recently, some insight was gained into the SLAM-
family receptor that is regulating conventional versus innate T cell development. 
In the absence of Ly9 (CD229), Eomes+ innate CD8+ T cells develop (Sintes et 
al., 2013). Further, when Ly9 deficient mice are crossed to mice deficient in 
CD124, the development of these Eomes+ innate CD8+ T cells is abolished 
(Sintes et al., 2013). This is similar to results seen in Itk, KLF2, and Id3 deficient 
mice. The interplay between SLAM-family receptor and TCR signaling during 
innate T cell development needs to be further investigated.  
B. PLZF+ Vγ1.1+ Vδ6.3+ T cells 
 γδ T cells are a traditional example of an innate T cell. These cells have a 
very limited TCR repertoire, have an activated phenotype, and are able to mount 
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an effector response immediately upon antigen stimulation (Carding and Egan, 
2002). Various subsets of γδ T cells can be found in the skin, mucosal tissues, or 
circulating in the lymphatics (Carding and Egan, 2002). These cells can be the 
first line of defense upon infection (Carding and Egan, 2002; Ishikawa et al., 
2007; Wallace et al., 1995). Interestingly, some γδ T cells subsets only develop 
during fetal ontogeny while others develop in the postnatal thymus (Carding and 
Egan, 2002).  
 As described previously, γδ T cells bifurcate from αβ T cells during the DN 
stages of development, and one hypothesis of this divergence implicates TCR 
signaling (Lauritsen et al., 2006). Interestingly, in the Itk, KLF2, and Id3 KOs and 
in the SLP-76Y145F signaling mutant, there is an increase in a population of γδ T 
cells expressing PLZF (Alonzo et al., 2010; Felices et al., 2009; Gordon et al., 
2011; Odumade et al., 2010; Verykokakis et al., 2010a). Additionally, these cells 
have an invariant TCR expressing Vγ1.1 and Vδ6.3 and produce IL-4 upon ex 
vivo stimulation (Alonzo et al., 2010; Felices et al., 2009; Gordon et al., 2011; 
Odumade et al., 2010; Qi et al., 2009; Verykokakis et al., 2010a). Thus, this 
subset of γδ T cells has been described as γδ NKT cells. Recent data from our 
lab demonstrates that these γδ NKT cells follow a similar developmental path as 
αβ iNKT cells and develop both fetally and postnatally (Yin et al., 2013). 
Interestingly, when Itk KO mice are crossed to TCRδ KO mice, the spontaneous 
hyper-IgE syndrome seen in Itk KOs is abrogated (Felices et al., 2009; Qi et al., 
2009). Thus, this data demonstrate the γδ NKT cells that expand in the absence 
of Itk are able to influence their environment. Therefore, these γδ NKT cells are 
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hypothesized to induce Eomes expression in conventional T cells, which would 
convert conventional αβ T cells into innate αβ T cells (Alonzo and Sant'Angelo, 
2011).  
C. Invariant natural killer (iNKT) cells 
The canonical invariant natural killer T (iNKT) cells are innate lymphocytes 
characterized by their invariant TCRα chain and the ability to secrete both IL-4 
and IFNγ upon stimulation (Kronenberg, 2005; Kronenberg and Engel, 2007). 
The invariant TCR expressed by iNKT cells utilizes mouse Vα14-Jα18 paired 
with either Vβ8.2, Vβ7, or Vβ2 or human Vα24-Jα18 paired with Vβ11 
(Kronenberg, 2005; Kronenberg and Engel, 2007). This TCR is specific for 
glycolipids bound to the MHC class Ib molecule CD1d (Kronenberg, 2005; 
Kronenberg and Engel, 2007). This glycolipid specificity includes the self-
glycosphingolipid iGB3 (Kronenberg, 2005; Kronenberg and Engel, 2007). In 
addition, iNKT cells have the ability to produce tumor necrosis factor (TNF), IL-2, 
IL-4, IL-13, IL-10, IL-5, IL-9, IL-12p70 and granulocyte-macrophage colony-
stimulating factor (GM-CSF) (Kronenberg, 2005; Kronenberg and Engel, 2007). 
Finally, these lymphocytes reside predominantly in the thymus, spleen, liver and 
bone marrow and are rarely detected in the lymph nodes or intestine 
(Kronenberg, 2005; Kronenberg and Engel, 2007).  
During development, iNKT cell precursors undergo three distinct stages of 
development that is characterized by cell surface marker expression and 
cytokine production. Stage one of iNKT cell development consists of thymocytes 
that are HSAhigh CD4high CD8- and lack expression of NK1.1 or CD44 and 
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produce IL-4 upon stimulation (Kronenberg, 2005; Kronenberg and Engel, 2007). 
Stage two of iNKT cell development is marked by upregulation of CD44 and 
downregulation of HSA, and stage three iNKT cells upregulate additional surface 
markers characteristic of iNKT cells, i.e. NK1.1 and CD69 (Kronenberg, 2005; 
Kronenberg and Engel, 2007). As iNKT cells mature, they undergo a switch in 
cytokine production. For example, immature iNKT cells produce high levels of IL-
4, and as iNKT cells mature, they produce higher levels of IFNγ but lower levels 
of IL-4 (Kronenberg, 2005; Kronenberg and Engel, 2007). Additionally, NK1.1- 
thymocytes expressing the mVα14-Jα18 TCR migrate into the periphery and 
later mature into NK1.1+ iNKT cells (Kronenberg, 2005; Kronenberg and Engel, 
2007). 
Role of TCR and SLAM Family Signaling in iNKT Cell Development 
Although it appears that a high threshold of TCR signaling is required for 
the development of iNKT cells (Moran et al., 2011), TCR signaling requirements 
between iNKT and conventional T cells appear to differ beyond this threshold. 
The Src kinase, Fyn, is required for iNKT cell development but has been shown 
to be dispensable for conventional T cell development (Gadue et al., 1999). 
Further, Fyn may have a role in iNKT cell development prior to TCR expression 
on developing NKT cells. This role of Fyn was suggested by studies in which 
Vα14 TCR transgenic mice were crossed to Fyn deficient mice (Gadue et al., 
2004). In these mice, the development of iNKT cells was restored (Gadue et al., 
2004). Interestingly, Fyn has been found to interact with SAP, the adaptor protein 
downstream of the SLAM family receptors (Latour et al., 2003). Not surprisingly, 
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the SLAM family of immune receptor proteins, specifically SLAMF1 and SLAMF6, 
have been implicated in the development of iNKT cells (Griewank et al., 2007). 
The requirement of SAP in this signaling cascade is exemplified by the defective 
development of iNKT cells in mice and humans deficient in SAP (Chung et al., 
2005; Nichols et al., 2005; Pasquier et al., 2005). Thus, the role of Fyn in iNKT 
cell development may be associated more with SLAM signaling than with a role 
downstream of the TCR, which may occur prior to TCR signaling during iNKT cell 
development.  
As described above, PLZF has been identified as a master regulator of 
iNKT cell development (Kovalovsky et al., 2008; Savage et al., 2008). Again, 
PLZF is highly expressed during stages one and two of iNKT cell development, 
but expression of PLZF decreases as iNKT cells mature (Kovalovsky et al., 2008; 
Savage et al., 2008). Therefore, although Fyn deficient liver iNKT cells express 
similar levels of PLZF as WT iNKT cells (Kovalovsky et al., 2008), it remains 
possible that PLZF expression may be decreased in immature thymic iNKT cells 
in Fyn deficient mice. However, iNKT cells deficient in SAP arrest at an early 
stage of development, and these arrested cells express PLZF (Savage et al., 
2008). Therefore, expression of PLZF is not dependent upon SLAM family 
signals and is most likely induced by strong TCR signals. Although this has not 
been directly shown for iNKT cells, strong TCR signaling has been shown to 
induce the expression of PLZF in γδ NKT cells. For example, when various γδ 
subsets were stimulated through their TCR on OP9-DL1 cell cultures, PLZF was 
expressed (Kreslavsky et al., 2009). Further, Vγ1.1+ Vδ6.3+ T cells express 
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higher levels of CD5 compared to Vγ1.1- Vδ6.3- T cells (Kreslavsky et al., 2009). 
This result demonstrates that γδ NKT cells receive stronger TCR signals during 
development, and that this stronger signal may induce the expression of PLZF.  
The Role of Itk in iNKT Cell Development and Function 
Previously, our lab and others have determined that Itk is important in 
iNKT cell development (Au-Yeung and Fowell, 2007; Felices and Berg, 2008; 
Gadue and Stein, 2002). This finding is interesting since Itk has been implicated 
in the development of conventional versus innate αβ T cells (Atherly et al., 
2006b; Broussard et al., 2006; Hu and August, 2008; Weinreich et al., 2010). 
Overall iNKT percentages and numbers are significantly decreased in Itk-
deficient mice in comparison to WT mice, and these decreases have been seen 
at both HSAhigh and HSAlow stages of development (Au-Yeung and Fowell, 2007; 
Felices and Berg, 2008). This result indicates that Itk may influence iNKT cell 
development prior to TCR expression (Felices and Berg, 2008). This potential 
role of Itk being independent of TCR signaling may be that Itk interacts with Fyn 
downstream of SLAM signaling prior to TCR expression. To date, Itk-deficient 
mice have not been crossed to Vα14 TCR transgenic mice to determine if the 
development of iNKT cells can be rescued, similarly to Fyn deficient mice. Thus, 
Itk may be required to promote PLZF expression downstream of SLAM-family 
signaling during iNKT cell development.  
 Upon stimulation through the TCR, Itk-deficient iNKT cells produce little IL-
4 or IFNγ (Au-Yeung and Fowell, 2007; Felices and Berg, 2008). However, when 
the requirement for Itk is bypassed using phorbol myristate acetate (PMA) and 
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ionomycin, cytokine production by itk-/- iNKT cells can be detected (Felices and 
Berg, 2008). We found that a higher proportion of Itk-deficient iNKT cells produce 
IL-4 instead of IFNγ (Felices and Berg, 2008). This result demonstrates the role 
for Itk in iNKT cell maturation. Nonetheless, Itk does not appear to be involved in 
the basal transcription of cytokine genes by iNKT cells since cytokine mRNA 
levels appear to be similar between itk-/- and WT iNKT cells (Au-Yeung and 
Fowell, 2007), and we did not find a role for Itk in the proliferation of iNKT cells 
(Felices and Berg, 2008). These data indicate a predominant role for Itk in the 
maturation, survival, and maintenance of iNKT cells. 
D. Mucosal-associated invariant T (MAIT) cells 
 Mucosal-associated invariant T (MAIT) cells are a subset of innate T cells 
that preferentially home to the mesenteric lymph node (mLN), gut lamina propia 
(LP), the liver, and the lung (Treiner et al., 2003). Although these cells are 
functionally and phenotypically similar to iNKT cells, they express the invariant 
TCR Vα19-Jα33 in mice or Vα7.2-Jα33 in humans and utilize the non-classical 
MHC-related molecule 1 (MR1) for their selection (Treiner et al., 2003). MAIT 
cells can be DN, CD4+ or CD8+ and can produce TNF, IL-17, IL-4, IL-5 IL-10, and 
IFNγ upon stimulation (Dusseaux et al., 2011; Gold et al., 2010; Kawachi et al., 
2006; Treiner et al., 2003). These cells tend to respond to bacterially, but not 
virally, infected cells (Dusseaux et al., 2011; Gold et al., 2013; 2010; Le Bourhis 
et al., 2010). This response to bacterial antigens may explain the requirement of 
commensal flora for the peripheral expansion of MAIT cells (Treiner et al., 2003). 
While iNKT cells can be found in the periphery of germ-free mice, MAIT cells are 
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absent (Treiner et al., 2003). Additionally, MAIT cells require the presence of B 
cells for their peripheral expansion. For instance, MAIT cells are absent in mice 
deficient in the immunoglobin heavy chain, and further, XLA patients deficient in 
Btk have reduced MAIT cells (Treiner et al., 2003). The Lantz group further 
investigated this role for B cells in MAIT cell peripheral expansion. In these 
experiments, splenic B cells were transferred into Vα19-Jα33 transgenic mice 
deficient in Rag. Remarkably, MAIT cell expansion in the periphery was restored 
(Martin et al., 2009). This restoration occurred even in the absence of MR1 
expression on the peripheral B cells (Martin et al., 2009). This suggests a role for 
MR1 in the thymic selection of MAIT cells; however, in the periphery, MR1 is 
irrelevant although B cells are necessary for MAIT cells to survive and expand. 
 Despite these key differences between iNKT and MAIT cells, these cell 
types may share developmental and transcriptional pathways. For example, 
human MAIT cells have been to shown to express PLZF, the master 
transcriptional regulator of iNKT cell development (Martin et al., 2009; Savage et 
al., 2008). However, mouse MAIT cells do not appear to express this key 
transcription factor (Martin et al., 2009). Although, both iNKT and human MAIT 
cells express PLZF, MAIT cells do not require SLAM-family receptor signals like 
iNKT cells (Chung et al., 2005; Griewank et al., 2007; Nichols et al., 2005; 
Pasquier et al., 2005). This was exemplified by demonstrating that while XLP 
patients lack iNKT cells, MAIT cells expressing PLZF were easily found in 
peripheral blood (Martin et al., 2009). This further demonstrates that TCR signals 
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are most likely regulating the expression of PLZF; therefore, SLAM-family 
receptor signaling is dispensable for PLZF induction. 
E. Thymocyte-selected CD4+ (T-CD4) cells 
Another subset of innate CD4+ T cells, called ‘thymocyte-selected CD4+ 
cells’ (T-CD4), has been described (Choi et al., 2005; Li et al., 2005). This subset 
involves MHC class II expression on thymocytes to positively select T-CD4 cells 
(Choi et al., 2005; Li et al., 2005). Although human thymocytes naturally express 
MHC class II, mouse thymocytes do not. In order to study T-CD4 cells in a 
mouse model, MHC class II was expressed on thymocytes via transgene-driven 
expression of CIITA on DP thymocytes (Choi et al., 2005; Li et al., 2005). This 
transgenic mouse was crossed to a MHC class II deficient mouse to obtain CD4+ 
T cells that were selected solely on hematopoietic cells (Choi et al., 2005; Li et 
al., 2005). The CD4+ T cells that emerged from these mice had an activated 
phenotype and were found to express PLZF (Lee et al., 2010; Min et al., 2011). 
Since these cells were selected on hematopoietic cells rather than thymic 
epithelial cells, they were termed thymocyte-selected CD4+ T (T-CD4) cells. 
Additionally, when CIITA transgenic and SAP deficient bone marrow were 
transferred into a MHC class II KO host in a mixed bone marrow chimera, 
thymocytes deficient in SAP failed to develop T-CD4 cells (Li et al., 2007). This 
result demonstrates a requirement for SAP in the development of T-CD4 cells, 
which indicates that T-CD4 cells may develop similarly to γδ NKT and iNKT cells 
(Li et al., 2007). Another aspect of T-CD4 cells that resembles iNKT cells is that 
strong TCR signaling promotes the development of T-CD4 cells. Using the 
32
Nur77GFP reporter, it was demonstrated that T-CD4 cells receive stronger TCR 
signals than conventional CD4+ T cells (Qiao et al., 2012). This result resonates 
with the increased expression of Nur77GFP seen in iNKT cells when compared to 
conventional CD4+ T cells (Moran et al., 2011).  Again, we see results 
demonstrating that strong TCR signals induce PLZF expression.   
Another aspect of these CIITA transgenic mice that resembles the innate 
T cell phenotype of Itk, KLF2, or Id3 KOs and the SLP-76Y145F signaling mutant, 
are the CD8+ T cells. When these cells were examined in CIITA transgenic mice, 
they were found to express Eomes (Min et al., 2011). Further, when the CIITA 
transgenic mice were crossed to IL-4 KO mice, the development of Eomes+ 
innate CD8+ T cells was abrogated (Min et al., 2011). Therefore, we see that T-
CD4 cells can influence the development of conventional cells similarly to the 
affects that PLZF+ CD3+ T cells have on CD8+ T cells in Itk, KLF2, and Id3 KO 
mice and the SLP-76Y145F mutant mouse (Gordon et al., 2011; Min et al., 2011; 
Verykokakis et al., 2010b; Weinreich et al., 2010).  
One intriguing possibility that the CIITA transgenic model presents is that 
the development of innate T cells is part of a physiological process seen in 
humans. For instance PLZF+ T-CD4 cells can be found in mice reconstituted with 
human cord blood (Lee et al., 2010). Additionally, PLZF+ T-CD4 cells are found in 
the fetal thymi and spleen of humans (Lee et al., 2010), and Eomes+ innate T 
cells have been found in the fetal spleen of humans (Min et al., 2011). Hence, the 
development of these innate T cells may be a natural process in humans set in 
place for the protection of the fetus and neonates. 
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2. T Cell Responses to Infection 
With the recent findings of these innate subsets of cells, a major question 
remaining is how do these innate T cells respond to a pathogen? Some 
information of these various subsets of innate cells and their roles in infection is 
available (Carding and Egan, 2002; Gold and Lewinsohn, 2013; Harding and 
Kubes, 2012; Kronenberg and Kinjo, 2009; Wallace et al., 1995). However, there 
is little information on how Eomes+ innate CD8+ T cells respond during a viral 
infection. Therefore, a goal of this thesis was to determine the ability of Eomes+ 
innate CD8+ T cells to form protective responses to viral infections. 
Conventional CD8+ T cells are able to respond and clear acute viral 
infections. During the primary response, memory CD8+ T cells are generated, 
and these memory T cells are able to respond more rapidly and robustly to a 
challenge infection (Williams and Bevan, 2007). This is thought to be one of the 
defining attributes of adaptive immunity versus innate immunity: conventional 
lymphocytes can form memory responses to a pathogen while innate immune 
cells cannot. For years, the requirements for memory formation have been 
studied. While B cells, CD4+ T cells, and CD8+ T cells have all been studied, the 
focus in this thesis will be on memory CD8+ T cells. For example, help from CD4+ 
T cells has been shown to be required for the generation of memory CD8+ T 
cells. When WT mice were depleted of CD4+ T cells or mice deficient in CD4 or 
MHC class II were infected with a variety of pathogens, CD8+ T cells fail to 
expand and have diminished IFNγ production and cytolytic function upon 
challenge (Janssen et al., 2003; Shedlock and Shen, 2003; Sun and Bevan, 
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2003). These defects occurred when CD4+ T cells were absent during the 
priming and acute phase of infection rather than when CD4+ T cells were absent 
during the recall response (Sun and Bevan, 2003). Thus, when examining the 
CD8+ T cell responses in the absence of Itk, it is important to understand how the 
absence of Itk influences CD4+ T cell differentiation.  
A. Differentiation of CD4+ T Cells 
 T cells expressing a TCR with a higher affinity for MHC class II that induce 
a high threshold of TCR signaling during positive selection develop into CD4+ T 
cells (Singer et al., 2008; Starr et al., 2003). These cells are a major component 
of the immune system, which is demonstrated by their ability to trigger antibody 
responses. Additionally, as previously described, memory formation of CD8+ T 
cells is impaired in the absence of CD4+ T cells (Bourgeois et al., 2002; Janssen 
et al., 2003; Shedlock and Shen, 2003; Sun and Bevan, 2003). Following antigen 
recognition, it was traditionally thought that CD4+ T cells have the ability to 
differentiate into T helper 1 (Th1) and T helper 2 (Th2) cells. Th1 cells are 
characterized by their ability to secrete IFNγ, IL-2, and LTα (Zhu and Paul, 2008). 
These cells differentiate under the control the transcription factor T-bet, and are 
required for the clearance of intracellular pathogens, such as Listeria 
monocytogenes, Toxoplasma gondii and Leishmania major (Zhu and Paul, 
2008). Th2 cells secrete IL-4, IL-5, IL-13, and IL-10 and are controlled by the 
transcription factor GATA-3 (Zhu and Paul, 2008). These cells are required for 
the clearance of extracellular pathogens, such as Schistosoma mansoni and 
Nippostrongylus brasiliensis (Zhu and Paul, 2008). In addition, Th2 cells have 
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been implicated in allergy and asthma disorders, which highlight the importance 
of controlling the regulation of Th2 cells (Zhu and Paul, 2008). In addition to Th1 
and Th2 CD4+ T cells, Th17 cells have been described. This subset of CD4+ T 
cells have been implicated in autoimmune disease, such as experimental 
autoimmune encephalomyelitis (EAE); however, Th17 cells may promote the 
clearance of fungal and extracellular bacterial infections (Zhu and Paul, 2008). 
Th17 cells secrete IL-17A, IL-17F, and IL-21 and are characterized by the 
transcription factor, RORγT (Zhu and Paul, 2008). Further, TGFβ and IL-6 have 
been found to play a major role in the differentiation of Th17 cells (Zhu and Paul, 
2008). Thus, a number of factors regulate the differentiation of CD4+ T cells upon 
activation.  
The Role of Tec Kinases in T Helper Cell Differentiation 
 The role of Tec kinases has been examined in the differentiation of Th1, 
Th2, and Th17 cells. Although Itk-deficient mice succumb to infection with T. 
gondii (Schaeffer et al., 1999), in vitro studies demonstrate that Itk-deficient CD4+ 
T cells preferentially differentiate into Th1 cells (Miller et al., 2004). This 
preference is due to disregulated expression of the transcription factor T-bet 
(Miller et al., 2004). Although Itk-deficient CD4+ T cells can be forced into the Th2 
lineage in vitro, these CD4+ T cells continue to have defects in IL-4 production 
upon secondary stimulation (Au-Yeung et al., 2006). Thus, Itk may be required 
for Th2 differentiation in combination with a role for Itk in the suppression of T-
bet. This could explain why Itk-deficient CD4+ T cells have defects in Th2 effector 
function upon secondary stimulation. Supporting this notion, Itk-deficient mice are 
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unable to mount the appropriate Th2 response to parasites, such as S. mansoni, 
N. brasiliensis, and fail to make the characteristic Th2 response against L. major 
in Balb/c mice (Fowell et al., 1999; Schaeffer et al., 2001). Intriguingly, evidence 
for the regulation of T-bet by Itk has been reported (Hwang et al., 2005). In 
addition to its regulation of T-bet, Itk has been shown to promote NFATc 
translocation (Fowell et al., 1999), which is a transcription factor required for IL-4 
production. In striking contrast to the role of Itk in T helper cell differentiation, Rlk 
appears to have a role in Th1 differentiation, which may in part explain the strong 
preference of Itk-deficient CD4+ T cells to differentiate into the Th1 lineage. Rlk is 
expressed in Th1 cells as early as 24 hours post-stimulation (Miller et al., 2004). 
Further, when Rlk/Itk-deficient mice are infected with S. mansoni, an appropriate 
Th2 response occurs, rather than the nonprotective Th1 response seen in mice 
deficient only in Itk (Schaeffer et al., 2001). Thus, with the current data available, 
the role of Itk and Rlk in the differentiation of T helper cells involves a complex 
network, and further investigation is required to understand how Itk regulates T-
bet and GATA-3 in an in vivo system.  
Additionally, the Tec family of kinases may also regulate the differentiation 
of Th17 cells. In the absence of Itk, CD4+ T cells that are differentiated into Th17 
cells in vitro have diminished IL-17A, but not IL-17F, production (Gomez-
Rodriguez et al., 2009). This skewing of IL-17 was also seen in vivo using a 
mouse model of asthma. When Itk KO mice were immunized with OVA, 
transcripts of IL-17A, but not IL-17F, were reduced in the lungs of Itk-deficient 
mice when compared to transcripts in the lungs of WT mice (Gomez-Rodriguez 
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et al., 2009). This reduced production of IL-17A was also seen when calcineurin 
inhibitors were used. Further, when Itk-deficient CD4+ T cells were retrovirally 
transduced with a vector containing NFATc1, IL-17A production is restored 
(Gomez-Rodriguez et al., 2009). Thus, the regulation of NFAT by Itk may 
regulate multiple differentiation pathways in CD4+ T cells.  
 To complicate matters further, Itk and Rlk/Itk-deficient mice also have a 
subset of innate CD4+ T cells that develop in the thymus. These CD4+ T cells 
have an activated phenotype, including the expression of high levels of CD44 
and CD122, and can secrete IL-4 and IFNγ immediately upon ex vivo stimulation 
(Hu and August, 2008); T-bet has also been found to be upregulated in Itk-
deficient CD4+ T cells with this innate phenotype (Hu and August, 2008). This 
may help explain why Itk-deficient CD4+ T cells preferentially differentiate into 
Th1 cells upon antigen stimulation and why Itk-deficient mice succumb to Th2 
mediated infections.  
 Interestingly, the innate phenotype of CD4+ T cells is not seen in Itk-
deficient mice crossed to the 5C.C7 TCR transgenic line (Miller et al., 2004). This 
is similar to the findings with itk-/- innate CD8+ T cells. In these studies, we 
observed that OT-I TCR transgenic itk-/- CD8+ T cells develop into conventional T 
cells (Atherly et al., 2006b). These data suggest that expression of these 
transgenic TCRs induces stronger signaling during development, thus 
overcoming the defects leading to innate T cell lineage commitment. This 
hypothesis is supported by data showing that in CD4+ T cells expressing a 
kinase-dead mutant of Itk, these innate CD4+ T cells develop (Hu and August, 
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2008). Thus, strong TCR signaling promoted by Itk, rather the role of Itk in TCR 
scaffolding, inhibits the development of innate cells in the thymus.  
B. Differentiation of CD8+ T cells 
 As briefly described above, upon antigen stimulation, CD8+ T cells are 
activated and differentiate into cytolytic effectors that are able to clear 
intracellular pathogens. Signals required for this differentiation include TCR, co-
receptor, and cytokine signaling (Williams and Bevan, 2007; Williams et al., 
2006a). After pathogen clearance, a pool of memory CD8+ T cells is retained that 
are able to respond more rapidly and robustly upon a challenge infection 
(Williams and Bevan, 2007) (Figure 1.7). The presence of CD4+ T cells during 
the acute phase of infection is thought to be vital to the efficient generation of 
memory CD8+ T cells. However, when CD8+ T cells from infected WT or MHC 
class II deficient mice are transferred into infection-matched WT hosts at eight 
days post-infection with LCMV, maintenance and cytokine function of memory 
CD8+ T cells primed in the absence of CD4 help was restored (Sun et al., 2004). 
Additionally, WT CD8+ T cells primed in the presence of CD4 help lost protective 
responses when transferred into MHC class II deficient mice hosts at eight days 
post-infection with LCMV (Sun et al., 2004). Thus, the role of CD4 help may be 
more important for the maintenance of memory rather than the priming of 
memory T cells.  
Regardless of CD4 help being required for the priming of naïve CD8+ T 
cells or for the maintenance of memory CD8+ T cells, one aspect of help provided 
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Figure 1.7. Model of Conventional Memory CD8+ T Cell Formation. Upon 
infection, CD8+ T cells are activated via signaling through their TCR, co-
stimulation molecules, and cytokine signaling. As the viral load increases, 
conventional CD8+ T cells are primed to respond and clear the antigen. However, 
a memory T cell pool remains that is able to respond more robustly and rapidly 
upon challenge. During the priming, CD8+ T cells require IL-2 signaling and help 
from CD4+ T cells to generate protective memory CD8+ T cells that are able to 
respond to a challenge (Williams and Bevan, 2006). 
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by CD4+ T cells is CD40-CD40L interactions. This is thought to promote the 
differentiation of memory CD8+ T cells. For instance, CD40 was shown to be 
expressed in CD8+ T cells, and in fact, memory CD8+ T cells deficient in CD40 
have reduced cytokine production (Bourgeois et al., 2002). Further, if CD40L is 
blocked in vitro, the cytolytic function of CD8+ T cells is reduced (Schoenberger 
et al., 1998). Interestingly, if anti-CD40 stimulation is provided in CD4+ T cell 
depleted mice or mice deficient in MHC class II during immunization, cytolytic 
function of “helpless” CD8+ T cells is restored (Bennett et al., 1998; 
Schoenberger et al., 1998). However, it is unclear if these CD40-CD40L 
interactions occur directly between CD4+ and CD8+ T cells or if CD4+ cells 
interact with CD8+ T cells via dendritic cells, which would result in a three-way 
cell interaction. Recent data suggests that primed CD4+ T cells are able to 
directly interact with CD8+ T cells (Ahmed et al., 2012).  
 Another role for CD4+ T cells to provide help to CD8+ T cells is through 
cytokine signaling. IL-2 is crucial for the proper differentiation of memory CD8+ T 
cells. Although studying the effect of IL-2 on the generation of memory CD8+ T 
cells has been challenging due to autoimmune disorders in mice deficient in IL-2 
and IL-2Rα mice, the Bevan group used a mixed bone marrow chimera strategy 
to examine memory CD8+ T cells lacking IL-2 signals (Williams et al., 2006b). In 
this study, WT and IL-2Rα bone marrow was transferred into an irradiated host. 
After reconstitution, the host was infected with LCMV. In these mixed bone 
marrow chimeras, the long-term maintenance of IL-2Rα-deficient memory CD8+ 
T cells was reduced (Williams et al., 2006b). Additionally, IL-2Rα-deficient 
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memory CD8+ T cells failed to expand upon challenge (Williams et al., 2006b). 
These results were not due to an altered TCR repertoire of IL-2Rα-deficient CD8+ 
T cells since similar results were seen when using P14 transgenic T cells 
deficient in IL-2Rα (Williams et al., 2006b). P14 transgenic T cells recognize the 
GP33-41 epitope of the LCMV glycoprotein. These studies by the Bevan group also 
examined WT and IL-2-deficient CD8+ T cells using mixed bone marrow 
chimeras. In this system, CD8+ T cells deficient in IL-2 generated memory CD8+ 
T cells that were able to respond adequately to a challenge stimulation (Williams 
et al., 2006b). Therefore, paracrine signaling of IL-2 is sufficient to induce the 
generation of memory CD8+ T cells, and CD4+ T cells could provide help to 
memory CD8+ T cells via IL-2.  
 Additionally, other cytokines have been recognized to be important for the 
maintenance of memory CD8+ T cells. Mice deficient in CD127 (IL-7Rα) and IL-
2Rβ were found to have a decrease in the maintenance of memory CD8+ T cells 
(Becker et al., 2002; Kaech et al., 2003). When P14 transgenic T cells were 
transferred into IL-15 deficient mice and given an IL-7 blocking antibody, the 
maintenance of memory CD8+ T cells was abolished (Kaech et al., 2003). 
However, the absence of IL-15 did not appear to influence the acute phase of the 
CD8+ T cell response to LCMV (Becker et al., 2002). Interestingly, it was found 
that antigen-specific T cells that are CD127high and KLRG1low are more likely to 
form long-lasting memory T cells (Joshi et al., 2007). Additionally, these cells 
produced more IL-2 and were more resistant to apoptosis during the contraction 
phases of an infection (Joshi et al., 2007). Thus, this subset of antigen specific 
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cells became known as memory precursor effector cells (MPECs). Conversely, a 
short-lived effector cell (SLEC) subset was also characterized in this study. 
SLECs are CD127low KLRG1high and are regulated by T-bet and IL-12 (Joshi et 
al., 2007). In the absence of T-bet, SLECs failed to differentiate during infection, 
and this was also seen in the absence of the transcriptional repressor B 
lymphocyte-induced maturation protein 1 (Blimp1) (Joshi et al., 2007; 
Rutishauser et al., 2009). Antigen-specific CD8+ T cells in Blimp1 deficient mice 
also had reduced expression of T-bet while having increased expression of 
Eomes and the transcriptional regulator B-cell lymphoma 6 (Bcl6) when 
compared to WT antigen-specific CD8+ T cells (Kallies et al., 2009). Interestingly, 
Blimp1 can negatively regulate Bcl6, and vice versa, in B cells and CD4+ T cells 
(Crotty et al., 2010). Thus, it appears that the interplay between these two 
transcriptional regulators continues in CD8+ T cells. Hence, it was thought that T-
bet and Blimp1 controlled the differentiation of effector T cells while Eomes and 
Bcl6 were involved in the differentiation of memory T cells. 
 Bcl6 is a member of the BTB/POZ-ZF family of transcription factors, which 
is the same family of transcriptional regulators as PLZF (Beaulieu and 
Sant'Angelo, 2011; Lee and Maeda, 2012). In CD8+ T cells, Bcl6 was found to 
promote the expansion of memory phenotype cells, specifically central memory T 
(Tcm) cells. Central memory CD8+ T cells are characterized by their expression of 
CD44, CD62L, CCR7, CD27, and CXCR3 (Williams and Bevan, 2007). This 
subset of memory cells is also characterized by production of IL-2 and by rapid 
proliferation upon antigen stimulation (Williams and Bevan, 2007). The regulation 
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of memory phenotype CD8+ T cells was determined through the use of a Bcl6 
deficient mouse and through the use of a Bcl6 transgenic mouse that expresses 
Bcl6 under the lck proximal promoter (Ichii et al., 2002). In the absence of Bcl6, 
there was a decrease in CD44high CD122high and CD44high CD62Lhigh memory 
CD8+ T cells (Ichii et al., 2002; Ichii et al., 2004). Conversely, there was an 
increase in these memory phenotype CD8+ T cells in the Bcl6 transgenic (Ichii et 
al., 2002; Ichii et al., 2004). Additionally, when WT or Bcl6 transgenic OT-I CD8+ 
T cells were immunized in vivo with OVA-pulsed dendritic cells or recombinant 
vaccinia virus expressing ovalbumin (rVV-OVA), Bcl6 transgenic CD8+ T cells 
had an increase in antigen-specific T cells when compared to WT CD8+ T cells 
(Ichii et al., 2002; Ichii et al., 2004). Despite this increase in antigen-specific T 
cells, granzyme B expression and cytolytic function of Bcl6 transgenic CD8+ T 
cells is reduced when compared to WT CD8+ T cells. However, IFNγ, IL-2, and 
perforin appear to by regulated independently of Bcl6 (Yoshida et al., 2006). 
These results suggest that Bcl6 may also negatively regulate effector memory T 
(Tem) differentiation. Tem are characterized by their high expression of CD44 and 
low expression of CD62L (Williams and Bevan, 2007). Additionally, these cells 
express high levels of KLRG1 but are low for CXCR3, CD27, and CD127 
(Williams and Bevan, 2007). Tem cells are more robust at exerting their effector 
functions upon antigen stimulation when compared to Tcm cells (Williams and 
Bevan, 2007). Thus, these studies suggest that Bcl6 promotes Tcm differentiation 
while inhibiting Tem differentiation. This is interesting since Blimp1 deficient CD8+ 
T cells are defective in the Tem formation. However, Blimp1 deficient CD8+ T cells 
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also have been found to have a reduction in granzyme B expression, which is 
uncharacteristic of Tem cells (Kallies et al., 2009).Thus, regulation of Bcl6 and 
Blimp1 in CD8+ T cells may be more complex than originally thought.  
 In addition to Bcl6 promoting memory CD8+ T cell differentiation, it is 
thought that Eomes also plays a role in differentiation of memory CD8+ T cells. 
Eomes was originally described to regulate effector functions of CD8+ T cells 
similarly to T-bet (Pearce et al., 2003). Since T-bet was the T-box transcription 
factor associated with SLEC formation (Joshi et al., 2007), it was thought that 
Eomes would then be the T-box transcription factor involved in MPEC formation. 
In fact, it appeared that Eomes was more highly expressed than T-bet in memory 
T cells compared to effector T cells (Intlekofer et al., 2005). Further, it was 
determined that IL-12 negatively regulates Eomes expression in P14 transgenic 
model utilizing recombinant L. monocytogenes expressing the glycoprotein (rLM-
GP) of LCMV (Takemoto et al., 2006). This idea was supported in T cell factor 1 
(TCF-1) deficient mice. TCF-1 is a transcription factor downstream on the 
canonical Wnt signaling pathway and has been characterized in T cell 
development. In this study, TCF-1 deficient mice were crossed to OT-I transgenic 
mice to obtain T cells deficient in TCF-1 (Zhou et al., 2010). Upon infection with 
recombinant L. monocytogenes expressing ovalbumin (rLM-OVA), there was an 
increase in SLECs and Tem cells in TCF-1 deficient CD8+ T cells (Zhou et al., 
2010). Correspondingly, there was a decrease in the MPEC and Tcm populations 
in the absence of TCF-1 (Zhou et al., 2010). This group went on to show that 
Eomes expression was reduced in the absence of TCF-1 and that TCF-1 could 
45
directly regulate Eomes (Zhou et al., 2010). Further, when an Eomes retroviral 
vector was transduced into TCF-1 deficient CD8+ T cells, memory differentiation 
was restored (Zhou et al., 2010). Thus, it appeared that TCF-1 and Eomes 
promoted the generation and maintenance of memory CD8+ T cells. However, it 
was recently determined that Eomes was not required for the maintenance of 
memory cells. If CD8+ T cells are deficient in Eomes, memory cells were present 
at 60 days post-infection, and these memory cells were able to provide protection 
upon challenge (Banerjee et al., 2010). Intriguingly, in competitive repopulation 
assays utilizing mixed bone marrow chimeras of WT and Eomes KO bone 
marrow, WT memory CD8+ T cells outcompeted Eomes-deficient memory CD8+ 
T cells in maintenance and upon challenge (Banerjee et al., 2010). These results 
show that although Eomes is not required for memory T cells differentiation, the 
presence of Eomes in memory T cells promotes a more protective and robust 
response.  
 Despite this potential role for Eomes in providing superior memory 
responses, it appears that in the case of Eomes, too much of a good thing may 
be detrimental to the immune response. Recently, it was demonstrated that a key 
difference in CD8+ T cells from mice acutely or chronically infected with LCMV 
was the expression of Eomes. At eight days post-infection, mice acutely and 
chronically infected with LCMV had similar expression of Eomes in antigen-
specific CD8+ T cells (Paley et al., 2012). However, once these cells entered the 
memory phase of the response, antigen-specific CD8+ T cells from chronically 
infected mice had higher Eomes expression than antigen-specific CD8+ T cells 
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from mice acutely infected with LCMV (Paley et al., 2012). Additionally, in the 
absence of Eomes, CD8+ T cells from chronically infected mice fail to express the 
exhaustion marker, programmed cell death protein 1 (PD-1) (Paley et al., 2012). 
Further, when the CD8+ T cells of patients chronically infected with hepatitis C 
virus (HCV) were examined, there was also a higher frequency of Eomes+ 
antigen-specific T cells in these patients (Paley et al., 2012). Interestingly, Blimp1 
is highly expressed in exhausted CD8+ T cells during chronic LCMV infection 
(Shin et al., 2009). Further, in Blimp1-deficient mice chronically infected with 
LCMV, CD8+ T cells have a reduction in the expression of exhaustion markers, 
such as PD-1, and are able to produce cytokines upon antigen stimulation (Shin 
et al., 2009). This result differs from WT mice chronically infected with LCMV. 
The CD8+ T cells of these mice express multiple markers of exhaustion and lose 
the ability to exert their effector functions upon antigen stimulation (Shin et al., 
2009). Hence, in the case of chronic infections, it appears that Blimp1 and 
Eomes may be involved in a similar pathway that induces an exhaustion 
phenotype of T cells in chronically infected hosts. These results are surprising 
since it appears that Eomes and Blimp1 work in separate pathways to promote 
memory and effector differentiation, respectively, during acute infections. 
Although there is much known about the differentiation of CD8+ T cells, these 
various studies illustrate that the generation of memory T cells is a dynamic and 
complex process that requires further study.  
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The Role of Itk-deficient Innate CD8+ T Cells in Infection 
 Despite this wealth of knowledge for the differentiation of conventional 
CD8+ T cells in response to intracellular pathogens, little is known about the role 
of Eomes+ innate CD8+ T cells during infection. A major defining attribute of 
innate CD8+ T cells is their ability to exert effector function immediately upon 
stimulation. Therefore, these innate T cells differ in their requirement of priming 
that we observe for conventional cells. Eomes+ innate T cells develop in the 
absence of Itk, KLF2, Id3, and CBP and in the absence of SLP-76 signaling 
(Atherly et al., 2006a; Broussard et al., 2006; Fukuyama et al., 2009; Gordon et 
al., 2011; Verykokakis et al., 2010b; Weinreich et al., 2010). The responses of 
peripheral KLF2 deficient CD8+ αβ T cells have been challenging to study since T 
cells deficient in KLF2 fail to emigrate from the thymus. KLF2 regulates S1P1, a 
surface receptor for the phospholipid S1P, that is required for the thymocytes to 
emigrate into the periphery (Carlson et al., 2006). Thus, thymic egress is lost in 
the absence of KLF2 (Carlson et al., 2006). 
Although the role of Id3 in the formation of memory has been studied, 
TCR transgenics (pmel-1 and OT-I) were utilized (Ji et al., 2011; Yang et al., 
2011). As we have seen with Itk-deficient TCR transgenics, the use of TCR 
transgenics can prevent the development of innate CD8+ T cells. These studies 
involving Id3 also saw similar results with the Id3 KOs. Still, it was determined 
that the maintenance of memory CD8+ T cells was lost in the absence of Id3 in 
conventional T cells (Ji et al., 2011; Yang et al., 2011). This resulted in few 
memory CD8+ T cells able to respond to a challenge infection (Ji et al., 2011; 
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Yang et al., 2011). Although these studies were more insightful for the generation 
of conventional memory CD8+ T cells, it does expand our knowledge in how 
memory CD8+ T cells are maintained. 
While little is currently known about how innate T cells deficient in KLF2 
and Id3 respond to infection, the SLP-76Y145F knock-in mouse has been the most 
useful in studying Eomes+ innate CD8+ T cells during infection. When these mice 
are infected with LCMV, innate CD8+ T cells have a skewed cytokine response at 
eight days post-infection (Smith-Garvin et al., 2010). More specifically, SLP-
76Y145F CD8+ T cells produce little TNF in response to peptide stimulation (Smith-
Garvin et al., 2010). Despite this skewed cytokine response, SLP-76Y145F mutant 
mice were able to produce long-lived memory CD8+ T cells (Smith-Garvin et al., 
2010). Thus, it appears that innate CD8+ T cells can sustain a pool of memory 
CD8+ T cells post-infection.  
In the absence of Itk, there have been no studies to date examining the 
formation of memory CD8+ T cells, and few infectious models have probed the 
responses of Itk-deficient CD8+ T cells. However, the August group has 
examined the role of Itk-deficient CD8+ T cells in response to L. monocytogenes. 
This group demonstrated that Itk-deficient mice have a significantly lower 
bacterial burden at day three post-infection with L. monocytogenes when 
compared to wild-type mice (Hu et al., 2007). Further, Itk-deficient CD8+ T cells 
were also able to decrease the bacterial burden of IFNγ-deficient mice upon 
adoptive transfer of these cells prior to infection (Hu et al., 2007). Thus, Itk-
deficient CD8+ T cells appear to function similarly to H2-M3-restricted CD8+ T 
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cells in regards to bacterial infections (Kerksiek and Pamer, 1999; Nataraj et al., 
1998).  
 Despite a positive role for Itk-deficient CD8+ T cells during L. 
monocytogenes infection, the absence of Itk appears to have a negative effect 
during viral infection. Cytotoxicity of CD8+ T cells deficient in Itk appears to be 
impaired in response to vaccinia virus (VV) and vesicular stomatitis virus (VSV) 
(Bachmann et al., 1997). This was demonstrated by examining the viral titer of 
WT or Itk KO mice infected with VV at six days post-infection. At this time point, 
Itk-deficient mice had a higher viral titer when compared to WT mice (Bachmann 
et al., 1997). In VSV, cytotoxicity was determined via a 51chromium (51Cr)-release 
assay at six days post-infection. In these assays, target cells are labeled with 
51Cr prior to incubation with effector cells. Specific lysis is measured by the 
amount of 51Cr released from the target cells. When WT or Itk KO immunized 
splenocytes were incubated with target cells at six days post-infection, there was 
a reduction in the specific lysis of target cells incubated with Itk KO splenocytes 
when compared to the lysis of target cells incubated with WT splenocytes 
(Bachmann et al., 1997). This study also reported a slight impairment in the 
cytoxicity of Itk-deficient CD8+ T cells when compared to wild-type CD8+ T cells 
in response to LCMV when using this 51Cr-release assay ((Bachmann et al., 
1997). However, our lab has not seen this defect (Atherly et al., 2006a). This 
discrepancy may be due to the use of different strains of LCMV (WE versus 
Armstrong). However, our lab has determined that additional defects occur in Itk-
deficient mice during LCMV infection. Decreases in CD8+ T cell proliferation, 
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IFNγ, and TNF production have been seen in response to the LCMV-specific 
epitopes, GP33 and NP396 (Atherly et al., 2006a). Additionally, this appeared to 
be a cell-intrinsic defect of Itk-deficient CD8+ T cells since itk-/- OT-I+ CD8+ T cells 
also had a similar defect in response to rVV-OVA (Atherly et al., 2006a). Further, 
we saw skewing of the cytokine response to LCMV. Itk-deficient CD8+ T cells had 
few antigen-specific cells producing TNF and IFNγ in response to stimulation 
(Atherly et al., 2006a). This skewing continued into the memory phase of the 
response (Atherly et al., 2006a). Nonetheless, these defects are modest, as Itk-
deficient mice are able to clear an LCMV infection with nearly normal kinetics 
(Atherly et al., 2006a), but we still wondered how these defects seen during the 
primary response could influence the memory response upon challenge. 
 Although these defects seen during viral infection are modest and Itk-
deficient mice appear to be able to clear viral pathogens, there is little data 
concerning the ability of innate T cells to generate memory. We have presumed 
that functional and protective memory CD8+ T cells are formed in the absence of 
Itk since these mice can clear acute infections. However, recent data describing 
null mutations of Itk in children born from consanguineous families, demonstrates 
that these patients succumb to Epstein-Barr virus (EBV) lymphoproliferative 
disorders (EBV-LPD) (Huck et al., 2009; Linka et al., 2012; Stepensky et al., 
2011). EBV is a γ-herpes virus that is a lifelong, asymptomatic infection for the 
majority of healthy individuals (Rickinson and Moss, 1997; Young and Rickinson, 
2004). Since CD8+ T cells play a role in suppressing EBV and prevents these 
lymphoproliferative disorders and lymphomas (Rickinson and Moss, 1997), we 
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hypothesized that innate T cells may have defects in forming protective memory 
CD8+ T cells since these Itk null patients succumb to this infection. Thus, a part 
of this thesis will focus on the ability of innate T cells to generate protective 
memory responses.  
C. Thesis Objectives 
 In the absence of Itk, KLF2, Id3, CBP, and SLP-76 signaling, innate CD8+ 
T cells develop that express the T-box transcription factor, Eomes (Atherly et al., 
2006a; Fukuyama et al., 2009; Gordon et al., 2011; Verykokakis et al., 2010b; 
Weinreich et al., 2010). These innate cells differentiate during development due 
to decreases in T cell receptor signaling combined with increased IL-4 signaling 
that occurs in the absence of these proteins (Gordon et al., 2011; Nayar et al., 
2012; Verykokakis et al., 2010b; Weinreich et al., 2010). CD3+ PLZF+ T cells 
have been implicated as a source for IL-4 that promotes the conversion of 
conventional T cells into Eomes+ innate T cells (Gordon et al., 2011; Verykokakis 
et al., 2010b; Weinreich et al., 2010). Although γδ NKT cells are the most likely 
source of IL-4, there are a variety of other innate cells types that express PLZF 
and could contribute to the induction of Eomes in innate T cells. Additionally, 
conversion of conventional CD4+ T cells into Eomes+ innate T cells has not been 
thoroughly examined although we know there is an increased population of 
CD44high CD4+ T cells in the absence of Itk. To take this a step further, little is 
known about the ability of Eomes+ innate CD8+ T cells to develop memory. Thus, 
we hypothesize that in the absence of Itk, conventional CD4+ T cells are 
converted to Eomes+ innate T cells and that an innate αβ T cell population 
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expressing PLZF mediates this conversion of conventional T cells. 
Additionally, we hypothesize that the Eomes+ innate CD8+ T cells 
developing in this high IL-4 environment are unable to generate protective 
memory responses. To address these hypotheses, this thesis will be presented 
in three parts: 
Chapter III: Development of Innate CD4+ and CD8+ αβ T cells in Itk-deficient 
Mice is Regulated by Distinct Pathways. 
A. Do CD4+ Eomesodermin+ αβ T cells develop in the absence of Itk? 
B. Does IL-15 regulate Eomesodermin+ innate αβ T cells?  
C. Do conventional CD4+ αβ T cells, MAIT cells, iNKT cells, or γδ T 
cells regulate the development of Eomesodermin+ innate αβ T 
cells?  
D. How does SAP regulate the development of CD1d tetramerneg 
PLZF+ CD3+ αβ T cells?  
Chapter IV: CD4+ PLZF+ αβ MAIT-like T cells develop and expand in the 
absence of Itk 
A. Do CD4+ PLZF+ CD1d tetramerneg αβ T cells transcribing IL-4 
develop in the absence of Itk? 
B. Where do PLZF+ CD1d tetramerneg αβ T cells home? 
C. Do PLZF+ CD1d tetramerneg αβ T cells have a restricted TCR 
repertoire? 
D. Do CD4+ PLZF+ CD1d tetramerneg αβ MAIT-like cells depend on 
MHC molecules for development?  
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E. Does IL-15 regulate the development and/or expansion of CD4+ 
PLZF+ CD1d tetramerneg αβ MAIT-like cells? 
F. Do CD4+ PLZF+ CD1d tetramerneg αβ MAIT-like cells depend on γδ 
T cells for development?  
Chapter V:  Eomesodermin+ innate CD8+ αβ T cells have impaired protective 
memory responses to lymphocytic choriomeningitis virus (LCMV) 
A. Do Itk KO memory T cells provide protection upon challenge? 
B. Are WT and Itk KO antigen-specific memory T cells present in 
similar frequencies and number? 
C.  Are Itk KO antigen-specific memory T cells functional? 
D. How do Itk KO memory T cells respond to challenge?  
E. Is CD4 help provided to Itk-deficient CD8+ T cells?  
F. Are subsets of memory T cells affected by the absence of Itk? 
G. Is this a cell intrinsic defect of Itk-deficient CD8+ T cells? 
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Chapter II: Materials and Methods 
1. Development of Eomesodermin+ and MAIT-like αβ T cells in the absence 
of Itk  
Mice: Wild-type (WT) C57Bl/6 mice were purchased from either Taconic Farms, 
Inc. (Hudson, NY), Jackson Laboratories (Bar Harbor, ME), or Charles River 
Laboratories International, Inc. (Wilmington, MA).  itk-/- mice were previously 
described (Atherly et al., 2006b; Lucas et al., 2002; Schaeffer et al., 2001) and 
housed at the University of Massachusetts Medical School in accordance with 
the institutional animal care and use committee (IACUC) and in a specific-
pathogen free environment.  IL-4 reporter (4get) mice were a gift from Markus 
Mohrs (Trudeau Institute, Saranac Lake, NY) and were crossed to itk-/- at the 
University of Massachusetts Medical School. cd1d-/- mice were a gift from the 
laboratory of Raymond Welsh and were crossed to itk-/- at the University of 
Massachusetts Medical School. mr1-/- and il-15-/- mice were a gift from Joonsoo 
Kang and were also crossed to itk-/- mice at the University of Massachusetts 
Medical School. sh2d1a-/- was a gift from Paul Stein and were crossed to itk-/- 
mice at the University of Massachusetts Medical School. H2dlAb1-Ea mice were 
purchased from Jackson Laboratories (Bar Harbor, ME) and were crossed to itk-/- 
at the University of Massachusetts Medical School. itk-/- β2m-/- mice were a kind 
gift from Pamela Schwartzberg (National Institute of Health).  itk-/- β2m-/- were 
crossed to itk-/- H2dlAb1-Ea mice at the University of Massachusetts Medical 
School. tcrd-/- were a gift from the laboratory of Raymond Welsh and were 
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crossed to itk-/- mice at the University of Massachusetts Medical School as 
previously described (Felices et al., 2009).  
Cell Preparation: Thymus, spleen, peripheral lymph nodes (pLN: including 
cervical, axillary, brachial and inguinal), mLN, liver and small intestine were 
harvested from mice and stored in RPMI (Gibco by Invitrogen, Grand Island, New 
York) supplemented with fetal bovine serum (FBS), L-glutamine, penicillin, 
streptomycin, β-mercaptoethanol, and Hepes (RPMI-10). Thymi were processed 
using forceps and frosted microscope slides. Spleen, pLN, and mLN were 
processed using only frosted microscrope slides. Thymus, spleen, pLN, and mLN 
were lysed with red blood cell (RBC) lysis buffer prior to single cell suspension 
with RPMI-10. Before harvesting, livers were perfused with 5 mL ice-cold 1X 
phosphate buffered saline (PBS). Livers were processed by cutting with a razor 
blade prior to suspending in 0.05% collagenase. After liver tissue was dissolved, 
red blood cells were lysed prior to suspending the cells in a discontinuous 
40/70% Percoll gradient to isolate lymphocytes. A single cell suspension was 
made from the lymphocytes after the Percoll gradient was performed. Intestinal 
intraepithelial lymphocytes (iIELs) were isolated by removing fecal matter and 
Peyer’s patches from the small intestine prior to shaking in media. Cell 
suspensions were filtered prior to suspending cells in a discontinuous 40/70% 
Percoll gradient. Single cell suspensions of the iIELs were made after the 
gradient was performed.  
57
Cell Stimulations: Cells were plated at 106-107 cells per well prior to stimulating 
with phorbol myristate acetate (PMA, 10 ng/mL) and ionomycin (1 µg/mL) for six 
hours at 37oC in the presence of brefeldin A and monensin.  
Extracellular/Intracellular Staining: Cells were plated at 106-107 cells per well 
prior to washing with fluorescence-activated cell sorting (FACS) buffer (1X PBS 
supplemented with 2% FBS). Fc receptors were blocked using supernatant from 
2.4G2 hybridomas grown in the lab prior to staining with the CD1d tetramer 
loaded with PBS57 (a gift from the NIH). Cells were stained with various 
combinations of the cell surface antibodies against CD4 (RM4-5), CD8 (53-6.7 or 
5H10), TCRβ (H57-597), TCRδ (GL3), Heat-shock antigen (HSA, CD24) (30-F1 
or M1/69), CD44 (IM7), CD62L (MEL-14), CD127 (IL-7Rα) (A7R34 or SB/199), 
CD124 (IL-4Rα) (mIL4R-M1), CD122 (IL-2Rβ) (5H4 or TM-β1), CXCR3 (CXCR3-
173), α4β7 (DATK32), CD103 (2E7), CCR6 (140706), CCR9 (eBioCW-1.2), Vα2 
(B20.1), Vα3.2 (RR3-16), Vα8.3 (B21.14), Vα11 (RR8-1), Vβ2 (B20.6), Vβ3 
(KJ25), Vβ4 (KT4), Vβ6 (RR4-7), Vβ7 (TR310), Vβ8.1/8.2 (MR5-2), Vβ8.3 
(1B3.3), Vβ10b (B21.5), Vβ11 (RR3-15), and Vβ14 (14-2). Cells were then 
permeabilized using either the eBioscience Foxp3/transcription factor staining kit 
or BD Cytofix/Cytoperm according to the manufacturer’s protocol prior to staining 
with antibodies against the transcriptions factors, Eomesodermin (Dan11mag) 
and PLZF (D-9) with an IgG1 secondary (A85-1), and the cytokines, IL-4 (BVD6-
24G2) and IFNγ  (XMG1.2).  
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2. Eomesodermin+ innate CD8+ T cells have impaired protective memory 
responses to LCMV 
Mice: WT C57Bl/6 mice were purchased from Taconic Farms, Inc. (Hudson, NY), 
Jackson Laboratories (Bar Harbor, ME), or Charles River Laboratories 
International, Inc. (Wilmington, MA). WT C57Bl/10 mice and itk-/- mice were 
previously described (Atherly et al., 2006b; Lucas et al., 2002; Schaeffer et al., 
2001) and housed at the University of Massachusetts Medical School in 
accordance with IACUC and in a specific-pathogen free environment. P14 
transgenic mice were a kind gift from the laboratory of Raymond Welsh and were 
crossed to itk-/- mice at the University of Massachusetts Medical School. 
Viral Infections and Adoptive Transfers: Mice were infected with 5 x 104 
plaque forming units (PFU) LCMV Armstrong intraperitoneally (i.p.) for all primary 
infections. At six to seven weeks post-immunization, 10-20 x 106 splenocytes 
were adoptively transferred intravenously (i.v.) into WT congenic hosts. When 
mice were challenged with LCMV CL13, this virus was given i.p. at the low dose 
of 105 PFU. rVV-GP was given i.p. at 5 x 106 PFU. WT or Itk KO P14 transgenic 
T cells were isolated from pLN and spleen using an untouched CD8 isolation kit 
(Miltenyi Biotec) according the manufacter’s protocol. Biotinylated anti-CXCR3 
antibody was also used in the untouched CD8 isolation kit to remove 
Eomesodermin+ T cells.  105-106 P14 CD8+ T cells were adoptively transferred 
into a WT congenic host prior to infection. Spleens were harvested at various 
points post-infection, processed with frosted microscrope slides, and red bloods 
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cells were lysed using ammonium chloride prior to stimulating or staining for flow 
cytometry. 
Peptide Stimulations and Intracellular Cytokine Staining: For intracellular 
cytokine stains, cells were plated at 1-10 x 106 cell/well and stimulated with either 
PMA (50 ng/mL) and ionomycin (500 ng/mL), the LCMV-specific peptide GP33-41 
(1 µg), the LCMV-specific peptide NP396-404 (1 µg), or left unstimulated for five 
hours at 37oC in the presence of brefeldin A and antibodies against CD107a 
(eBio1D4B). After the incubation, cells were stained with surface markers prior to 
permeabilization (BD Cytoperm/Cytofix) and staining for TNF (MP6-XT22) and 
IFNγ (XMG1.2). To examine CD40L upregulation on CD4+ T cells in response to 
stimulation, splenocytes were plated at 1-10 x106 cells/well and stimulated with 
either PMA (50 ng/mL) and ionomycin (500 ng/mL), the LCMV-specific peptide 
GP61-80 (1µg), or left unstimulated for five hours at 37oC. After incubation, cells 
were stained with antibodies against CD4 (RM4-5), TCRβ (H57-597), CD44 
(IM7), and CD40L (MR1) prior to running on an LSRII (BD Biosciences).  
Extracellular/Intracellular Staining: Cells were plated at 106-107 cells per well 
prior to washing with FACS buffer (1X PBS supplemented with 2% FBS). Fc 
receptors were blocked using supernatant from 2.4G2 hybridomas grown in the 
lab prior to staining with the GP33-41 or NP396-404 tetramers (a gift from the 
laboratory of Raymond Welsh). Cells were stained with various combinations of 
the cell surface antibodies against CD4 (RM4-5), CD8 (53-6.7 or 5H10), 
TCRβ (H57-597), CD44 (IM7), CD45.1 (A20), CD45.2 (104), CD127 (A7R34), 
KLRG1 (2F1), CD62L (MEL-14), Vα2 (B20.1), Vβ8.1/8.2 (MR5-2), or CXCR3 
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(CXCR3-173). Cells were then permeabilized with eBiosciences 
Foxp3/transcription factor staining kit prior to staining with antibodies against T-
bet (eBio4B10) and Eomesodermin (Dan11mag). 
Plaque Assays: Viral supernatants were obtained from infected spleens at three 
days post-infection with LCMV CL13.  The tissue suspension was centrifuged at 
2,000 revolutions per minute (rpm) for 20 minutes prior to freezing aliquots of the 
viral supernatant. To measure viral titer, aliquots were thawed and serially diluted 
by 10 fold prior to incubating with Vero cells that were at 70% confluency for 90 
minutes at 37oC. After the incubation, cells were overlaid with 1:1 mixture of 1% 
Seakem’s agarose: EMEM-complete (6% FBS, 2.5% penicillin-streptomycin-L-
glutamine (PSQ), and 1% fungizone). After four days, cells were stained with a 
1:1 mixture of Seakem’s agarose: EMEM-complete containing 1.5% neutral red. 
Viral titer was calculated as the Log of ((((number of plaques) x dilution factor) / 
volume plated) x total volume of the spleen supernatant).  
In Vivo Cytotoxicity Assays: WT and Itk KO mice were immunized with LCMV 
Armstrong. At 42 days post-infection, splenocytes from congenic mice were 
harvested, processed and loaded with 1 uM of peptide for 45 minutes at 37oC. 
Congenic splenocytes were loaded with either the LCMV-specific epitope GP33-
41, the LCMV-specific epitope NP396-404, or the irrelevant peptide ovalbumin. After 
peptide loading, cells were labeled with 5- (and 6 )-carboxyfluorescein diacetate 
succinimidyl ester (CFSE), a dye that readily crosses the plasma membrane and 
binds with free amines intracellularly. GP33-41 loaded splenocytes were labeled 
with 2.5 µM CFSE (CFSEhigh), NP396-404 labeled splenocytes were labeled with 0.8 
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µM CFSE (CFSEint), and OVA loaded splenocytes were labeled with 0.25 µM 
CFSE (CFSElow). CFSE labeled cells were mixed at a 1:1:1 ratio, and 6 x 107 
cells were adoptively transferred i.v. into an immunized host. Four hours after 
transfer, host mice were sacrificed and splenocytes were harvested. Cells were 
stained for the congenic marker and run on a flow cytometer (LSRII).  
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Chapter III: Development of Innate CD4+ and CD8+ αβ T cells in Itk-deficient 
Mice is Regulated by Distinct Pathways. 
One important clue to dissecting the signals regulating T cell lineage 
development has come from studies of genetically-altered mice.  In the absence 
of the Tec kinase, Itk, as well as in mice lacking the transcription factors Klf2, Id3, 
and CBP, conventional CD8+ T cells developing in the thymus are converted into 
innate/memory-like T cells expressing high levels of the effector-promoting 
transcription factor, Eomes (Atherly et al., 2006a; Fukuyama et al., 2009; 
Verykokakis et al., 2010b; Weinreich et al., 2010).  While the involvement of Itk 
indicates a role for TCR signaling in this process, further evidence supporting this 
conclusion comes from studies demonstrating an identical phenotype in mice 
expressing a mutant form of the adapter protein SLP-76, SLP-76Y145F, which 
lacks the ability to recruit Itk in response to TCR stimulation (Gordon et al., 
2011).  Together, these data indicate that intact TCR signaling pathways are 
critical for the normal development of conventional CD8+ T cells.  
However, dampened TCR signaling is not the only requirement for the 
expression of Eomes. There is also a requirement for IL-4 to fully induce Eomes 
expression in CD8+ αβ T cells (Gordon et al., 2011; Nayar et al., 2012; 
Verykokakis et al., 2010b; Weinreich et al., 2010). In the absence of the IL-
4Rα (CD124), Eomes is no longer expressed in itk-/- CD8+ T cells (Weinreich et 
al., 2010). Further, it has been shown that the T cells expressing the transcription 
factor PLZF are required to induce Eomes expression in CD8+ T cells (Gordon et 
al., 2011; Verykokakis et al., 2010b; Weinreich et al., 2010). In the absence of Itk, 
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there is an increase in PLZF+ γδ T cells expressing the Vγ1.1 Vδ6.3 TCR, a.k.a 
γδ NKT cells (Felices et al., 2009). In general, it is thought that these γδ NKT cells 
are responsible for the excess of IL-4 in the absence of Itk (Alonzo and 
Sant'Angelo, 2011). While it is true that γδ NKT cells are responsible for the 
hyper-IgE syndrome seen in Itk KO mice (Felices et al., 2009; Qi et al., 2009), it 
is unknown whether γδ NKT cells are required to induce Eomes expression in 
CD8+ T cells. Multiple cell types (i.e. iNKT cells, MAIT cells) are capable of IL-4 
production, so while the most likely candidate for an IL-4 source is γδ NKT cells, it 
is possible that other cell types are contributing to this excess of IL-4.  
Additionally, the effect of thymic IL-4 on the development of CD4+ αβ T 
cells has not been addressed. It is known that itk-/- CD4+ αβ T cells have an 
increased frequency of activated cells, but it is unknown if these cells are 
expressing Eomes similarly to itk-/- CD8+ αβ T cells (Hu and August, 2008). In this 
chapter, we aim to examine if itk-/- CD4+ αβ T cells are conventional T cells that 
are upregulating Eomes in response to excess IL-4 in the environment. We also 
aim to address if γδ T cells are responsible for this innate-like phenotype of αβ T 
cells.  
A. CD4+ Eomesodermin+ αβ  T cells Develop in the Absence of Itk.  
 As previously shown (Atherly et al., 2006b; Broussard et al., 2006), there 
are fewer CD4+ T cells in the absence of Itk due to an increased frequency of 
CD8 SP thymocytes when compared to CD4 SP thymocytes (Figure 3.1A). This 
results in a decreased ratio of CD4:CD8 SP thymocytes (Figure 3.1A). Further, in  
66
Figure 3.1: Mature Eomesodermin+ CD8 and CD4 T cells develop in the 
absence of Itk. Thymocytes from WT and Itk KO mice were isolated and stained 
with CD1d tetramer and with antibodies specific for CD4, CD8, TCRβ, TCRγδ, 
HSA (CD24), CD44, CD62L, CD122 (IL-2Rβ), CXCR3, CD124 (IL-4Rα), and 
Eomesodermin. (A) Increased CD4:CD8 ratio in Itk deficient thymi. Gated on total 
thymocytes. (B and C) Eomesodermin+ T cells are increased in the absence of 
Itk. Flow cytometry plots with graphs showing an increase in the percentage and 
number of Eomesodermin+ CD8 SP thymocytes (B) or CD4 SP thymocytes (C). 
Gated on TCRβ+ HSAlow CD8 SP thymocytes (B) or on TCRγδneg TCRβhigh CD1d 
Tetramerneg HSAlow CD4 SP thymocytes (C). n = 20-22 mice per group. Results 
are respresentative of more than five independent experiments. Statistical 
analysis was done using a Mann-Whitney test. (D and E) Eomesodermin+ T cells 
express increased CD62L, CD122, CD124, and CXCR3. Mature WT CD8 SP or 
CD4 SP thymocytes are shown in gray while mature Itk KO CD8 SP or CD4 SP 
thymocytes are shown in black. (D) WT and Itk KO thymocytes are gated on 
TCRβ+ HSAlow CD8 SP cells. (E) WT is gated on CD4 SP TCRβ+ CD1d 
tetramerneg HSAlow thymocytes. Itk KO is gated on CD4 SP TCRβ+ CD1d 
tetramerneg HSAlow Eomesodermin+ thymocytes. Results are representative of at 
least three independent experiments.  
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the absence of Itk, CD8+ αβ T cells induce the expression of Eomes due to 
increased IL-4 signaling (Figure 3.1B) (Gordon et al., 2011; Verykokakis et al., 
2010b; Weinreich et al., 2010). Additionally, due to this IL-4 signaling, these cells 
upregulate IL-4Rα (CD124) and have a memory-like phenotype by expressing 
CD62L and IL-2Rβ (CD122) (Figure 3.1D). itk-/- CD8+ T cells also express high 
levels of the chemokine receptor CXCR3 (Figure 3.1D).  
To determine whether itk-/- CD4+ αβ T cells also underwent altered 
development, we characterized CD4+ CD8- (CD4 SP) thymocytes from itk-/- mice. 
For this analysis, we excluded iNKT cells, which are known to have a memory-
like phenotype (Kronenberg, 2005; Kronenberg and Engel, 2007).  When 
conventional, mature (TCRβhigh HSAlow) CD1d tetramerneg CD4 SP thymocytes 
are gated upon, we found an increased population of itk-/- cells expressing 
Eomes compared to WT CD4SP thymocytes (Figure 3.1C). Like the CD8SP 
thymocytes, Eomes+ itk-/- CD4SP thymocytes expressed increased levels of 
CD44, CD62L, IL-2Rβ (CD122), IL-4Rα (CD124), and CXCR3 (Figure 3.1C&E). 
In addition to the upregulated expression of Eomes, CD44, CD62L, IL-2Rβ, IL-
4Rα, and CXCR3, itk-/- Eomes+ CD8SP T cells can produce IFNγ upon ex vivo 
stimulation. This effector function is shared with itk-/- CD4SP thymocytes (Figure 
3.2). Together, these data indicate that innate-like CD4+ αβ T cells expressing 
Eomes develop in the absence of Itk. 
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Figure 3.2: Eomesodermin+ CD4+ thymoctyes produce IFNγ in response to 
stimulation. Thymocytes from WT and Itk KO mice were harvested and 
stimulated with 10 ng/mL PMA and 1 µg/mL ionomycin for six hours at 37oC in 
the presence of brefeldin A and monensin. Cells were then stained with CD1d 
tetramer and with antibodies against CD4, CD8, HSA, IFNγ, and eomesodermin. 
Flow cytometry plots are gated on CD4 SP CD1d tetramerneg HSAlow thymocytes. 
Results are representative of two experiments involving 2-4 mice per group. 
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B. IL-15 regulates the expansion of Eomesodermin+ T cells.   
 Previously, we and others have demonstrated the importance of IL-15 in 
the development and/or maintenance of itk-/- CD44high CD8+ T cells (Atherly et al., 
2006b; Dubois et al., 2006). As shown in Figure 3.3A, Eomes+ CD8SP 
thymocytes are substantially reduced in number in the absence of IL-15; 
however, the presence of a significant residual population of itk-/- Eomes+ CD8SP 
in the absence of IL-15 indicates that IL-15 is critical for the maintenance and/or 
expansion of these cells, rather than for their development per se. Interestingly, 
the frequency and number of itk-/- Eomes+ CD4SP thymocytes increased 
dramatically in the absence of IL-15 (Figure 3.3B). This increase is likely due to 
the reduced number of Eomes+ itk-/- CD8SP cells that would compete with the 
CD4+ T cells for survival cytokines, such as IL-7 or IL-4. These data indicate that 
CD4+ Eomes+ T cells are independent of IL-15 for their development, 
maintenance and expansion. Thus, while both of these subsets of innate T cells 
in itk-/- mice express Eomes, they are differentially regulated by IL-15. 
C. Conventional CD4+ T cells promote the expansion and development of 
Eomesodermin expressing αβ T cells.  
 Eomes expressing itk-/- CD8+ T cells are conventional αβ T cells being 
converted to this innate phenotype by IL-4 (Weinreich et al., 2010). We wanted to 
determine if Eomes+ CD4+ T cells were also conventional T cells that are 
converting to an innate phenotype. Therefore, Itk KO mice were crossed to MHC 
class II KO mice (H2dlAb1-Ea). Unexpectedly, we first observed that, in the absence 
of MHC class II, the frequency and number of Eomes+ CD8+ αβ T cells were 
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Figure 3.3: IL-15 regulates the expansion of Eomesodermin+ αβ  T cells. 
Thymocytes from WT, Itk KO, IL-15 KO, and Itk/IL-15 DKO mice were harvested 
and stained with CD1d tetramer and with antibodies against CD4, CD8, TCRδ, 
TCRβ, HSA (CD24), CD44, and Eomes. (A) Flow cytometry plots combined with 
graphs showing the frequency and absolute number of mature CD8 SP T cells 
(TCRβhigh HSAlow) expressing Eomes. (B) Flow cytometry plots combined with 
graphs showing the frequency and absolute number of mature CD4 SP T cells 
(TCRδneg TCRβhigh HSAlow CD1d tetramerneg) expressing Eomes. n = 6-7 mice 
per group. Results are from three independent experiments. Statistical analysis 
performed using a one-way ANOVA. *p < 0.05 **p < 0.05 ***p < 0.0005 ****p < 
0.0001 
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significantly decreased (Figure 3.4A). In addition, lack of MHC class II expression 
led to a near disappearance of itk-/- Eomes+ CD4SP thymocytes (Figure 3.4B). 
These latter data support the conclusion that itk-/- Eomes+ CD4SP thymocytes 
are conventional CD4+ T cells that are converted to an innate phenotype. The 
reason for the reduced numbers of itk-/- innate CD8SP in mice lacking 
conventional αβ CD4+ T cells is unclear, but may reflect an unforeseen 
contribution this conventional T cell subset. 
D. Eomesodermin+ αβ  T cells develop independently of MAIT cells.  
 The data shown above indicate that both conventional CD8+ and CD4+ αβ 
T cells aberrantly upregulate Eomes expression in itk-/- mice.  For the CD8SP 
thymocytes, this altered development is dependent on excess IL-4 in the 
environment.  One potential source of IL-4 is a subset of innate T cells called 
MAIT cells. MAIT cells are invariant (mouse Vα19-Jα33, human Vα7.2-Jα33), 
are dependent on MR1 for development, and preferentially home to the mLN or 
gut LP (Treiner et al., 2003). Vα19 transgenic cells can produce copious amounts 
of IL-4, and PLZF expression has been detected in human Vα7.2+ cells (Kawachi 
et al., 2006; Savage et al., 2008). As shown in Figure 3.5, a deficiency in MR1 
had no effect on the numbers of itk-/- CD8SP or CD4SP thymocytes expressing 
high levels of Eomes.  
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Figure 3.4: CD4+ T cells promote the expansion and development of 
Eomesodermin expressing αβ T cells. Thymocytes from WT, Itk KO, MHC II 
KO, and Itk/MHC II DKO mice were isolated and stained with CD1d tetramer and 
with antibodies against CD4, CD8, TCRδ, TCRβ, HSA, CD44, and 
Eomesodermin. (A) Flow cytometry plots along with graphs depicting the 
frequency and cell number of CD8 SP TCRβhigh HSAlow Eomesodermin+ 
thymocytes. (B) Flow cytometry plots along with graphs depicting the frequency 
and cell number of CD4 SP TCRδneg TCRβhigh HSAlow CD1d tetramerneg 
Eomesodermin+ thymocytes. n = 6-8 mice per group. Results are representative 
of three independent experiments. Statistical analysis was performed using a 
one-way ANOVA. **p < 0.005 ***p < 0.0005 ****p < 0.00001 
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Figure 3.5: itk-/- Eomesodermin+ αβ  T cells develop independently of MAIT 
cells. Thymocytes from WT, Itk KO, MR1 KO, and Itk/MR1 DKO mice were 
harvested and stained with CD1d tetramer and with antibodies against CD4, 
CD8, TCRδ, TCRβ, HSA (CD24), and CD44. (A) Flow cytometry plots with 
graphs depicting the frequency and number of eomesodermin+ CD8 SP TCRβhigh 
HSAlow thymocytes. (B) Flow cytometry plots with graphs depicting the frequency 
and number of eomesodermin+ CD4 SP TCRδneg TCRβhigh HSAlow CD1d 
tetramerneg thymocytes. n = 5-8 mice per group. Results are representative of 
three independent experiments. Statistical analysis performed using a one-way 
ANOVA. **p < 0.005 ****p < 0.0001 
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E. iNKT cells promote the development of Eomesodermin+ αβ T cells.  
 A second potential source of excess IL-4 in itk-/- mice is iNKT cells. 
Although mature iNKT cells mostly produce IFNγ with little IL-4, immature iNKT 
cells can produce abundant amounts of IL-4 (Kronenberg, 2005; Kronenberg and 
Engel, 2007). Additionally, there is a defect in NKT cell maturation in the absence 
of Itk (Au-Yeung and Fowell, 2007; Felices and Berg, 2008). Thus, these 
defective itk-/- iNKT cells could be contributing to the development of Eomes+ αβ 
T cells.  
 To test for a role of iNKT cells, we crossed itk-/- mice to CD1d-deficient 
mice, and examined the thymocytes in these mice.  In the absence of iNKT cells, 
we observed a slight decrease in the frequency of CD8SP Eomes+ cells (Figure 
3.6A). Additionally, CD4SP Eomes+ cells were substantially reduced in Itk/CD1d 
double-deficient mice (Figure 3.6B). Detailed analysis revealed that the 
percentages and absolute numbers of CD4SP thymocytes were identical 
between itk-/- and itk-/-cd1d-/- mice, indicating that iNKT cells contributed to the 
conversion of conventional CD4SP to Eomes+ CD4SP, and not to their 
development per se.  These data show that iNKT cells are promoting Eomes 
upregulation in conventional CD4+ but not CD8+ thymocytes.  
 If iNKT cells are contributing significant amounts of IL-4 to the thymic 
environment of itk-/- mice, then IL-4Rα (CD124) expression should also be 
decreased on itk-/- CD8SP and CD4SP thymocytes in the absence of iNKT cells 
since IL-4 signaling is known to induce a positive feedback loop leading to 
upregulation of the IL-4R (Perona-Wright et al., 2010). Although there was a 
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Figure 3.6: iNKT cells promote the development of Eomesodermin+ αβ  T 
cells. Thymocytes from WT, Itk KO, CD1d KO, and Itk/CD1d DKO mice were 
harvested and stained with CD1d tetramer and with antibodies against CD4, 
CD8, TCRδ, TCRβ, HSA (CD24), CD44, and Eomes. (A) Flow cytometry plots 
combined with graphs showing the frequency and absolute number of mature 
CD8 SP T cells (TCRβhigh HSAlow) expressing Eomes. (B) Flow cytometry plots 
combined with graphs showing the frequency and absolute number of mature 
CD4 SP T cells (TCRδneg TCRβhigh HSAlow CD1d tetramerneg) expressing Eomes. 
n = 7-9 mice per group. Results are from four independent experiments. 
Statistical analysis performed using a one-way ANOVA. *p < 0.05 ***p < 0.0005 
****p < 0.0001 
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slight decrease in the geometric mean fluorescence intensity (MFI) of CD124 on 
mature Itk/CD1d double-deficient CD8SP and CD4SP cells compared to those in 
itk-/- mice, CD124 was still highly expressed on itk-/- mature SP thymocytes in the 
absence of iNKT cells (Figure 3.7). One possible explanation for these data is 
that loss of IL-4 normally contributed by iNKT cells in itk-/- mice is not sufficient to 
impact CD124 expression, but is enough to prevent Eomes up-regulation; 
alternatively, iNKT cells may regulate innate T cell development in itk-/- mice by a 
mechanism independent of IL-4 production. 
F. Eomesodermin+ T cells develop independently of γδ  T cells.  
 The data shown above indicate that iNKT cells are essential for the 
development of innate Eomes+ CD4+ αβ T cells in itk-/- mice.  Nonetheless, the 
Itk/CD1d double-deficient mice still had a substantial population of Eomes+ CD8+ 
T cells. In addition to αβ iNKT cells, a closely-related subset of NKT cells has 
been described that expresses an invariant γδ TCR, utilizing Vγ1.1/Vδ6.3 (Pereira 
and Boucontet, 2012; Yin et al., 2013). Recent studies have reported a dramatic 
expansion in this population in itk-/- mice, as well as in other lines of mice that 
develop Eomes+ innate CD8+ T cells (Felices et al., 2009; Gordon et al., 2011; Qi 
et al., 2009; Verykokakis et al., 2010b). γδ NKT cells also produce IL-4 in 
response to stimulation (Felices et al., 2009), and have been proposed as a 
possible cellular source of the excess IL-4 driving innate T cell development in 
itk-/- mice (Alonzo and Sant'Angelo, 2011).  
 To address the role of γδ T cells, we crossed itk-/- mice to TCRδ-deficient 
(tcrd-/-) mice.  To our surprise, thymocytes in the itk-/- mice lacking γδ T cells were  
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Figure 3.7: iNKT cells may contribute to IL-4 signals received by T cells. 
Thymocytes from WT, Itk KO, CD1d KO, and Itk/CD1d DKO mice were 
harvested and stained with CD1d tetramer and with antibodies against CD4, 
CD8, TCRδ, TCRβ, HSA, and CD124. (A) Flow cytometry plots and graph 
depicting the geometric mean fluorescence intensity (MFI) of CD124. Gated on 
CD8 SP TCRβhigh HSAlow thymocytes. (B) Flow cytometry plots and graph 
depicting the geometric MFI of CD124. Gated on CD4 SP TCRδneg TCRβhigh 
HSAlow thymocytes. Flow cytometry plots: WT (gray shaded), Itk KO (black solid 
line), CD1d KO (gray dashed line), Itk/CD1d DKO (black dashed line). n = 2-3 
mice per group. Results are from one experiment. Statistical analysis was 
performed using a one-way ANOVA. *p < 0.05 **p < 0.005 ****p < 0.0001    
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indistinguishable from those in single itk-/- mice.  Both the CD8SP and CD4SP 
subsets had comparable proportions and numbers of cells expressing Eomes 
when itk-/- were compared to itk-/-tcrd-/- thymocytes (Figure 3.8). Thus, although γδ 
NKT cells contribute significantly to the hyper-IgE syndrome seen in Itk-deficient 
mice (Felices et al., 2009; Qi et al., 2009), these cells do not contribute to the 
development of Eomes+ αβ T cells.  
G. SAP-dependent PLZF+ CD1d tetramerneg αβ T cells develop in the 
absence of Itk.  
 The data presented above ruled out a role for γδ NKT cells and MAIT cells 
in the development of eomes+ αβ T cells in itk-/- mice. Additionally, the data 
indicated that CD1d-dependent αβ iNKT cells were not essential for the 
development of Eomes+ innate CD8+ T cells. This led us to consider the 
possibility that itk-/- mice might have an additional population of PLZF+ cells 
capable of producing IL-4. Therefore, we examined mature itk-/- CD4SP αβ 
thymocytes (TCRδneg, TCRβhigh, HSAlow, CD1d-tetramerneg) and found an 
increased population of PLZF+ cells compared to WT mature CD4SP thymocytes 
(Figure 3.9A-C). These cells also produced IL-4 upon stimulation (Figure 3.9D).  
Eomes+ αβ T cells in itk-/- mice are dependent on the SLAM family 
receptor signaling molecule, SAP, for their development (Horai et al., 2007; 
Verykokakis et al., 2010b), this observation has been linked to the requirement 
for SAP in the development of PLZF+ cells in other mouse models (Verykokakis 
et al., 2010b). To determine if itk-/- CD4SP PLZF+ CD1d-tetramerneg 
αβ thymocytes were also dependent on SAP, we examined Itk/SAP double-
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Figure 3.8: Eomesodermin+ T cells develop independently of γδ  T cells. 
Thymocytes from WT, Itk KO, TCRδ KO, or Itk/TCRδ DKO mice were harvested 
and stained with CD1d tetramer and with antibodies against CD4, CD8, TCRβ, 
HSA, CD44, and Eomesodermin. (A) Flow cytometry plots along with graphs 
depicting the frequency and cell number of CD8 SP TCRβhigh HSAlow Eomes+ 
thymocytes. (B) Flow cytometry plots along with graphs depicting the frequency 
and cell number of CD4 SP TCRβhigh HSAlow CD1d tetramerneg Eomes+ 
thymocytes. n = 4-7 mice per group. Results are representative of two 
independent experiments. Statistical analysis was performed using a one-way 
ANOVA. *p < 0.05, **p < 0.005, ***p < 0.0005, ****p < 0.0001 
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Figure 3.9: IL-4 producing CD1d tetramerneg PLZF+ αβ T cells develop in the 
absence of Itk. Thymocytes from WT or Itk KO mice were harvested and stained 
with CD1d tetramer and with antibodies against CD4, CD8, TCRδ, TCRβ, HSA, 
Eomes, and PLZF. (A) Flow cytometry plots showing the presence of PLZF+ αβ T 
cells in the absence of Itk. (B) Frequency and (C) cell number of CD4 SP 
TCRδneg TCRβhigh CD1d tetramerneg HSAlow PLZF+ thymocytes. n = 20-23 mice 
per group from 8 independent experiments. Statistical analysis was performed 
using a Mann-Whitney student t test. ****p < 0.0001 (D) WT and Itk KO 
thymocytes were harvested and stimulated for six hours at 37oC with PMA and 
ionomycin in the presence of brefeldin A and monensin. Cells were then stained 
with CD1d Tetramer and with antibodies against CD4, CD8, HSA, IL-4, and 
PLZF. Flow cytometry plots are gated on CD4 SP CD1d tetramerneg HSAlow 
thymocytes. Results are representative of two independent experiments involving 
2-4 mice per group.  
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deficient mice.  As shown, SAP was essential for the development of PLZF+ 
CD4SP CD1d-tetramerneg αβ thymocytes in itk-/- mice (Figure 3.10).  
Furthermore, all itk-/- Eomes+ CD4SP thymocytes reverted to a conventional 
CD4SP phenotype in the absence of SAP (Figure 3.10).  
H. Summary 
 We have shown here that in the absence of Itk, conventional CD4+ αβ T 
cells expressing Eomes develop. Further, we show that the expansion of these 
cells is inhibited by IL-15, but iNKT cells promote the expression of Eomes in 
CD4+ T cells. We further found a population of mature CD4+ αβ T cells 
expressing PLZF that did not bind to the CD1d tetramer. In the absence of SAP, 
and thus SLAM family receptor signaling, these PLZF+ αβ T cells failed to 
develop. Additionally, Eomes+ αβ T cells failed to develop in the absence of SAP. 
Therefore, we have discovered a novel population of PLZF+ αβ T cells that may 
promote the development of Eomes+ innate T cells and expand in the absence of 
Itk. These PLZF+ αβ T cells may be a non-canonical NKT or MAIT-like population 
that could be a first line of defense against infection.  
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Figure 3.10: itk-/- CD4 SP CD1d tetramerneg TCRβhigh HSAlow PLZF+ and 
Eomes+ thymocytes are dependent on SLAM-family receptor signaling for 
development. Thymocytes from WT, Itk KO, SAP KO, and Itk/SAP DKO mice 
were harvested, processed, and stained with CD1d tetramer and with antibodies 
against CD4, CD8, TCRβ, HSA, Eomes, and PLZF. (A) Flow cytometry plots 
depicting CD4 SP TCRβhigh HSAlow CD1d tetramerneg Eomes+ and PLZF+ 
thymocytes. (B) Frequency and (C) cell number of CD4 SP TCRβhigh HSAlow 
CD1d tetramerneg Eomes+ and PLZF+ thymocytes. n = 10-12 mice per group. 
Results are representative of four independent experiments. Statistical analysis 
was performed using a one-way ANOVA. ****p < 0.0001 
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Chapter IV Attributions 
 
The material in this chapter consists of a work performed by Amanda Prince 
(AP). AP bred itk-/-, itk/il15-/-, itk/mr1-/-, itk/B2m-/- and itk/cd1d-/- mice. Catherine 
Yin (CY) bred itk-/-, H2dlAb1-Ea/itk-/-, 4get/itk-/- and itk/tcrd-/- mice. 
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Chapter IV: CD4+ PLZF+ αβ  MAIT-like T cells develop and expand in the 
absence of Itk 
 In the absence of Itk, innate-like αβ T cells develop. These αβ T cells 
express the T-box transcription factor, Eomes, and are able to produce 
IFNγ immediately upon ex vivo stimulation (Atherly et al., 2006b; Broussard et al., 
2006; Weinreich et al., 2010). This upregulation of Eomes in αβ T cells is thought 
to occur due to decreased TCR signal strength and increased IL-4 signaling 
(Gordon et al., 2011; Nayar et al., 2012; Verykokakis et al., 2010b; Weinreich et 
al., 2010). IL-4 is known to be a requirement for the development of these 
Eomes+ αβ T cells due to Itk/CD124 DKO mice lacking Eomes+ αβ T cells 
(Weinreich et al., 2010). Related to the production of IL-4, these cells also require 
the SAP for their development (Horai et al., 2007; Verykokakis et al., 2010b). 
SAP is an adaptor molecule required for SLAM-family receptor signaling, and is 
required for the development of PLZF+ T cells (Verykokakis et al., 2010b). PLZF+ 
T cells produce IL-4 to induce this Eomes+ innate-like phenotype. When Itk KO 
mice are crossed to Plzflu/lu mutant mice, Eomes+ αβ T cells fail to develop 
(Weinreich et al., 2010). Complementary to this requirement for IL-4 to induce 
Eomes in innate-like T cells, the absence of Itk leads to an increase in a 
population of γδ NKT cells expressing the Vγ1.1 Vδ6.3 TCR and PLZF (Felices et 
al., 2009; Qi et al., 2009). These cells transcribe IL-4, and γδ T cells induce a 
hyper-IgE syndrome in Itk-deficient mice (Felices et al., 2009; Qi et al., 2009). 
Thus, these Itk-deficient γδ T cells could induce Eomes expression in 
conventional αβ T cells. However, when we crossed Itk KO mice to TCRδ KO 
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mice, we did not see a decrease in Eomes expressing αβ T cells (unpublished 
data). This lead us to examine itk-/- CD4+ αβ T cells further, and thus discover a 
population of CD1d tetramerneg αβ T cells expressing PLZF that develop in the 
absence of Itk. As we saw in the previous chapter, the development of these 
cells is dependent on SLAM-family receptor signaling, and these cells were able 
to produce IL-4 upon ex vivo stimulation. In this chapter, we aim to further 
characterize these itk-/- CD1d tetramerneg PLZF+ αβ T cells and to address the 
developmental requirements for these cells.  
A. CD4+ PLZF+ CD1d tetramerneg αβ T cells transcribing IL-4 develop in the 
absence of Itk.  
 In the absence of Itk, we see a significant increase in the frequency and 
number of CD4+ PLZF+ thymocytes (Figure 4.1A) (Weinreich et al., 2010). When 
we further examined this population based on TCRδ or TCRβ expression, we see 
that although there is a significant population of γδ T cells expressing PLZF, the 
majority of CD4+ PLZF+ thymocytes are actually αβ T cells (Figure 4.1B). While in 
a WT mouse the majority of CD4+ PLZF+ TCRβ+ thymocytes are iNKT cells 
(Figure 4.1C), surprisingly, in the absence of Itk, we see that this is not the case. 
The majority of itk-/- CD4+ PLZF+ TCRβ+ thymocytes are CD1d tetramerneg, and 
this population is significantly increased over the WT population (Figure 4.1C).  
 Next, we wanted to determine if we could correlate IL-4 transcripts with 
PLZF expression. We utilized the IL-4 reporter (4get) mouse that contains a 
bicistronic promoter that adds an internal ribosome entry site containing green
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Figure 4.1: CD4+ PLZF+ αβ  T cells develop in the absence of Itk. Thymocytes 
from WT or Itk KO mice were harvested and stained with CD1d tetramer and with 
antibodies against CD4, TCRδ, TCRβ, and PLZF. (A) Flow cytometry plots 
combined with graphs indicating the frequency and cell number of CD4+ PLZF+ 
thymocytes from WT and Itk KO mice. (B) Flow cytometry plots combined with 
graphs indicating the frequency (WT and Itk KO) and cell number (Itk KO only) of 
TCRδ or TCRβ CD4+ PLZF+ thymocytes. Gated on CD4+ PLZF+ thymocytes. (C) 
Flow cytometry plots combined with graphs indicating the frequency and cell 
number of CD4+ PLZF+ TCRβ+ CD1d tetramerneg thymocytes. Gated on CD4+ 
PLZF+ TCRβ+ thymocytes. n = 20-27 mice per group. Results are representative 
of six independent experiments. Statistical analysis was performed using a Mann 
Whiteny t test. ***p < 0.0005 ****p < 0.0001 
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fluorescent protein (IRES-GFP) component to the untranslated region of the IL-4 
locus (Mohrs et al., 2001). These mice allowed us to examine IL-4 transcription in 
WT or Itk KO thymocytes. We found that there was an increase in the frequency 
of GFP+ thymocytes in Itk KO mice when compared to WT mice, which is similar 
to PLZF expression (Figure 4.2A). Additionally, we found that most of the cells 
producing IL-4 transcripts were TCRβ+ although there was a significant 
population of γδ T cells producing IL-4 (Figure 4.2B). Finally, the majority of CD4+ 
GFP+ TCRβ+ thymocytes were iNKT cells in WT mice, but again, this was not 
true in the absence of Itk. In Itk KO mice, we saw that the majority of CD4+ GFP+ 
TCRβ+ thymocytes were not binding the CD1d tetramer (Figure 4.2C). Therefore, 
we saw the IL-4 reporter expression correlated well with PLZF expression. Thus, 
these itk-/- CD4+ PLZF+ TCRβ+ CD1d tetramerneg thymocytes were capable of 
producing abundant amounts of IL-4 that would be able to convert conventional 
αβ T cells into innate-like T cells expressing Eomes.  
B. PLZF+ CD1d tetramerneg αβ T cells home to the spleen and mesenteric 
lymph node.  
 We next wanted to determine whether these PLZF+ CD1d tetramerneg αβ T 
cells could be found in peripheral organs. Upon examination of the pLN (inguinal, 
auxiliary, and cervical), spleen, mLN, iIELs, and liver, we found that PLZF+ CD1d 
tetramerneg αβ T cells were present in peripheral organs and that these cells 
preferentially homed to the spleen and mLN (Figure 4.3). Although we did see a 
significant increase in the frequency and cell number of
98
 
Figure 4.2: IL-4 transcripts correlate to PLZF expression in mature itk-/- 
CD4+ CD1d tetramerneg αβ  T cells. Thymocytes from WT 4get or Itk KO 4get 
mice were harvested, processed, and stained with CD1d tetramer and with 
antibodies against CD4, TCRδ, and TCRβ. (A) Flow cytometry plots along with 
graphs depicting the frequency and cell number of CD4+ GFP+ thymocytes. (B) 
Flow cytometry plots and graphs depicting the frequency (WT and Itk KO) and 
number (Itk KO only) of CD4+ GFP+ TCRδ+ or CD4+ GFP+ TCRβ+ thymocytes. 
(C) Flow cytometry plots along with graphs depicting the frequency and number 
of CD4+ GFP+ TCRβ+ CD1d tetramerneg thymocytes. n = 18-19 mice per group. 
Results are representative of four independent experiments. Statistical analysis 
was performed using a Mann Whitney t test. ****p < 0.0001 
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Figure 4.3: itk-/- PLZF+ MAIT-like cells preferentially home to spleen and 
mesenteric lymph node (mLN). pLN (inguinal, auxiliary, and cervical), spleens, 
mLNs, iIELs, and livers were harvested, processed and stained with CD1d 
tetramer and with antibodies against CD4, CD8, TCRδ, TCRβ, HSA, CD44, and 
PLZF. (A) Flow cytometry plots from each organ displaying CD44high PLZF+ 
lymphocytes. WT organs are on the top row while Itk KO organs are on the 
bottom row. pLNs, spleens, and mLNs are gated on CD4+ TCRδneg TCRβhigh 
HSAlow CD1d tetramerneg lymphocytes while iIELs and liver are gated on TCRδneg 
TCRβhigh HSAlow CD1d tetramerneg lymphocytes. (B) Frequency and (C) cell 
number of CD44high PLZF+ from each organ. n > 20 mice per group and the 
results are representative of more than five independent experiments for pLN, 
spleen, and mLN. n = 8-10 samples and the results are representative of two 
independent experiments for iIELs. n = 9-12 mice per group and is representative 
of one experiment for liver. Statistical analysis was performed using a Mann-
Whitney t test. *p < 0.05 **p < 0.005 ***p < 0.0005 ****p < 0.0001 
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PLZF+ CD1d tetramerneg αβ T cells in the pLN and liver, the numbers of these 
cells in the pLN and liver were 10-100 fold less than the numbers found in the  
spleen or mLN (Figure 4.3C). Interestingly, we saw a significant decrease in 
frequency and number of PLZF+ CD1d tetramerneg αβ T cells in the iIELs (Figure 
4.3B&C). Therefore, we wanted to determine if CD4+ PLZF+ CD1d tetramerneg αβ 
T cells expressed the cell surface receptors necessary for homing to mucosal 
epithelial tissues.  
 First, we wanted to determine the activation status of CD4+ PLZF+ CD1d 
tetramerneg αβ T cells. We examined CD44, CD62L, and CD127 expression on 
CD4+ PLZF+ CD1d tetramerneg TCRβhigh thymocytes and compared the 
expression of these activation markers to conventional WT or Itk KO thymocytes 
(CD4+ TCRδneg TCRβhigh CD1d tetramerneg HSAlow). We found that CD4+ PLZF+ 
CD1d tetramerneg αβ T cells had an activated phenotype with upregulated CD44 
and downregulated CD62L expression (Figure 4.4A). Interestingly, we also saw 
increased CD127 (IL-7Rα) expression on CD4+ PLZF+ CD1d tetramerneg αβ T 
cells (Figure 4.4A). MAIT cells also express CD127 (Dusseaux et al., 2011), 
which indicates that these cells may be related to itk-/- CD4+ PLZF+ αβ T cells. 
 Further, we examined the expression of the gut-homing receptors α4β7, 
CD103, and CCR6 on CD4+ PLZF+ CD1d tetramerneg αβ T cells. MAIT cells 
express α4β7 and CCR6 (Dusseaux et al., 2011; Treiner et al., 2003), and 
CD103 is commonly expressed on cells in the intestinal mucosa (Agace et al., 
2000). We found that these cells had the ability to express α4β7, CD103, and 
CCR6 (Figure 4.4B). However, we did not always see these cells expressing 
102
Figure 4.4: itk-/- PLZF+ MAIT-like αβ  T cells have an activated phenotype 
and express gut-homing receptors. Thymocytes from WT and Itk KO mice 
were harvested, processed, and stained with CD1d tetramer and with antibodies 
against CD4, CD8, TCRδ, TCRβ, HSA, CD44, CD62L, CD127, α4β7, CD103, 
CCR6, and PLZF. (A) Histograms showing CD44, CD62L, and CD127 
expression. Gray shaded histograms are WT conventional thymocytes (CD4 SP 
TCRδneg TCRβhigh CD1d tetramerneg HSAlow). Black shaded histograms are Itk KO 
conventional thymocytes (CD4 SP TCRδneg TCRβhigh CD1d tetramerneg HSAlow). 
Black open histograms are Itk KO PLZF+ MAIT-like thymocytes (CD4+ PLZF+ 
TCRδneg TCRβhigh CD1d tetramerneg). Results are representative of at least five 
independent experiments. (B) Histograms showing gut homing receptor (α4β7, 
CD103, and CCR6) expression. Gray shaded histograms are WT conventional 
thymocytes (CD4 SP TCRδneg TCRβhigh CD1d tetramerneg HSAlow). Black shaded 
histograms are Itk KO conventional thymocytes (CD4 SP TCRδneg TCRβhigh 
CD1d tetramerneg HSAlow). Black open histograms are Itk KO PLZF+ MAIT-like 
thymocytes (CD4+ PLZF+ TCRδneg TCRβhigh CD1d tetramerneg). Results are from 
4-6 independent experiments. (C) Gut-homing receptor correlations on Itk 
deficient thymocytes. Gut-homing receptor expression had wide variability 
between experiments, but we saw correlations between the frequency of CD4+ 
PLZF+ (itk-/- CD4 SP TCRδneg TCRβhigh CD1d tetramerneg HSAlow), of CD8+ 
Eomes+ (itk-/- CD8 SP TCRβhigh HSAlow), and of gut-homing receptor expression 
on PLZF+ (itk-/- CD4 SP TCRδneg TCRβhigh CD1d tetramerneg HSAlow) thymocytes. 
n = 7-14 mice per group. Results are representative of 4-6 independent 
experiments.   
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these gut-homing receptors. We found that CD4+ PLZF+ CD1d tetramerneg αβ T 
cells expressed α4β7 and CD103 in 67% of experiments (four out of six 
experiments) while CCR6 expression was seen in 50% of experiments (two out 
of four experiments). MAIT cells rely on the commensal gut flora for their 
maintenance (Treiner et al., 2003). Therefore, we hypothesized that this gut-
receptor expression could potentially correlate with the microbial environment of 
the mice. 
If the microbial environment was influencing gut-homing receptor 
expression, we reasoned that the expression of α4β7, CD103, or CCR6 may 
correlate with changes in CD4+ PLZF+ CD1d tetramerneg αβ T cells or with 
changes in Eomes+ αβ T cells. Interestingly, we found that α4β7 expression 
positively correlated with an increase in CD4+ PLZF+ CD1d tetramerneg αβ T cells 
and with an increase in CD8+ Eomes+ αβ T cells (Figure 4.4C). Further, CD103 
expression positively correlated with the presence of CD4+ PLZF+ CD1d 
tetramerneg αβ T cells (Figure 4.4C). However, CCR6 expression negatively 
correlated with CD8+ Eomes+ αβ T cells (Figure 4.4C). Taken together these data 
suggest that the expression of these gut-homing receptors on and the presence 
of CD4+ PLZF+ CD1d tetramerneg αβ T cells may be due to dynamics in the 
microbial environment. Thus, we have christened these cells as MAIT-like and 
will refer to them in this manner for the remainder of this thesis.  
C. itk-/- MAIT-like cells have a restricted TCR repertoire. 
 Many of the innate-like populations of αβ T cells expressing PLZF (i.e. 
iNKT and MAIT cells) have a restricted TCR repertoire that is considered to be 
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invariant (Gapin, 2009). Hence, we wanted to determine if itk-/- MAIT-like cells 
had a restricted TCR repertoire. Accordingly, WT and Itk KO thymocytes were 
stained with various Vβ and Vα antibodies. Interestingly, we found significant 
decreases in Vβ14 and Vα2 expression on itk-/- MAIT-like T cells (Vβ14 gating: 
CD4 SP TCRβhigh HSAlow PLZF+; Vα2 gating: CD4 SP TCRδneg TCRβhigh CD1d 
tetramerneg HSAlow PLZF+) when these cells were compared to WT or Itk KO 
conventional thymocytes (Figure 4.5) (Vβ14 gating: CD4 SP TCRβhigh HSAlow; 
Vα2 gating: CD4 SP TCRδneg TCRβhigh CD1d tetramerneg HSAlow). Additionally, 
we saw significant increases in Vα3.2 and Vα11 expression on itk-/- MAIT-like T 
cells (CD4 SP TCRδneg TCRβhigh CD1d tetramerneg HSAlow PLZF+) when 
compared to conventional WT or Itk KO thymocytes (gated on CD4 SP TCRδneg 
TCRβhigh CD1d tetramerneg HSAlow Eomes- PLZF-) (Figure 4.5). We saw no 
difference in Vα8.3 usage between these three populations (Figure 4.5). Thus, 
itk-/- MAIT-like cells appear to have a restricted TCR repertoire similarly to iNKT 
and MAIT cells.  
D. itk-/- MAIT-like cells develop independently of MHC class I.  
 As described previously, PLZF is expressed in iNKT cells and in human 
MAIT cells (Kovalovsky et al., 2008; Martin et al., 2009; Savage et al., 2008). 
Since itk-/- MAIT-like cells appear to be closely related to MAIT and iNKT cells, we 
examined whether itk-/- MAIT-like cells required either MR1 or CD1d for their 
development. MR1 and CD1d are non-classical class Ib MHC molecules that are 
required for the selection of MAIT cells or iNKT cells, respectively
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Figure 4.5: itk-/- MAIT-like cells have a skewed TCR repertoire. Thymocytes 
from WT or Itk KO mice were harvested and stained with CD1d tetramer and with 
antibodies against either Vβ14, Vα2, Vα3.2, Vα8.3, or Vα11 and against CD4, 
CD8, TCRδ, TCRβ, HSA, Eomes, and PLZF. Vβ14 is gated on CD4 SP TCRβhigh 
HSAlow thymocytes. Vα2, Vα3.2, Vα8.3, and Vα11 are gated on CD4 SP TCRδneg 
TCRβhigh CD1d tetramerneg HSAlow thymocytes. Black bars represent WT 
conventional CD4 αβ T cells. Gray bars represent Itk KO CD4 αβ T cells. White 
bars represent Itk KO PLZF+ MAIT-like αβ T cells. n = 6-7 mice per group. 
Results are representative of two independent experiments. Statistical analysis 
was performed using a one-way ANOVA. ***p < 0.0005 ****p < 0.0001  
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(Treiner et al., 2003; Kronenberg, 2005; Kronenberg and Engel, 2007). 
Therefore, Itk KO mice were crossed to MR1 KO or crossed to CD1d KO mice, 
and the presence of itk-/- MAIT-like cells was examined. Interestingly, the 
absence of MR1 or CD1d had no effect on the development of itk-/- MAIT-like T 
cells (Figure 4.6 and 4.7).  
 Although itk-/- MAIT-like cells were unaltered by the absence of MR1 or 
CD1d, it was still possible that these cells are being positively selected on class I 
MHC molecule (i.e. Qa, TL, H2-M3, etc.). The vast majority of class I MHC 
molecules require β2m for their cell surface expression (Rodgers and Cook, 
2005). Thus, in the absence of β2m, we would be able to prevent the expression 
of the majority of class I MHC molecules and subsequently prevent the positive 
selection of many innate-like lymphocytes. Consequently, we utilized Itk/β2m 
DKO mice to examine the development of itk-/- MAIT-like T cells. Incredibly, we 
found that the absence of β2m had no effect on the development of itk-/- MAIT-
like T cells (Figure 4.8). Therefore, we hypothesize that this subset of T cells 
required a class Ib MHC molecule that does not require the use of β2m for 
expression or this subset of T cells utilized class II MHC for positive selection. 
E. MHC class II-restricted cells regulate the expansion of itk-/- MAIT-like 
cells.  
 Since itk-/- MAIT-like cells did not appear to be positively selected upon a 
class I MHC molecule, we examined Itk/MHC II DKO mice for the presence of 
these MAIT-like T cells. While we did not see a difference in frequency of itk-/- 
MAIT-like T cells between Itk KO and Itk/MHC II DKO mice, there was a 
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Figure 4.6: itk-/- CD4+ PLZF+ αβ T cells develop independently of MR1. 
Thymocytes from WT, Itk KO, MR1 KO, or Itk/MR1 DKO mice were isolated and 
stained with CD1d tetramer and with antibodies against CD4, TCRδ, TCRβ, and 
PLZF. (A) Flow cytometry plots showing gating strategy. CD4+ PLZF+ TCRβ+ 
thymocytes were gated on prior to examining the binding of CD1d tetramer. 
Frequency (B) and absolute cell numbers (C) of CD4+ PLZF+ TCRδneg TCRβhigh 
CD1d tetramerneg thymocytes. n = 5-8 mice per group. Results are representative 
of three independent experiments. Statistical analysis performed using a one-
way ANOVA. *p < 0.05  **p < 0.005 ****p < 0.0001 
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Figure 4.7: itk-/- CD4+ PLZF+ αβ T cells develop independently of CD1d. 
Thymocytes from WT, Itk KO, CD1d KO, or Itk/CD1d DKO mice were harvested 
and stained with CD1d tetramer and with antibodies against CD4, TCRδ, TCRβ, 
and PLZF. (A) Flow cytometry plots depicting the gating strategy. Binding of the 
CD1d tetramer was examined on CD4+ PLZF+ TCRβ+ thymocytes. Frequency (B) 
and cell number (C) of CD4+ PLZF+ TCRβ+ CD1d tetramerneg thymocytes. n = 7-9 
mice per group. Results are from four independent experiments. Statistical 
analysis performed using a one-way ANOVA. ****p < 0.0001****p < 0.0001 
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Figure 4.8: itk-/- MAIT-like cells develop independently of β2m. Thymocytes 
from WT, Itk KO, β2m KO, and Itk/β2m DKO mice were processed and stained 
with CD1d tetramer and with antibodies against CD4, TCRδ, TCRβ, and PLZF. 
(A) Flow cytometry plots depicting CD4+ PLZF+ TCRβ+ thymocytes binding to 
CD1d tetramer. (B) Frequency and (C) cell number of CD4+ PLZF+ TCRβ+ CD1d 
tetramerneg thymocytes. n = 5-10 mice per group. Results are representative of 
three independent experiments. Statistical analysis was performed using a one-
way ANOVA. *p < 0.05, **p < 0.005, ****p < 0.0001 
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significant decrease in the number of itk-/- MAIT-like T cells in the absence of 
class II MHC (Figure 4.9). Thus, while the absence of class II MHC does not 
appear to prevent the development of itk-/- MAIT-like cells, the presence of a 
class II MHC restricted T cell does appear to regulate the expansion of itk-/- 
MAIT-like T cells. 
F. itk-/- MAIT-like cells develop independently of γδ  T cells. 
 Since it appeared that itk−/− MAIT-like cells did not require a known MHC 
molecule for development, we began to hypothesize that these cells may develop 
similarly to γδ T cells and not require MHC molecules for development (Carding 
and Egan, 2002). Thus, we wondered if γδ T cells may aid in the development of 
itk-/- MAIT-like cells. First we examined if itk-/- MAIT-like cells expressed TCRδ 
intracelllularly. However, we found that the majority of itk-/- CD4+ PLZF+ 
thymocytes expressed only TCRβ (Figure 4.10). We then determined if itk-/- 
MAIT-like cells were present in the absence of γδ T cells. Thus, we examined the 
presence of itk-/- MAIT-like cells in Itk/TCRδ DKO mice. Again, we found that the 
absence of γδ T cells did not effect to the development of itk-/- MAIT-like cells 
(Figure 4.11). Although these cells appear to develop independently of MHC, 
similarly to γδ T cells, the development of itk-/- MAIT-like cells does not appear to 
be influenced by γδ T cells, which indicates that these MAIT-like cells are a 
separate lineage from γδ T cells. 
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Figure 4.9: itk-/- MAIT-like cells may partially depend on CD4+ T cells for 
expansion. Thymocytes from WT, Itk KO, MHC II KO, or Itk/MHC II DKO mice 
were harvested and stained with CD1d tetramer and with antibodies against 
CD4, TCRδ, TCRβ, and PLZF. (A) Flow cytometry plots depicting gating strategy. 
CD4+ PLZF+ TCRβ+ thymocytes were gated on prior to examining binding of the 
CD1d tetramer. Frequency (B) and cell number (C) of CD4+ PLZF+ TCRβ+ CD1d 
tetramerneg thymocytes are shown in graphs. n = 6-8 mice per group. Data is 
representative from three independent experiments. Statistical analysis was 
performed using a one-way ANOVA. **p < 0.005 ****p < 0.00001 
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Figure 4.10: itk-/- PLZF+ MAIT-like cells do not express TCRδ . Thymocytes 
from WT and Itk KO mice were harvested and stained for CD4 and stained 
intracellulary for TCRδ, TCRβ, and PLZF.  Results are representative of two 
independent experiments. 
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Figure 4.11: itk-/- MAIT-like cells develop independently of γδ  T cells. 
Thymocytes from WT, Itk KO, TCRδ KO, and Itk/TCRδ DKO mice were stained 
with CD1d tetramer and with antibodies against CD4, CD8, TCRβ, HSA, CD44, 
and PLZF. (A) Flow cytometry plots showing CD44high PLZF+ cells. (B) Frequency 
and (C) cell number of CD4 SP TCRβhigh CD1d tetramerneg HSAlow PLZF+ 
thymocytes. n = 4-7 mice per group. Results are from two independent 
experiments. Statistical analysis was performed using a one-way ANOVA. *p < 
0.05, ***p < 0.0005, ****p < 0.0001 
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G. IL-15 regulates the expansion of itk-/- MAIT-like cells in the periphery. 
 Although we were unable to determine the MHC molecule required for the 
positive selection of itk-/- MAIT-like T cells, previous data had suggested a close 
relationship between these cells and iNKT cells. For example, itk-/- MAIT-like cells 
express PLZF and require SAP for their development. Hence, we wanted to 
examine other elements required for iNKT cell development. IL-15 is an 
important cytokine required for terminal maturation and maintenance of iNKT 
cells (Ohteki et al., 1997). However, the absence of IL-15 had no effect on the 
development of itk-/- MAIT-like cells (Figure 4.12). However, we noticed that in 
the absence of IL-15, the number of itk-/- MAIT-like cells significantly increased in 
the spleen and mLN (Figure 4.13). Thus, IL-15 may negatively regulate the 
expansion of itk-/- MAIT-like cells in the periphery. Alternatively, since CD8+ T 
cells are reduced in the absence of Itk and IL-15, this absence may allow itk-/- 
MAIT-like cells to homeostatically expand.  
H. Summary 
 We have shown that in the absence of Itk, CD4+ PLZF+ CD1d tetramerneg 
αβ T cells with an activated phenotype develop. The PLZF expression of these 
itk-/- CD4+ PLZF+ CD1d tetramerneg αβ T cells strongly correlated to the presence 
of IL-4 transcripts seen with IL-4 reporter mice. Additionally, these cells have a 
restricted TCR repertoire and preferentially home to the spleen and mLN. Thus, 
we have christened these cells “MAIT-like.” Further, we determined that these 
cells do not appear to require a known MHC molecule for their development, yet 
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Figure 4.12: itk-/- CD4+ PLZF+ MAIT-like cells develop independently of IL-15. 
Thymocytes from WT, Itk KO, IL-15 KO, and Itk/IL-15 DKO mice were harvested, 
processed, and stained with CD1d tetramer and with antibodies against CD4 
TCRδ, TCRβ, and PLZF. (A) Flow cytometry plots depicting gates for CD4+ 
PLZF+ TCRβ+ CD1d tetramerneg thymocytes. (B) Frequency and (C) cell number 
of CD4+ PLZF+ TCRβ+ CD1d tetramerneg thymocytes. n = 6-7 mice per group. 
Results are representative of three independent experiments. Statistical analysis 
was performed using a one-way ANOVA. **p < 0.005 ****p < 0.0001 
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Figure 4.13: IL-15 regulates the expansion of itk-/- CD4+ PLZF+ MAIT-like 
cells in the periphery. Spleens and mLNs from WT, Itk KO, IL-15 KO, and 
Itk/IL-15 DKO mice were harvested, processed, and stained with CD1d tetramer 
and with antibodies against CD4, TCRδ, TCRβ, and PLZF. (A) Frequency of 
CD4+ PLZF+ TCRβ+ CD1d tetramerneg thymocytes. (B) Cell number of CD4+ 
PLZF+ TCRβ+ CD1d tetramerneg thymocytes. n = 6-7 mice per group. Results are 
representative of three independent experiments. Statistical analysis was 
performed using a one-way ANOVA. *p < 0.05 **p < 0.005 ***p < 0.0005 ****p < 
0.0001 
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are a separate lineage from γδ T cells. However, it does appear that conventional 
CD4+ αβ T cells and IL-15 regulate the expansion of these itk-/- MAIT-like T cells. 
Thus, we have attempted to characterize a novel subset of innate-like 
lymphocytes that expand in the absence of Itk. 
To conclusively show that itk-/- MAIT-like cells are closely related to MAIT 
cells and may be the equivalent of MAIT cells in the mouse, we will need to 
determine if itk-/- MAIT-like cells require commensal gut flora for their 
maintenance. To do this, we will need to treat Itk KO mice with a strong antibiotic 
cocktail in an attempt to make the these mice “germ-free” prior to examining the 
presence of itk-/- MAIT-like cells in the absence of commensal gut flora. While we  
hypothesize that itk-/- MAIT-like cells will require commensal gut flora for their 
development, these experiments are ongoing.  
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Chapter V: Eomesodermin+ innate CD8+ αβ T cells have impaired protective 
memory responses to lymphocytic choriomeningitis virus (LCMV) 
 Conventional CD8+ αβ T cells are a fundamental component of our 
immune system’s defense against intracellular pathogens. Upon activation, 
conventional CD8+ αβ T cells are primed to expand and differentiate in order to 
exert effector functions, such as cytokine production and cytolysis (Williams and 
Bevan, 2007). Upon clearance of a pathogen, CD8+ T cells contract, yet a small 
pool of memory cells is retained that are programmed to respond more rapidly 
and robustly to a secondary challenge (Williams and Bevan, 2007). The dynamic 
network of signaling requirements resulting in transcription factor activation that 
programs memory CD8+ T cells is under investigation. However, many parts of 
this network have been examined and we have some knowledge on the 
requirements for formation of protective and functional memory.  
 During a primary response to LCMV, CD4+ helper T cells are not required 
to help CD8+ T cells to clear this virus. However, when CD4 deficient or class II 
MHC deficient mice are infected with LCMV, there is a decrease in the frequency 
of antigen-specific CD8+ T cells at 28 days post-infection and a defect in the 
expansion of these CD8+ T cells upon secondary stimulation (Janssen et al., 
2003). Thus, it was determined that although CD4+ T cells are not required for 
the primary response to LCMV, CD4+ T cells are required for the differentiation of 
protective memory CD8+ T cell responses. The help provided by CD4+ T cells to 
CD8+ T cells includes IL-2 signaling and CD40-CD40L interactions (Bennett et 
al., 1998; Bourgeois et al., 2002; Schoenberger et al., 1998; Williams et al., 
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2006b). Without these signals, CD8+ memory T cell responses are impaired upon 
recall.  
 Although the response to intracellular pathogens and the formation of 
memory by conventional CD8+ T cells is well documented (Williams and Bevan, 
2007), little is known about the recall of Eomes+ innate CD8+ αβ T cells. These 
cells develop in the absence of Itk, KLF2, Id3, and CBP and in the absence of 
SLP-76 signaling (Atherly et al., 2006a; Broussard et al., 2006; Fukuyama et al., 
2009; Gordon et al., 2011; Verykokakis et al., 2010b; Weinreich et al., 2010). The 
responses of peripheral KLF2-deficient CD8+ αβ T cells are challenging to study 
since T cells deficient in KLF2 fail to emigrate from the thymus due the absence 
of S1P1 (Carlson et al., 2006). The role of Id3 in the formation of memory has 
been studied, and it was determined that the maintenance of memory CD8+ T 
cells was lost in the absence of Id3 (Ji et al., 2011; Yang et al., 2011). However, 
these studies were performed using TCR transgenic (pmel-1 and OT-I) mice 
deficient in Id3 (Ji et al., 2011; Yang et al., 2011), which prevents the 
development of innate CD8+ T cells (Atherly et al., 2006b). Therefore, this study 
involving Id3 may be more useful in studying the role of Id3 in conventional CD8+ 
T cell rather than innate CD8+ T cells.  
One studying examining the function of Eomes+ innate CD8+ T cells 
involved the SLP-76Y145F knock-in mouse. When these mice are infected with 
LCMV, innate CD8+ T cells have a skewed cytokine response at 8 days post-
infection (Smith-Garvin et al., 2010). Despite this skewed cytokine response, 
SLP-76Y145F mutant mice were able to produce long-lived memory CD8+ T cells 
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(Smith-Garvin et al., 2010). Thus, it appeared that innate CD8+ T cells could 
sustain a pool of memory CD8+ T cells post-infection.  
 In the absence of Itk, there have been a few studies involving the 
response of Itk-deficient innate CD8+ T cells during the primary response. For 
example, when Itk KO mice are infected with L. monocytogenes, these mice 
have a lower bacterial burden at day three post-infection when compared to WT 
mice (Hu et al., 2007). However, when Itk KO mice are infected with viruses, the 
response is delayed when compared to WT mice. At day six post-infection with 
vaccinia virus (VV) or vesticular stomatitis virus (VSV), Itk KO mice had reduced 
cytolytic function (Bachmann et al., 1997). When Itk KO mice are infected with 
LCMV  (strain Armstrong), Itk KO mice are able to clear LCMV similarly to WT 
mice (Atherly et al., 2006a). Despite this ability of Itk KO mice to clear LCMV, Itk-
deficient CD8+ T cells have reduced numbers of IFNγ+ CD8+ T cells in response 
to stimulation with the LCMV-specific peptides NP396 and GP33 (Atherly et al., 
2006a). Additionally, this appeared to be a defect of Itk-deficient CD8+ T cells 
since itk-/- OT-I+ CD8+ T cells had a similar defect in response to rVV-OVA 
(Atherly et al., 2006a). Further, we saw skewing of the cytokine response to 
LCMV. Itk-deficient CD8+ T cells had few antigen-specific cells producing TNF 
and IFNγ in response to stimulation (Atherly et al., 2006a). This skewing 
continued into the memory phase of the response, which indicates that the 
polyfunctionality of memory CD8+ T cells may be impaired in the absence of Itk 
(Atherly et al., 2006a). Thus, we wondered if Itk-deficient memory CD8+ T cells 
may have a skewed response upon a challenge infection. 
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 In addition to defects seen during the primary response in the absence of 
Itk, recent data has shown that patients with Itk null mutations suffer from 
Epstein-Barr Virus (EBV) induced lymphoproliferative disorders (Huck et al., 
2009; Linka et al., 2012; Stepensky et al., 2011). These patients succumb to 
these disorders and only one patient receiving a bone marrow transplant has 
survived this disorder (Stepensky et al., 2011). EBV is a γ-herpes virus that is a 
lifelong, asymptomatic infection for the majority of individuals (Young and 
Rickinson, 2004). However, in the absence of Itk, patients succumb to this 
infection (Huck et al., 2009; Linka et al., 2012; Stepensky et al., 2011). Thus, we 
hypothesized that this may be due to a defective memory CD8+ T cell response 
in the absence of Itk. Therefore, we utilized LCMV and Itk-deficient mice to study 
the role of Itk in the generation of protective memory repsonses. 
A. Itk KO memory T cells have impaired protection upon challenge.  
 To test if Itk KO memory T cells could provide protection upon challenge, 
WT and Itk KO mice were infected with LCMV Armstrong. After six to seven 
weeks post-immunization, spleens from naïve or immunized (WT and Itk KO) 
mice were harvested, processed, and transferred into a congenic host. One day 
after transfer, host mice were infected with LCMV (strain CL13). After three days 
post-infection, spleens were harvested and processed to assess the viral titer via 
a plaque assay (Figure 5.1A). We found that mice receiving WT memory T cells 
had a reduced viral titer when compared to mice receiving naïve WT splenocytes 
(Figure 5.1B). However, mice receiving Itk-deficient memory T cells had similar 
viral titers as mice receiving Itk-deficient naïve splenocytes (Figure 5.1B).
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Figure 5.1: Protection from memory CD8+ T cells is defective in the absence 
of Itk. (A) Experimental Design. WT or Itk KO mice were initially infected with 5 x 
104 PFU LCMV Armstrong. Around 42 days post-infection, total splenocytes were 
harvested and transferred to WT congenic hosts. Host mice were then infected 
with 105 PFU LCMV CL13. Spleens from infected mice were harvested on day 3 
post-infection with LCMV CL13. (B) Viral titers from the spleens of mice receiving 
LCMV naïve WT or Itk KO splenocytes (black bars) or receiving LCMV immune 
WT or Itk KO splenocytes (gray bars). n = 3 mice per group per experiment. 
Results are representative of three independent experiments. Statistical analysis 
was performed using a student’s t-test. **p < 0.005. 
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Therefore, we concluded that Itk-deficient memory T cells had impaired 
protection upon a challenge infection. 
B. WT and Itk KO memory CD8+ T cells are present in similar frequencies 
and cell numbers post-infection. 
 We next wanted to determine if WT and Itk KO memory CD8+ T cells were 
present at similar frequencies and cell numbers during the memory phase of the 
primary response. If these Itk-deficient memory CD8+ T cells had a defect in 
maintenance and were significantly reduced in frequency and cell number, then it 
would be unfair to compare protective responses by transferring total 
splenocytes. Therefore, we infected WT and Itk KO mice with LCMV Armstrong, 
and at 42 days post-infection, splenocytes were harvested, processed, and 
stained with tetramers specific for the GP33 and NP396 epitopes of LCMV. We 
found no differences in the frequency or cell number of CD44high GP33+ or 
NP396+ CD8+ T cells between WT and Itk KO mice (Figure 5.2).  
Additionally, we examined IFNγ production by memory CD8+ T cells in WT 
and Itk KO mice at 42 days post-infection. When WT or Itk KO splenocytes were 
stimulated ex vivo with GP33 or NP396 peptides for five hours in the presence of 
brefeldin A, we saw similar frequencies and numbers of IFNγ producing WT or 
Itk-deficient CD8+ CD44high cells (Figure 5.3). Therefore, Itk-deficient memory 
CD8+ T cells are maintained similarly to WT memory CD8+ T cells. 
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Figure 5.2: Itk-deficient memory CD8+ T cells are present in similar 
frequency and number as WT memory CD8+ T cells. WT and Itk KO mice 
were infected with 5 x 104 PFU LCMV Armstrong. At 42 days post-infection, 
spleens were harvested, processed, and stained with tetramers for either the 
GP33 or NP396 LCMV-specific epitopes and with antibodies against CD8 and 
CD44. (A) Flow cytometry plots depicting the presence of GP33+ or NP396+ 
CD44high CD8+ splenocytes in WT or Itk KO mice on d0 or d42 post-infection (B) 
Frequency and (C) cell number of GP33+ or NP396+ CD44high CD8+ splenocytes 
at d42 post-infection. No significant difference between WT or Itk KO memory 
CD8+ T cells was seen. Statistical analysis was performed using a Mann Whitney 
t test. GP33: n = 8-10 mice per group from four independent experiments. 
NP396: n = 7 mice per group from three independent experiments.  
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Figure 5.3: WT and Itk KO mice have similar frequencies and numbers of 
IFNγ  producing CD8+ memory T cells. WT and Itk KO mice were infected with 
5 x 104 PFU LCMV Armstrong. At 42 days post-infection, splenocytes were 
harvested, processed, and stimulated with peptides for the GP33 or NP396 
LCMV epitopes for 5 hours at 37oC in the presence of brefeldin A. Splenocytes 
were then stained for CD8, TCRβ, CD44, and IFNγ. (A) Flow cytometry plots 
depicting CD44high IFNγ+ CD8+ TCRβ+ splenoctyes. (B) Frequency and (C) cell 
number of CD44high IFNγ+ CD8+ TCRβ+ splenocytes. n = 9-13 mice per group. 
Results are representative of five independent experiments. Statistical analysis 
was performed using a student’s t test. 
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C. WT and Itk KO memory CD8+ T cells have similar cytolytic function. 
 Another contributing factor to the impaired protection of Itk KO memory T 
cells could be diminished cytolytic responses to antigen. To test this, we 
examined the degranulation marker CD107a. CD107a and CD107b line the 
membrane of cytotoxic granules and are expressed on the cell surface upon 
degranulation (Betts et al., 2003). Therefore, if antibodies against CD107a are 
added during stimulation, we can detect CD107a levels on the surface of the cell 
during degranulation. When we examined CD107a expression on WT or Itk KO 
CD8+ T cells stimulated with GP33 or NP396 peptides at 42 days post-infection, 
we saw similar frequencies and cell numbers of CD107a+ CD8+ T cells (Figure 
5.4). Therefore, degranulation of memory CD8+ T cells was not affected by the 
absence of Itk.  
In addition to examining the degranulation of WT and Itk KO memory 
CD8+ T cells, we also performed an in vivo cytotoxicity assay to assess if peptide 
coated targets could be effectively lysed by Itk-deficient memory CD8+ T cells. In 
this assay, WT and Itk KO mice were infected with LCMV Armstrong. After 42 
days of infection, we transferred in congenic splenocytes that were loaded with 
either the irrelevant peptide ovalbumin (OVA), the antigen-specific peptide 
NP396, or the antigen-specific peptide GP33. Additionally, these congenic 
splenocytes were labeled with varying concentrations of CFSE. This dye readily 
crosses the cell membrane and can crosslink to intracellular proteins to label 
cells. We labeled OVA loaded targets as CFSElow, NP396 targets as CFSEint, and 
GP33 targets as CFSEhigh. These cells were transferred into immunized mice for 
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Figure 5.4: Itk KO CD8+ memory T cells have similar degranulation to WT 
CD8+ memory T cells. WT and Itk KO mice were infected with 5 x 104 PFU 
LCMV Armstrong. At 42 days post-infection, spleens were harvested, processed, 
and stimulated for 5 hours at 37oC in the presence of 5 µg/mL GP33 or NP396 
peptides and brefeldin A. (A) Flow cytometry plots depicting CD107a expression 
in WT or Itk KO CD8+ TCRβ+ splenocytes 42 days post-infection. (B) Frequency 
and (C) cell number of CD107a+ CD8+ TCRβ+ splenocytes. No significant 
differences were found between WT and Itk KO memory CD8+ T cells. Statistical 
analysis was performed via a Mann Whitney t test. n = 8 mice per group. Results 
are representative of four independent experiments. 
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four hours before cytolysis was assessed. We found that both naïve WT and Itk 
KO mice had not lysed OVA, NP396, or GP33 target cells (Figure 5.5A). 
However, in mice immunized with LCMV, we found comparable lysis of NP396 
and GP33 target cells between WT and Itk KO mice (Figure 5.5A&B). Between 
multiple experiments, we found no differences between the percent specific lysis 
of WT or Itk KO immunized mice (Figure 5.5B). Therefore, Itk-deficient memory 
CD8+ T cells appear to have similar cytolytic function as WT memory CD8+ T 
cells.  
D. Itk KO memory CD8+ T cells respond to a challenge infection similarly to 
the primary infection.  
 Since there were no obvious defects in Itk-deficient resting memory CD8+ 
T cells, we wanted to examine how Itk-deficient memory CD8+ T cells responded 
during the challenge infection. WT and Itk KO mice were infected with LCMV 
Armstrong, and six to seven weeks post-infection, total splenocytes were 
transferred into a congenic host. One day after transfer, the host was infected 
with LCMV CL13. At seven days post the challenge infection, TNF and IFNγ 
production by splenocytes was assessed after stimulation with GP33 or NP396 
peptides. Itk-deficient memory CD8+ T cells trended towards an increase in the 
frequency of IFNγ+ TNF- CD8+ T cells with a decrease in the IFNγ+ TNF+ CD8+ T 
cells when compared to WT memory T cells (Figure 5.6A&B). Although these 
changes were not statistically significant, when we compared the ratio of IFNγ+ 
TNF+: IFNγ+ TNF- CD8+ T cells, we saw a significant decrease in this ratio in Itk 
KO memory T cells compared to WT memory T cells (Figure 5.6C). This result 
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Figure 5.5: Cytotoxicity of Itk-deficient memory CD8+ T cells is similar to 
WT memory CD8+ T cells. WT or Itk KO mice were infected with 5 x 104 PFU 
LCMV Armstrong and 42 days post-infection, mice received CFSE-labeled and 
peptide loaded splenocytes from congenic (CD45.1) WT mice. Transferred cells 
rested in the host mice for five hours prior to sacrificing the mice and harvesting 
their spleens for staining with antibodies against CD45.1 (congenic marker). Loss 
of CFSE-labeled cells was assessed on CD45.1+ splenocytes. (A) Flow 
cytometry plots depicting CFSE fluorescence in naïve or immune WT and Itk KO 
mice. CFSEhigh: GP33 (LCMV) labeled splencytes, CFSEint: NP396 (LCMV) 
labeled splenocytes, and CFSElow: OVA (control) labeled splenocytes. (B) 
Percent specific lysis of GP33 and NP396 labeled cells. Percent specific lysis 
was determined by this equation: 100 x (1-((# experimental mouse target 
peak/#experimental mouse control peak)/(# control mouse target peak/# control 
mouse target peak))). No significant differences in cytotoxicity were seen 
between WT and Itk KO mice. Statistical analysis was determined by a Mann 
Whitney t test. Results are representative of two independent experiments. 
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Figure 5.6: Cytokine production of memory T cells is skewed upon 
challenge in the absence of Itk. WT and Itk KO mice were infected with 5 x 104 
PFU LCMV Armstrong. At 42 days post-infection, mice were sacrificed and 
adoptively transferred into a congenic (CD45.1+) host. One day post-transfer, 
mice were infected with 105 PFU LCMV CL13. At seven days post-infection, 
spleens were harvested, processed, and stimulated with GP33 or NP396 
peptides for 5 hours at 37oC in the presence of brefeldin A. (A) Flow cytometry 
plots displaying IFNγ and TNF production of CD45.2+ CD8+ CD44high 
splenocytes. (B) Frequency of IFNγ+ TNF- and IFNγ+ TNF+ memory CD8+ T cells 
in response to GP33 or NP396 stimulation. (C) Ratio of IFNγ+ TNF+: IFNγ+ TNF- 
producing memory CD8+ T cells for GP33 or NP396 stimulated splenocytes. (D) 
Number of IFNγ+ TNF- or IFNγ+ TNF+ memory CD8+ T cells stimulated with GP33 
or NP396 peptides. Black bars represent WT CD8+ memory T cells while gray 
bars represent Itk KO memory CD8+ T cells. n = 9 mice per group. Results 
represent three independent experiments. Statistical analysis was performed 
using a student’s t test. *p < 0.05, ***p ≤ 0.0005, ****p < 0.0001 
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demonstrates that the cytokine response of Itk KO memory CD8+ T cells is 
skewed during the challenge response and that this skewed response is similar 
to the primary response of Itk KO CD8+ T cells to infection (Atherly et al., 2006a). 
Further, this data demonstrates that Itk-deficient memory CD8+ T cells may have 
reduced polyfunctionality when compared to WT memory CD8+ T cells. This may 
indicate a biological significance that results in a defect in protective memory 
responses in the absence of Itk.  
When we examined the cell numbers of IFNγ+ TNF- and IFNγ+ TNF+ CD8+ 
T cells between WT and Itk KO memory cells, we saw that the number of Itk KO 
memory T cells producing cytokine in response to stimulation was significantly 
reduced when compared to WT memory T cells (Figure 5.6D). We wanted to 
determine if this was due to an overall decrease in the expansion of memory T 
cells upon challenge or due to loss of function. Therefore, we examined the 
frequency of GP33+ and NP396+ via tetramer binding (Figure 5.7A&B). We found 
that there were no significant differences between WT and Itk KO memory T cells 
in the frequency of antigen-specific CD8+ T cells. However, when we examined 
the fold expansion of the antigen-specific population in response to the challenge 
infection, we saw that while WT memory T cells expanded robustly in response 
to challenge, Itk-deficient memory T cells had impaired expansion upon a 
challenge infection (Figure 5.7C). Therefore, this impaired expansion may be 
responsible for the impaired protection of Itk KO memory CD8+ T cells.
145
Figure 5.7: Itk-deficient memory CD8+ T cells have decreased expansion 
upon challenge. WT and Itk KO mice were infected with 5 x 104 PFU LCMV 
Armstrong. At 42 days post-infection, mice were sacrificed and total splenocytes 
were transferred into a congenic (CD45.1) host. Host mice were infected with 105 
PFU LCMV CL13. At seven days post-infection, spleens were harvested, 
processed, and stained with dimers or tetramers against the GP33 and NP396 
epitopes of LCMV and with antibodies against CD45.2, CD8, and CD44. (A) Flow 
cytometry plots and (B) graphs depicting the frequency of WT or Itk KO GP33 or 
NP396 specific memory CD8+ T cells. (C) Fold expansion of antigen-specific WT 
or Itk KO memory CD8+ T cells. Fold expansion of antigen specific cells was 
determined by dividing the number of antigen specific cells in an infected host by 
the number of antigen specific cells in an uninfected host. n = 3 mice per group 
per experiment. Data is representative of two independent experiments. 
Statistical analysis was performed using a student’s t test. *p < 0.05, **p < 0.005, 
***p < 0.0005 
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E. CD4 help is provided in the absence of Itk. 
 We began to wonder if CD4 help was provided in the absence of Itk since 
Itk-deficient memory CD8+ T cells have diminished expansion upon challenge. 
Although CD4 help is not crucial for clearance of a primary infection with LCMV, 
it is critical for memory CD8+ T cell programming and maintenance (Janssen et 
al., 2003; Sun and Bevan, 2003). In the absence of Itk, we do see a population of 
innate CD4+ T cells develop (Hu and August, 2008). Although this population is 
small, it may affect CD4 help provided to CD8 T cells in an antigenic 
environment. One aspect of this help provided by CD4 T cells is CD40-CD40L 
interaction (Bennett et al., 1998; Bourgeois et al., 2002; Schoenberger et al., 
1998). Thus, we wanted to determine if CD40L was upregulated on Itk KO 
antigen-specific CD4+ T cells. WT and Itk KO mice were infected with LCMV 
Armstrong, and on days seven or eight, 28 or 30, or 42 post-infection, 
splenocytes were stimulated with the LCMV CD4 epitope GP61. WT CD4+ T cells 
upregulated CD40L in response to this stimulation (Figure 5.8). Interestingly, we 
saw that Itk KO CD4+ T cells also upregulated CD40L in response to GP61 
stimulation and that the frequency of CD4 T cells expressing CD40L was 
significantly increased (Figure 5.8A&B). This may be due to the overall decrease 
in CD4 T cells in the absence of Itk, which could lead to an increase in the 
frequency of the antigen specific population of CD4+ T cells upon infection.  
Although we did see a significant decrease in the number of CD40L+ CD4+ T 
cells at day 42 post-infection, since the frequency is increased, we do not think 
this affects the help provided to CD8+ T cells. Additionally, although these 
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Figure 5.8: Itk-deficient CD4+ T cells can provide help to CD8+ T cells. WT 
and Itk KO mice were infected with 5 x 104 PFU LCMV Armstrong. At days 0, 7/8, 
28/30, and 42 post-infection, spleens were harvested, processed and stimulated 
with a peptide specific for the LCMV CD4 epitope, GP61, for five hours at 37oC. 
Splenocytes were then stained with antibodies against CD4, TCRβ, CD44, and 
CD40L. (A) Flow cytometry plots along with graphs depicting the frequency (B) 
and number (C) of CD4+ TCRβ+ CD44high CD40L+ splenocytes. n = 7-11 mice per 
group. Results are representative of four independent experiments. Statistical 
analysis was performed using a student’s t test. *p < 0.05 
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differences are statistically significant, they appear to be minor biological 
differences that do not account for the large discrepancy in expansion of WT and 
Itk KO antigen-specific memory CD8+ T cells upon challenge. Thus, these 
differences in CD40L expression between WT and Itk-deficient antigen-specific 
CD4+ T cells are most likely not biologically significant.  
F. Memory precursor subsets are present in the absence of Itk. 
 Since Itk-deficient memory CD8+ T cells fail to expand robustly upon 
challenge, we wanted to examine the primary response to determine if there 
were any obvious differences in the subsets of memory precursor effector cells 
(MPECs), short-lived effector cells (SLECs), effector memory (Tem) cells, or 
central memory (Tcm) cells. The Kaech group initially characterized MPECs and 
SLECs, and found that these populations were present post-infection with LCMV. 
MPECs are defined as being CD127high and KLRG1low and tend to produce more 
IL-2 than SLECs (Joshi et al., 2007). Additionally, MPECs have a reduction in cell 
death during the contraction phase of an infection (Joshi et al., 2007). SLECs are 
characterized by being CD127low KLRG1high and are thought to be terminally 
differentiated effector cells. SLECs require IL-15 for maintenance and are 
regulated by IL-12 and T-bet (Joshi et al., 2007). We examined MPEC and SLEC 
populations of Itk-deficient memory CD8+ T cells (Figure 5.9). Interestingly, we 
found no differences in the frequencies or numbers of MPECs and SLECs 
between WT and Itk KO memory T cells (Figure 5.9). Thus, skewing of these 
populations is probably not contributing to the impaired expansion of Itk KO 
memory T cells. 
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Figure 5.9: WT and Itk KO antigen-specific T cells have similar frequencies 
and numbers of MPEC and SLEC CD8+ T cells. WT and Itk KO mice were 
infected with 5 x 104 PFU LCMV Armstrong. At days 7/8, 28/30, or 42 post-
infection, spleens were harvested, processed, and stained with tetramers specific 
for GP33 or NP396 epitopes and with antibodies against CD8, CD44, CD127, 
and KLRG1. (A) Flow cytometry plots and graphs depicting the (B) frequency or 
(C) cell number of MPECs (CD127high KLRG1low) or SLECs (CD127low KLRG1high) 
amongst antigen-specific CD8+ T cells. n = 3-9 mice per group. Results are 
representative of 2-3 independent experiments. Statistical analysis was 
performed using a student’s t test. No statistical significance was found between 
WT or Itk KO memory CD8+ T cells at days 7/8, 28/30, or 42 post-infection. 
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We also examined effector and central memory populations of CD8+ T 
cells. Tem cells are CD44high and CD62Llow and respond immediately by exerting 
effector functions upon secondary stimulation (Williams and Bevan, 2007). Tcm 
cells are CD44high CD62Lhigh and proliferate robustly upon challenge (Williams 
and Bevan, 2007). Since Itk KO memory CD8+ T cells can exert their effector 
function but have impaired proliferation in response to challenge, we 
hypothesized that these subsets may be skewed in Itk-deficient memory T cells. 
Interestingly, we saw a decrease in the frequency of Tem CD8+ T cells between 
WT and Itk KO mice (Figure 5.10A&B). Itk-deficient CD8+ T cells also trended 
towards an increase in the Tcm population when compared to WT CD8+ T cells 
(Figure 5.10A&B).  Although we did see a statistically significant difference in 
effector memory numbers at day 28/30 post-infection in the NP396 population, 
this was the only time point where Tem and Tcm cell numbers differed between WT 
and Itk KO memory T cells (Figure 5.10C). Thus, although we did see skewing of 
these populations, it was not the result we expected and did not explain the 
impaired expansion of Itk-deficient memory CD8+ T cells upon challenge. 
Further, although we saw statistically significant differences in these populations 
between WT and Itk-deficient memory CD8+ T cells, these differences cannot 
explain the defective expansion of Itk-deficient antigen-specific memory CD8+ T 
cell upon challenge. Thus, these difference in Tem and Tcm populations between 
immunized WT and Itk KO mice is most likely not biologically significant.  
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Figure 5.10: Effector memory CD8+ T cells are decreased in the absence of 
Itk. WT and Itk KO mice were infected with 5 x 104 PFU LCMV Armstrong. At 
days 7/8, 28/30, or 42 post-infection, spleens were harvested, processed, and 
stained with tetramers specific for the GP33 or NP396 epitopes and with 
antibodies against CD8, CD44, and CD62L. (A) Flow cytometry plots and graphs 
depicting the (B) frequency or (C) cell number of Tem (CD44high CD62Llow) or Tcm 
(CD44high CD62Lhigh) antigen specific CD8+ T cells. n = 5-8 mice per group. 
Results are representative of three independent experiments. Statistical analysis 
was performed using a Mann Whitney t test. *p < 0.05, **p < 0.005 
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G. T-bet and Eomesodermin are differentially expressed between WT and 
Itk KO memory T cells. 
 We next turned toward transcription factor differences as a means to 
explain the impaired expansion of Itk-deficient memory CD8+ T cells. We 
examined the two T-box transcription factors, T-bet and Eomes. T-bet has been 
characterized to regulate SLECs and effector functions of memory CD8+ T cells 
(Joshi et al., 2007). Eomes is highly expressed in innate CD8+ T cells prior to 
infection (Atherly et al., 2006b; Dubois et al., 2006); therefore, it’s possible that 
early Eomes expression could affect CD8 memory T cell programming. We 
analyzed T-bet and Eomes expression on days seven or eight, 28 or 30, or 42 
post-infection with LCMV Armstrong in WT or Itk KO mice. Although naïve WT or 
Itk KO CD8+ T cells had little T-bet expression, we found that there was a 
significant decrease in the frequency and the number of T-bet+ antigen-specific 
(GP33 and NP396) CD8+ T cells during the acute phase of infection (day 7/8) 
(Figure 5.11). Although Eomes was not expressed by many naïve WT CD8+ 
memory T cells, we did see that the majority of naïve Itk KO CD8+ T cells 
express this transcription factor (Figure 5.11A). However, during the memory 
phases of the primary infection (days 28/30 and 42), we saw a significant 
increase in the frequency of Itk KO antigen-specific memory T cells expressing 
Eomes when compared to WT memory T cells (Figure 5.11A&B). Although we 
did not see any significant changes in cell numbers of this Eomes+ population, 
we hypothesize that the skewed regulation of T-bet and Eomes in the absence of 
Itk may lead to the impaired expansion of Itk-deficient CD8+ T cells. 
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Figure 5.11: T-bet and Eomes are differentially regulated in Itk-deficient 
memory CD8+ T cells. WT and Itk KO mice were infected with 5 x 104 PFU 
LCMV Armstrong. At days 7/8, 28/30, or 42 post-infection, spleens were 
harvested, processed, and stained with tetramers specific for the GP33 or NP396 
LCMV epitopes and with antibodies against CD8, CD44, CD62L, T-bet, and 
Eomes. Black lines/bars represents cells from WT mice while gray lines/bars 
represent cells from Itk KO mice. (A) Flow cytometry plots showing T-bet or 
Eomes expression in GP33 or NP396 specific CD8+ T cells. T-bet or Eomes 
expression in naïve mice is represented by shaded histograms, expression in 
day 7/8 infected mice is represented by solid lines, expression in d28/30 infected 
mice is represented by long dashed lines, and expression in d42 infected mice is 
represented by short dashed lines. The average percentage of cells expressing 
T-bet or Eomes is shown on the right in the flow cytometry plot. A black line on 
the flow cytometry plot denotes T-bet or Eomes negative cells. Naïve WT cells 
are gated on CD8+ CD44low CD62Lhigh splenocytes. Naïve Itk KO cells are gated 
on CD8+ splenocytes. Splenocytes from day 7/8, 28/30, and 42 mice are gated 
on CD8+ CD44high tetramer+ T cells. Graphs depicting the (B) frequency and (C) 
cell number of T-bet+ or Eomes+ tetramer-specific CD8+ T cells are shown. n = 4-
9 mice per group. Results are representative of 2-4 independent experiments. 
Statistical analysis was performed using a student’s t test. *p < 0.05, **p < 0.005 
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Eomes has recently been described to be highly expressed in exhausted CD8+ T 
cells in the context of high-dose LCMV CL13 infection and is expressed in the 
CD8+ T cells of hepatitis C virus (HCV) patients (Paley et al., 2012). Therefore, in 
the absence of Itk, memory CD8+ T cells may have a higher frequency of Eomes+ 
CD8+ T cells that leads to an exhaustion-like phenotype of their memory cells. 
Alternatively, high expression of Eomes and reduced expansion of memory T 
cells may be a defining characteristic of innate CD8+ T cells. Thus, the CD8+ 
memory T cells that form in the absence of Itk may not be defective. 
H. Itk-deficient innate Eomesodermin+ CD8+ T cells persist in P14 TCR 
transgenic. 
 In previous studies, when Itk KO mice have been crossed to an OT-I TCR 
transgenic, innate CD8+ T cell development was halted (Atherly et al., 2006b). 
We wondered if this high frequency of Eomes+ memory CD8+ T cells that endure 
in LCMV-immune Itk KO mice was a characteristic of innate CD8+ T cells or 
intrinsic to cells lacking Itk. Therefore, we crossed Itk KO mice to P14 transgenic 
mice. P14 recognizes the GP33-41 epitope of LCMV, and we utilized this model to 
obtain a naïve, conventional population of Itk KO CD8+ T cells to study in the 
context of infection. However, upon further examination of Itk-deficient P14 T 
cells, we saw that a small population of innate cells remained (Figure 5.12A). 
Hence, we used an untouched CD8 isolation kit combined with anti-CXCR3 to 
remove innate CD8+ T cells and obtain a naïve, conventional population of Itk-
deficient P14 T cells (Figure 5.12B). We then transferred this naïve P14 
population into a congenic host prior to infection. 
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Figure 5.12: Itk-deficient P14 transgenic T cells maintain an activated 
phenotype. Itk KO mice were crossed to P14 transgenic mice, and CD8+ T cells 
from WT and Itk KO P14 transgenic mice were isolated using an untouched 
CD8+ isolation kit with the addition of CXCR3 specific antibodies to remove 
activated cells. Isolated CD8+ T cells were then transferred into a WT host prior 
to infection with rVV-GP or LCMV Armstrong. (A) Splenocytes from WT and Itk 
KO P14 transgenic mice prior to isolation of naïve CD8+ T cells. (B) Splenocytes 
from WT and Itk KO P14 transgenic mice after isolation of CD8+ T cells. Results 
represent two independent experiments. 
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I. Memory formation of conventional Itk KO P14 transgenic T cells is similar 
to WT P14 transgenic T cells. 
 After naïve WT and Itk KO P14 transgenic T cells are transferred into a 
congenic host, host mice were infected with LCMV Armstrong. At days 8 and 30 
post-infection, we examined if WT and Itk KO P14 T cells were present in similar 
frequencies and numbers in host mice. We saw no significant differences 
between WT or Itk KO P14 transgenic T cells in this aspect (Figure 5.13). We 
next examined if Tem, Tcm, MPEC, or SLEC formation was affected by the 
absence of Itk in P14 transgenic T cells. Between WT and Itk KO P14 transgenic 
T cells, we found no significant differences in the frequency or number of effector 
and central memory cells (Figure 5.14A/B/C). Interestingly, when we examined 
MPEC and SLEC formation, we saw a significant decrease between WT and Itk 
KO P14 transgenic T cells in the frequency of SLECs. This corresponded to a 
significant increase in the frequency of MPECs between WT and Itk KO P14 T 
cells (Figure 5.14D/E/F). This result was surprising to us since were saw no 
significant differences in these populations between LCMV-immune WT or Itk KO 
mice. However, we saw no significant differences in the cell number of MPECs or 
SLECs between WT or Itk KO P14 transgenic T cells. Therefore, this difference 
in MPECs and SLECs between WT and Itk KO P14 transgenic T cells may have 
no biological significance upon a challenge infection. 
 We next looked at T-bet and Eomes expression of WT or Itk KO P14 
transgenic T cells. Intriguingly, we saw no significant differences in the frequency 
or number of WT and Itk KO P14 transgenic T cells expressing T-bet during the
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Figure 5.13: WT and Itk KO P14 transgenic T cells are present in similar 
frequencies and numbers post-infection. WT and Itk KO P14 transgenic T 
cells were isolated using an untouched CD8+ T cell isolation kit and antibodies 
against CXCR3. Isolated P14 T cells were transferred into a naïve congenic host, 
and host mice were infected with LCMV Armstrong one day after transfer. At 
days 8 and 30 post-infection, spleens were harvested and processed with 
antibodies against Vα2 and CD45.1 (congenic marker). (A) Flow cytometry plots 
depict Vα2+ CD45.1+ splenocytes. (B) Frequency and (C) cell number of Vα2+ 
CD45.1+ splenocytes. n = 3-6 mice per group. Results are representative of 1-2 
experiments. Statistical analysis was performed using a student’s t test. No 
statistical significance was found. 
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Figure 5.14: Itk-deficient P14 transgenic T cells have skewed SLEC and 
MPEC frequencies. WT or Itk KO P14 naïve transgenic T cells were isolated 
and transferred into a WT congenic host. One day post-transfer, host mice were 
infected with 5 x 104 PFU LCMV Armstrong. At days 8 and 30 post-infection, 
mice were sacrificed and spleens were harvested, processed, and stained with 
antibodies against Vα2, CD45.1 (congenic marker), CD44, CD62L, CD127, and 
KLRG1. (A) Flow cytometry plots depicting CD44 and CD62L expression on 
Vα2+ CD45.1+ splenocytes. (B) Frequency and (C) cell number of Tem (CD44high 
CD62Llow) or Tcm (CD44high CD62Llow) P14 transgenic splenocytes. (D) Flow 
cytometry plots showing KLRG1 and CD127 expression on Vα2+ CD45.1+ 
splenocytes. (E) Frequency and (F) cell number of SLEC (CD127low KLRG1high) 
or MPEC (CD127high KLRG1low) P14 transgenic splenocytes. n = 3-6 mice per 
group. Results are respresentative of 1-2 independent expriments. Statistical 
analysis was performed using a student’s t test. ***p < 0.0005 **p < 0.005 *p < 
0.05.  
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acute phase of infection (day 8 p.i.) (Figure 5.15A/B/C). And when we looked at 
the memory phase (day 30 p.i.), we saw only a slight decrease in the frequency 
of T-bet expressing P14 transgenic T cells between WT and Itk KO (Figure 
5.15D&E). Although Itk KO P14 transgenic T cells trended toward a higher 
frequency of Eomes expressing CD8+ T cells when compared to WT P14 
transgenic T cells, this difference was not statistically or biologically significant. 
Therefore, it appears that conventional T cells deficient in Itk are able to be 
programmed similarly to WT conventional memory T cells. 
J. Itk-deficient P14 memory T cells are able to respond to a challenge 
infection. 
 Since it appeared that conventional P14 T cells deficient in Itk were able to 
follow a similar memory differentiation program as WT P14 transgenic T cells, we 
wanted to see how Itk-deficient P14 T cells responded to a challenge infection. 
Thus, after transfer of naïve WT or Itk KO P14 T cells into a congenic host, the 
host was infected with rVV expressing the LCMV glycoprotein (rVV-GP). This 
allowed P14 transgenic T cells to respond without producing neutralizing 
antibody that would prevent a challenge infection with LCMV. At 42 days post-
infection, host mice were given LCMV CL13. We then examined the cytokine 
production and expansion of WT or Itk KO P14 transgenic T cells seven days 
post the challenge infection. We found that WT and Itk KO P14 transgenic T cells 
had similar frequencies of IFNγ+ TNF- and IFNγ+ TNF+ in response to stimulation 
with GP33 (Figure 5.16A&B). Additionally, when we examined the ratio of IFNγ+ 
TNF+: IFNγ+ TNF- P14 transgenic T cells, we found that there were no significant 
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Figure 5.15: T-bet and Eomesodermin expression within P14 transgenic T 
cells is skewed at d30 post-infection in the absence of Itk. WT and Itk KO 
P14 transgenic T cells were isolated and transferred into a congenic host. One 
day post-adoptive transfer, host mice were infected with 5 x 104 PFU LCMV 
Armstrong. At days 8 (A-C) and 30 (D-F) post-infection, splenocytes were 
isolated and stained with antibodies against CD8, CD45.1 (congenic marker), T-
bet, and Eomes. (A & D) Flow cytometry plots depicting T-bet or Eomes 
expression in P14 transgenic T cells (CD8+ CD45.1+ splenocytes) at d8 (A) or 
d30 (D) post-infection. (B & E) Frequency and (D & F) cell number of T-bet+ 
CD8+ CD45.1+ or Eomes+ CD8+ CD45.1+ P14 transgenic T cells at d8 (B & C) or 
d30 (E & F) post-infection. n = 3-6 mice per group. Results are representative of 
1-2 independent experiments. Statistical analysis was performed using a 
student’s t test. *p < 0.05. 
 
165
 
 
 
166
 
Figure 5.16: Itk KO P14 transgenic T cells have similar cytokine responses 
as WT P14 transgenic T cells upon secondary stimulation. WT or Itk KO P14 
transgenic T cells were isolated and transferred into a WT congenic host. At one 
day post-transfer, host mice were infected with rVV-GP. At 42 days post-
infection, mice were given a secondary infection of 105 PFU LCMV CL13. At 7 
days post-infection with LCMV CL13, spleens were harvested and stimulated 
with GP33 peptide for 5 hours at 37oC in the presence of brefeldin A. Cells were 
then stained with antibodies against CD8, CD45.1, TNF, and IFNγ. (A) Flow 
cytometry plots depicting IFNγ and TNF production by transferred P14 
splenocytes. (B) Graphs showing no significant differences in the frequency of 
IFNγ+ TNF+ or IFNγ+ TNF- CD8+ CD45.1+ splenocytes. (C) Ratio of IFNγ+ TNF+: 
IFNγ+ TNF- CD8+ CD45.1+ splenocytes is not significantly different between WT 
or Itk KO P14 transgenic T cells. (D) Cell numbers of IFNγ+ TNF+ and IFNγ+ TNF- 
CD8+ CD45.1+ splenocytes. n= 3-6 mice per group. Results are representative of 
1-2 independent experiments. Statistical analysis was performed using a 
student’s t test.  
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differences between WT or Itk KO memory T cells (Figure 5.16C). Further, when 
we examined the cell number of IFNγ+ TNF+ and IFNγ+ TNF- P14 transgenic T 
cells, we found no significant differences between WT or Itk KO memory T cells 
(Figure 5.16D). Additionally, we examined the frequency and cell number of total 
P14 transferred cells and found no significant differences between WT or Itk KO 
P14 transgenic T cells upon a challenge infection (Figure 5.17). Therefore, it 
appears that conventional T cells lacking Itk are able to respond to infection in a 
manner similar to WT conventional T cells.  
K. Itk KO conventional T cells can provide protective memory responses. 
 Since Itk-deficient conventional P14 transgenic T cells appeared to follow 
a memory differentiation path that is similar to WT conventional T cells, we 
wanted to determine if memory Itk KO conventional P14 transgenic T cells could 
provide protection upon a challenge response. Therefore, post-transfer of WT or 
Itk KO P14 transgenic T cells, host mice were infected with rVV-GP. At 42 days 
post-infection, host mice were given a challenge infection with LCMV CL13. At 
three days post the challenge infection, viral titer was assessed (Figure 5.18A).  
Immunized mice receiving WT P14 transgenic T cells had a lower viral titer than 
naïve mice receiving WT P14 transgenic T cells (Figure 5.18B). Amazingly, 
immunized mice receiving Itk KO P14 transgenic T cells also had a lower viral 
titer when compared to naïve mice receiving Itk KO P14 transgenic T cells 
(Figure 5.18B). Therefore, conventional memory Itk KO P14 transgenic T cells 
are able to provide protective memory responses to a challenge infection.  
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Figure 5.17: WT and Itk KO P14 transgenic T cells have similar frequencies 
and numbers upon secondary infection. WT and Itk KO P14 transgenic T cells 
were isolated and transferred into a congenic host. One day post-transfer, host 
mice were infected with rVV-GP. At 42 days post-infection, mice were given a 
secondary infection with LCMV CL13. At 7 days post-infection with LCMV CL13, 
spleens were harvested, processed, and stained with antibodies against Vα2 and 
CD45.1 (congenic marker). (A) Flow cytometry plots depicting Vα2+ CD45.1+ 
splenocytes in mice receiving WT or Itk KO P14 transgenic T cells. (B) 
Frequency and (C) cell number of Vα2+ CD45.1+ splenocytes. n = 3-6 mice per 
group. Results are representative of 1-2 independent experiments. Statistical 
analysis was performed using a student’s t test.  
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Figure 5.18: Itk KO P14 transgenic memory T cells provide protection upon 
a secondary infection. WT and Itk KO P14 transgenic T cells were isolated and 
transferred into a WT congenic host. One day post-transfer, host mice were 
infected with 5 x 106 PFU rVV-GP. At 42 days post-infection, mice were given a 
secondary infection of 105 PFU LCMV CL13. At 3 days post-infection with LCMV 
CL13, spleens were harvested and processed to assess viral titer. (A) 
Experimental design. (B) Viral titer results from a plaque assay. Viral titer was 
calculated by taking the log value of ((number of plaques x dilution factor)/volume 
plated) x total volume of spleen supernatant. Statistical analysis was performed 
using a one-way ANOVA.   
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L. Summary 
 In this chapter, we have demonstrated that innate CD8+ T cells developing 
in the absence of Itk are unable to provide protective memory responses. 
Further, it appears that protection is impaired due to diminished expansion of Itk 
KO memory CD8+ T cells upon challenge. This reduced expansion may be 
impaired due to an increased frequency of Eomes+ CD8+ memory T cells that 
develop in Itk KO mice. This phenotype may be characteristic of an innate T cell 
response to a viral infection. However, recent data from the Wherry group 
demonstrates that exhausted CD8+ T cells express high levels of Eomes (Paley 
et al., 2012). Hence, Itk KO mice may provide the right environment to promote 
Eomes expression in CD8+ T cells and render them with an exhaustion-like 
phenotype upon infection. Intriguingly, this exhaustion-like phenotype does not 
persist when Itk is absent from conventional P14 transgenic T cells. Thus, this 
data suggests that this phenotype is specific to innate cells during viral infections 
or to the environment of an Itk KO mouse  
 This data provides an interesting model for how EBV-associated 
lymphoproliferative disorders develop in Itk null patients. Although most healthy 
patients have a lifelong and asymptomatic infection of EBV (Young and 
Rickinson, 2004), it appears that Itk null patients are unable to control the latent 
phases of EBV (Huck et al., 2009; Linka et al., 2012; Stepensky et al., 2011). 
After the lytic phase of this virus, EBV goes latent and will re-emerge during 
times of stress or immunosuppression (Luzuriaga and Sullivan, 2010). Therefore, 
during this reoccurrence phase, Itk-deficient Eomes+ CD8+ memory T cells may 
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be reactivated and impaired in their response. This may generate an even higher 
frequency of antigen-specific CD8+ T cells expressing Eomes that would be more 
impaired in their response to EBV. This cycle may continue until Itk-deficient 
CD8+ T cells pools were completely exhausted, which would allow EBV to run 
rampant and induce lymphoproliferative disease.  
 However, this model may only apply to Itk null patients. Itk has been a 
target for inhibition by drug companies due to its specific expression in T cells 
(Riether et al., 2009). Thus, if an Itk inhibitor was utilized for immunosuppression 
in transplant patients or in the context of autoimmunity, these deleterious affects 
of memory T cell formation may be averted. The high Eomes expression seen in 
naive CD8+ T cells from Itk KO mice is largely due to anomalies in development 
that result in abundant amounts of IL-4 aberrantly being produced (Felices et al., 
2009; Qi et al., 2009; Weinreich et al., 2010). Thus, Itk null patients most likely 
mimic the developmental anomalies seen in Itk KO mice. However, patients 
receiving an Itk inhibitor would more likely mimic the results we see with Itk-
deficient conventional P14 transgenic T cells. When we utilize the P14 transgenic 
model, we obtain a naïve, conventional population of Itk-deficient CD8+ T cells. 
Remarkably, these conventional Itk-deficient CD8+ T cells have no impairments 
in memory T cell formation when compared to WT P14 transgenic T cells. Thus, 
our experiments suggest that while it is deleterious to lose Itk during the 
development of our immune system, targeting Itk after our immune system is 
intact may provide patients with relief from autoimmune disorders or graft versus 
host disease while still providing a functioning immune system.  
172
 
 
 
 
 
 
Chapter VI: Discussion 
 
173
Chapter VI: Discussion 
 Previously, the generation of memory innate T cells has been challenging 
to study due to the minute population of these cells. However, in the absence of 
Itk, we see an abundance of Eomes+ innate CD8+ T cells that develop (Atherly et 
al., 2006a; Dubois et al., 2006; Weinreich et al., 2010). Although the role of Itk 
has been thoroughly studied in CD4+ T helper cell differentiation (Au-Yeung et 
al., 2006; Fowell et al., 1999; Gomez-Rodriguez et al., 2009; Miller et al., 2004; 
Schaeffer et al., 2001), relatively little is known about how Eomes+ innate CD8+ T 
cells deficient in Itk respond to viral infections (Atherly et al., 2006a; Bachmann et 
al., 1997). Previously, it has been demonstrated that Itk-deficient mice have a 
lower bacterial burden of L. monocytogenes at three days post-infection (Hu et 
al., 2007). This indicates that itk-/- Eomes+ innate CD8+ T cells may function 
similarly to H2M3-restricted CD8+ T cells (Kerksiek and Pamer, 1999; Nataraj et 
al., 1998). However, this study did not examine the ability of Itk KO mice to clear 
L. monocytogenes. Previous studies have shown that conventional CD8+ T cells 
are dispensable for protective memory responses to L. monocytogenes (Seaman 
et al., 2000). Thus, it would be interesting to determine if Itk-deficient CD8+ T 
cells are able to provide protective memory responses against bacterial 
infections since this thesis shows that protective memory is not formed in 
response to LCMV. 
 Despite the enhanced response of itk-/- CD8+ T cells to L. monocytogenes, 
studies involving viral infections of Itk KO mice have demonstrated that cytotoxic 
effector responses of innate CD8+ T cells are diminished during acute infection 
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(Bachmann et al., 1997). However, these mice are able to clear LCMV, VV, and 
VSV, although the kinetics are delayed (Atherly et al., 2006a; Bachmann et al., 
1997). Therefore, I studied the role of protective memory responses of Eomes+ 
innate CD8+ T cells utilizing the LCMV model of infection. This is a well-
characterized model of viral infection in which CD8+ T cells mediate clearance. 
Despite the ability of CD8+ T cells to mediate clearance of LCMV, IL-2 and CD4+ 
T cell help are required to generate protective memory responses (Janssen et 
al., 2003; Williams et al., 2006b). We found that Eomes+ innate CD8+ T cells 
seemed to behave much like “helpless” memory CD8+ T cells in that they had 
reduced expansion upon challenge (Janssen et al., 2003) (Figure 6.1). However, 
Itk-deficient innate CD8+ T cells were able to produce IFNγ and exert cytotoxic 
function at 42 days post-infection with LCMV Armstrong, which differs from 
“helpless” memory CD8+ T cells (Janssen et al., 2003). Additionally, memory 
CD8+ T cells appeared to be maintained similarly between WT and Itk KO mice in 
frequency and cell number, which differs from helpless CD8+ T cells and from Id3 
deficient memory CD8+ T cells (Janssen et al., 2003; Ji et al., 2011). This may be 
due to reduced TNF production in the absence of Itk. TNFR deficient mice have 
been shown to have defects in the contraction of antigen-specific T cells (Suresh 
et al., 2005). Thus, since Itk-deficient CD8+ T cells have reduced production of 
TNF (Atherly et al., 2006a), this may allow for Itk-deficient CD8+ T cells to escape 
contraction.  
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Figure 6.1: Model of Memory Responses by Eomes+ Innate CD8+ T cells. 
Upon infection with LCMV, Eomes+ innate CD8+ T cells are able to respond and 
clear virus. After the virus is cleared, a small pool of memory T cells remain; 
however, memory cells derived from innate T cells are unable to robustly expand 
and respond upon challenge. 
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Despite this dissimilarity to “helpless” CD8+ T cells, we did investigate the 
ability of Itk-deficient CD4+ T cells to respond to the LCMV-specific epitope, 
GP61 and found that itk-/- CD4+ T cells were able to upregulate the expression of  
CD40L upon stimulation. Blocking CD40L has been shown abrogate the cytolytic 
function of CD8+ T cells. Thus in the absence of Itk, this mechanism of CD4 help 
appears to be intact. However, CD40-CD40L interactions may not be the main 
mechanism of CD4 help during LCMV infection (Sun and Bevan, 2004). CD4+ T 
cells may also provide help to CD8+ T cells via IL-2 or CD27-CD70 interactions 
(Williams et al., 2006b) (Nolte et al., 2009). Although CD27-CD70 interactions 
were not examined in this study, it is known that Itk-deficient T cells produce little 
IL-2 in response to stimulation (Schaeffer et al., 1999). Therefore, this could 
explain why itk-/- innate CD8+ T cells cannot provide protection upon challenge. 
To further support this idea, itk-/- memory CD8+ T cells appear to resemble IL-
2Rα-deficient memory CD8+ T cells in that expansion of antigen-specific memory 
CD8+ T cells is impaired upon challenge (Williams et al., 2006b). To address this 
role of IL-2 in the formation of protective memory CD8+ T cells responses, WT 
and Itk KO mice could be provided with IL-2 complexes during the acute phases 
of infection (Boyman et al., 2006; Williams et al., 2006b). This would provide IL-2 
signaling in the absence of Itk. Another method that could be utilized to address 
this issue of IL-2 production and CD4 help would be to make mixed bone marrow 
chimeras with WT and Itk KO bone marrow. This strategy should provide Itk-
deficient CD8+ T cells with WT CD4+ T cells help and IL-2 during the acute phase 
of infection. The model utilized in this thesis to address these issues of IL-2 
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signaling and CD4 help was the P14 transgenic T cell model. Through the 
transfer of P14 transgenic T cells, we were able to provide Itk-deficient CD8+ T 
cells with paracrine IL-2 signaling and with CD4 help from WT CD4+ T cells. 
Additionally, this model provided us with a method to study naïve, conventional 
CD8+ T cells deficient in Itk.  
 Although Itk-deficient T cells are defective in their IL-2 production 
(Schaeffer et al., 1999), we did see differential regulation of the T-box 
transcription factors, T-bet and Eomes, in innate CD8+ T cells. During the acute 
phases of infection, Itk-deficient CD8+ T cells had fewer cells expressing T-bet, 
which may important for programming memory T cells. Although the frequency of 
Eomes+ antigen-specific T cells did not differ significantly between WT and Itk 
KO mice during the acute phases of infection, as CD8+ T cells entered the 
memory phase of the infection, Itk KO mice had a higher frequency of CD8+ T 
cells expressing Eomes when compared to WT mice. In addition to this study, Itk 
has been demonstrated to interact with and phosphorylate T-bet in vitro (Hwang 
et al., 2005). Further, Itk-deficient and SLP-76Y145F mutant mice have defects in 
the asymmetric division of T-bet in actively dividing T cells (Chang et al., 2011). 
Thus, Itk may be crucial in regulating T-bet and Eomes expression in CD8+ T 
cells. This regulation of T-bet and Eomes may also help define the response of 
conventional versus innate T cells to viral infections. While this study shows that 
Itk-deficient Eomes+ innate CD8+ T cells are unable to provide protective memory 
responses to LCMV, Seaman et. al. determined that H2M3-restricted CD8+ T 
cells were able to form protective memory responses to L. monocytogenes 
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(Seaman et al., 2000). Further, these H2M3-restricted memory T cells were able 
to divide in response to challenge (Seaman et al., 2000). Thus, perhaps Eomes+ 
innate CD8+ T cells found in the absence of Itk would be able to provide 
protective responses to bacterial pathogens. Thus, the inability of these cells to 
provide protection in response to LCMV may demonstrate that innate T cells may 
not be the optimal cell type to respond to viral infections, which may explain the 
delayed response of Itk-deficient CD8+ T cells to viral infections (Bachmann et 
al., 1997).  
Interestingly, this high frequency of Eomes expression in CD8+ T cells 
resembles exhausted CD8+ T cells during a chronic LCMV CL13 infection (Paley 
et al., 2012). In this study, mice acutely infected with LCMV Armstrong or 
chronically infected with LCMV CL13 were compared at eight days post-infection 
(Paley et al., 2012). Similar to the differences we see between WT and Itk KO 
antigen-specific CD8+ T cells, there was no difference in the frequency of 
Eomes+ antigen-specific CD8+ T cells between acutely and chronically infected 
mice at this point in the infection (Paley et al., 2012). However, as these mice 
entered the memory phase of the infection (i.e. d30 post-infection), chronically 
infected mice had a higher frequency of Eomes+ antigen-specific T cells when 
compared to acutely infected mice (Paley et al., 2012). Thus, the phenotype of 
the chronically infected mice mirrors the phenotype of itk-/- innate CD8+ memory T 
cells. Thus, regulation of Eomes and T-bet may be critical in the differentiation of 
a CD8+ T cells to become an efficient and protective memory cell or to become 
an innate and exhausted-like memory T cell (Figure 6.2). Alternatively, high 
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expression of Eomes may be a shared characteristic between innate CD8+ T 
cells and exhausted conventional CD8+ T cells that results in the inability of 
innate and exhausted CD8+ T cells to respond appropriately to viral infections.  
What is intriguing about this phenotype of Itk-deficient and LCMV CL13 
chronically infected memory T cells is that the CD8+ T cells of HCV patients also 
express high levels of Eomes (Paley et al., 2012). Further, Itk null patients have 
EBV-associated lymphoproliferative disorders, and quantitative real-time 
polymerase chain reaction (qPCR) demonstrated that these patients have 
increased Eomes expression in their CD8+ T cells (Huck et al., 2009; Linka et al., 
2012; Stepensky et al., 2011). Thus, I hypothesize that exhausted and Itk-
deficient CD8+ T cells may become unresponsive to antigen stimulation due to
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Figure 6.2: Itk Regulates Expression of Eomes and T-bet. In the absence of 
Itk, Eomes+ innate CD8+ T cells develop that are able to clear an acute infection. 
However, memory cells derived from innate CD8+ T cells are unable to respond 
robustly to challenge. These innate T cells have an increase in antigen-specific 
cells expressing Eomes and a decrease in antigen-specific cells expressing T-
bet. This may render them with an exhaustion-like phenotype. However, in the 
presence of Itk, conventional CD8+ T cells develop. Antigen-specific memory T 
cells from WT mice have a higher frequency of cells expressing T-bet with a 
lower frequency of cells expressing Eomes. This provides them with the ability to 
respond rapidly to challenge. Therefore, Itk may help regulate the generation of 
exhausted and innate memory CD8+ T cells versus conventional effector and 
memory CD8+ T cells. 
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this increased expression of Eomes, which would render them unable to protect 
the host. If we imagine a chronic infection where exhausted T cells are 
repeatedly stimulated, this repeated stimulation may result in increasing levels of 
Eomes expressed upon each subsequent stimulation. In regard to Itk regulating 
Eomes, if CD8+ T cells are continuously stimulated, we can imagine that the TCR 
signaling cascade would become unresponsive and the activation of Itk may 
become diminished. Thus, this could potentially disrupt the regulation T-bet by Itk 
and allow for an increased frequency of Eomes+ CD8+ T cells. Thus, as more 
CD8+ T cells express Eomes, this would render the CD8+ T cells useless in 
suppressing a latent viral infection (Figure 6.3). 
  Another captivating result from this study is that Itk-deficient naïve, 
conventional CD8+ T cells utilized for the P14 transgenic model were seemingly 
unaffected by the absence of Itk. This result is slightly confounding in that it 
appears a presumed reduction in the strength of TCR signaling upon antigen 
stimulation does not alter the differentiation of an antigen-specific CD8+ T cell. 
Contradicting to these results, in vitro studies from our lab using an OT-I TCR 
transgenic demonstrate that affinity for antigen can indeed alter the expression of 
transcription factors, such as IRF4 and Eomes (unpublished data). Thus, either 
TCR signal strength is not crucial in the context of an in vivo infection or the P14 
transgenic T cell has such a high affinity for antigen that the absence of Itk is 
irrelevant. We have previously demonstrated that a high affinity TCR transgenic 
can suppress the development of innate CD8+ T cells, such as with an OT-I 
transgenic model (Atherly et al., 2006b). Hence, it would be interesting to 
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Figure 6.3: Model of Epstein-Barr Virus (EBV) Infection in the Absence of 
Itk. Patients with null mutations in Itk are unable to control EBV infection, which 
may be due to the presence Eomes+ innate CD8+ T cells. Since protective 
memory responses are impaired in the absence of Itk, this may due to antigen-
specific CD8+ T cells expressing increased levels of Eomes upon subsequent 
stimulation. This would render Itk-deficient antigen-specific T cells to become 
exhausted and allow EBV to replicate out of control, which would result in 
patients succumbing to this chronic viral infection. 
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examine Itk-deficient TCR transgenics in a system utilizing viruses or 
immunizations containing altered peptide ligands. I would hypothesize that as the 
TCR affinity for the peptide/MHC complex is reduced, the influence of Itk on 
CD8+ T cell differentiation will become more pronounced.  
 Along these lines of Itk regulating TCR signal strength, our lab has 
demonstrated that interferon regulatory factor 4 (IRF4) is highly expressed upon 
T cell stimulation (Nayar et al., 2012). This upregulation of IRF4 is thought to 
inhibit the expression of Eomes in CD8+ T cells (Nayar et al., 2012). Hence, we 
would expect that even in our P14 transgenic model that Eomes expression 
would be increased in the absence of Itk, in which IRF4 expression should also 
be diminished. Although we do see increased Eomes expression in Itk-deficient 
P14 transgenic T cells at d30 post-infection when compared to WT P14 
transgenic T cells, this difference is not statistically or biologically significant. 
Another potential explanation for this result involves the signal three aspect of 
cytokine signaling. Cytokine signaling, such as IL-2, could potentially induce IRF4 
expression in the context of infection independently of TCR signal strength.  
Since cytokine signaling may be compensating for the absence of Itk in 
antigen-specific CD8+ T cells, this may provide another explanation for the 
discrepancy between infections with Itk KO mice and Itk KO P14 transgenic T 
cells. Since the proliferative defects seen in memory CD8+ T cells from Itk KO 
mice resemble the defects seen in IL-2Rα-deficient memory CD8+ T cells 
(Williams et al., 2006b), we could imagine that the P14 transgenic model would 
allow paracrine IL-2 signals to be received by Itk-deficient CD8+ T cells. These 
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paracrine signals could potentially rescue the phenotype of Itk-deficient CD8+ T 
cells. Additionally, providing IL-2 to mice chronically infected with LCMV CL13 
results in an increase in the frequency of antigen-specific CD8+ T cells and a 
reduction in viral titer (Blattman et al., 2003). Further, IL-2 signaling has been 
demonstrated to regulate Blimp-1 in CD8+ T cells (Gong and Malek, 2007). Since 
Blimp-1 is important for the differentiation of SLECs and highly expressed in 
exhausted CD8+ T cells (Kallies et al., 2009; Rutishauser et al., 2009; Shin et al., 
2009), we could imagine that IL-2 signals may also regulate the expression of T-
bet and Eomes. Consequently, IL-2 signaling may be able to overcome defects in 
TCR signaling. Thus, in addition to or in combination with TCR signaling, IL-2 
may help regulate the differentiation of an effector CD8+ T cell versus an 
exhausted CD8+ T cell.  
 One last explanation for the differences seen between infections with Itk 
KO mice and infections using Itk-deficient P14 transgenic T cells is the host 
environment. As described previously in this thesis, in the absence of Itk, we see 
an expansion of PLZF+ T cells that produce IL-4 to induce expression of Eomes 
in conventional αβ T cells (Felices et al., 2009; Gordon et al., 2011; Qi et al., 
2009; Verykokakis et al., 2010b; Weinreich et al., 2009). Although this IL-4 
production may be affected during the acute phases of an LCMV infection, Itk-
deficient CD8+ T cells express high levels of Eomes prior to infection. 
Additionally, there is no evidence to suggest that this high IL-4 environment is 
deteriorated post-infection. Therefore, the cytokine environment of Eomes+ 
innate CD8+ T cells is potentially vastly different from the cytokine environment 
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seen by conventional CD8+ T cells. Accordingly, we can imagine that these 
differences in cytokine environment could drastically influence the differentiation 
of memory CD8+ T cells in these two models. In fact, this study demonstrates 
exactly this notion that the defect in protective memory responses of itk-/- CD8+ T 
cells is not a cell intrinsic defect, but that the extrinsic factors in an Itk KO mouse 
dictate the differentiation of memory CD8+ T cells (Figure 6.4).  
However, we do not know how a naïve, conventional CD8+ T cell 
transferred into an Itk KO environment would respond to an infection. It’s 
probable that the preexisting expression of Eomes in Itk-deficient innate CD8+ T 
cells alters the differentiation of CD8+ T cells upon infection. To test this 
hypothesis, we could utilize the bystander CD8+ T cell model in which Eomes 
expression is induced in response to type I IFN signaling (Marshall et al., 2010). 
If WT P14 transgenic T cells have Eomes induced via PolyI:C prior to transfer 
into a naïve WT host that is infected afterwards, we may be able to determine if 
Eomes expression prior to antigen stimulation is detrimental to the formation of 
protective memory responses. Additionally, we could transfer WT naïve P14 
transgenic T cells into an Itk KO host prior to infection to determine if the 
environment of an Itk KO mouse is the cause of altered memory formation of 
innate CD8+ T cells. I hypothesize that in both situations we would see 
abnormalities in protective memory responses. In the bystander CD8+ T cell 
model, we can imagine that these bystander T cells are being aberrantly 
activated due to the cytokine environment. Therefore, we could envision that the 
immune system is trying to “shut off” these activated cells in order to prevent 
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Figure 6.4: Development of Innate T cells Influences the Formation of 
Protective Memory Responses. In the absence of Itk, reduced TCR signaling 
combined with increased IL-4 in the thymic environment, results in the development 
of Eomes+ innate T cells. Upon infection with LCMV, these Eomes+ innate CD8+ T 
cells in Itk-deficient mice are able to respond and clear the virus. Further, a pool of 
memory CD8+ T cells is maintained in Itk KO mice after LCMV is cleared. However, 
upon a challenge infection, Itk-deficient memory CD8+ T cells have reduced 
expansion that results in impaired protective memory responses. Thus, the innate 
environment of an Itk mouse may not be conducive to promoting protective memory 
responses against viral infections.  
 
187
188
autoimmunity. This could also been the mechanism in a chronic infection model, 
in which chronic stimulation would render a CD8+ T cells anergic. Although these 
mice were not infected, studies involving mixed bone marrow chimeras 
consisting of WT OT-I transgenic bone marrow mixed with KLF2-deficient bone 
marrow, WT OT-I transgenic CD8+ T cells expressed Eomes due to the KLF2-
deficient environment (Weinreich et al., 2010). Thus, it is probable that the high 
IL-4 environment of an Itk KO mouse could promote Eomes expression in WT 
P14 transgenic T cells, which would influence the generation of memory P14 
transgenic T cells. 
This high IL-4 environment seen in the absence of Itk is due in part to a 
novel group of CD4+ PLZF+ αβ T cells that expand in the absence of Itk and 
produce abundant amounts of IL-4. We have christened these MAIT-like cells 
since these cells preferentially home to the spleen and mLN. Additionally, these 
MAIT-like cells express CD127 and the gut-homing receptors α4β7, CCR9, and 
CCR6 but were low for expression of CXCR3, CD122, and CD62L. This 
phenotype is similar to MAIT cells found in humans (Dusseaux et al., 2011; 
Treiner et al., 2003). Further, we determined that these MAIT-like cells have a 
restricted TCR repertoire. Additionally, these cells were found to develop 
independently of any β2m-dependent MHC class I molecule and independently 
of MHC class II. Thus, these cells may develop similarly to γδ T cells and not 
require an MHC molecule for selection. Another likely scenario would be that 
these MAIT-like cells require a non-classical MHC class I molecule that 
expresses independently of β2m, such as MHC-class-I-like located near the 
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leukocyte receptor complex (MILL), endothelial protein C receptor (EPCR), 
retinoic acid early transcript 1 (RAE1), or zinc α2-glycoprotein (ZAG) (Rodgers 
and Cook, 2005). 
Although we did not see a requirement of MHC class II in the development 
of these CD4+ PLZF+ MAIT-like cells, the total numbers of CD4+ PLZF+ MAIT-like 
cells were significantly decreased between Itk KO and Itk/MHC II DKO mice. This 
data demonstrates while MAIT-like cells can develop in the absence of 
conventional CD4+ T cells, the expansion of MAIT-like cells is severely impaired. 
What is interesting to note about this phenotype of Itk/MHC II DKO, is that we 
see the same trend in Itk/β2m/MHC II triple knock-out (TKO) mice. In these TKO 
mice, the overall thymic cellularity is decreased although we see WT frequencies 
of DP thymocytes (data not shown). Our lab has previously seen a slight defect 
in the DN to DP transition of Itk deficient thymocytes (Lucas et al., 2007). Hence, 
it may be possible that itk-/- SP thymocytes are providing a feedback loop to 
immature thymocytes that induces their expansion. This recent data indicates 
that development of innate T cells in the absence of Itk is more complex that 
previously thought and requires further investigation. 
Although we did not find an MHC requirement for the development of 
CD4+ PLZF+ MAIT-like cells, we did see that these cells required SAP for their 
development. This is similar to the requirements of SAP for the development of 
iNKT cells (Nichols et al., 2005; Pasquier et al., 2005; Verykokakis et al., 2010b). 
Thus, it is appealing to think that TCR and SLAM-family receptor signaling work 
together to regulate the expression of PLZF. However, MAIT cells are still 
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present in XLP patients although they express PLZF. Additionally, PLZF is 
expressed in SAP-deficient iNKT cells although the development of these cells is 
arrested (Savage et al., 2008). In our studies with itk-/- CD4+ PLZF+ MAIT-like 
cells, we see a complete loss of PLZF expression. Based on the differences seen 
between iNKT, MAIT, and MAIT-like cells, we can imagine a complex network 
involving multiple levels of regulation that promotes the differentiation of these 
PLZF+ innate T cell subsets.  
Since we did not detect a requirement for MHC molecules but did find a 
role for SAP in the development of itk-/- CD4+ PLZF+ MAIT-like cells, we thought 
that γδ NKT cells may be playing a role. It’s been proposed that the expansion of 
γδ NKT cells in Itk-deficient mice is responsible for the IL-4 that induces Eomes 
expression in conventional T cells (Alonzo and Sant'Angelo, 2011). Thus, we 
hypothesized that γδ NKT cells may be involved in the development and 
expansion of CD4+ PLZF+ MAIT-like cells. However, the absence of γδ T cells 
had no affect on the development of MAIT-like cells. Additionally, we examined 
the influence of IL-15 on the development of MAIT-like cells. The maintenance of 
iNKT cells is reliant on IL-15 signaling (Ohteki et al., 1997). Since iNKT cells also 
express PLZF, we hypothesized that IL-15 may be important in the maintenance 
of CD4+ PLZF+ MAIT-like cells. While we found that the absence of IL-15 had no 
influence on the development of thymic CD4+ PLZF+ MAIT-like cells, we saw that 
cell numbers of CD4+ PLZF+ MAIT-like cells in the spleen and mLN were 
increased in the absence of IL-15. Thus, IL-15 may be negatively regulating the 
expansion of peripheral MAIT-like cells. Alternatively, these MAIT-like cells may 
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homeostatically expand in the absence of IL-15 due to the lack of CD8+ T cells in 
the periphery. Thus, IL-15 may not be involved in the regulation of MAIT-like 
cells. This second explanation seems more likely since MAIT-like cells fail to 
express IL-2Rβ (data not shown), which is required for IL-15 signaling.  
Since we did not see a requirement of MHC molecules, γδ T cells, or IL-15 
signaling in the development of CD4+ PLZF+ MAIT-like cells, these cells may be 
developing aberrantly in the absence of Itk by escaping negative selection. 
Strong TCR signaling has been shown to induce PLZF expression (Moran et al., 
2011; Qiao et al., 2012). Thus, in WT thymocytes where TCR signaling is intact, 
these MAIT-like cells could be negatively selected. Consequently, in the absence 
of Itk and reduced TCR signal strength, these MAIT-like cells may now be 
positively selected. Although this explanation is likely, there could be multiple 
reasons for the abundance of these MAIT-like cells in Itk KO mice. One 
interesting thought is that these MAIT-like cells develop in a WT mouse and are 
not an artifact of the Itk KO. Although KLF2, Id3, CBP, and SLP-76Y145F mice 
were not utilized in this study, we may find an expansion of this MAIT-like 
population in these mice. Additionally, when WT and SAP KO mice are 
compared directly, we do see significant decrease (~10 fold) in this population in 
the absence of SAP using a student’s t test (data not shown). This decrease is 
not seen when WT mice are compared solely with MR1- or CD1d-deficient mice. 
Thus, there is a potential for these CD4+ PLZF+ MAIT-like cells to be a novel 
population in WT mice. Additionally, while MAIT cells are a significant population 
in humans, this population is rare in mice, and murine MAIT cells do not express 
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PLZF (Martin et al., 2009). Thus, this study may help further describe a murine 
population of MAIT cells that are the equivalent of the MAIT cell population found 
in humans.  
Although there are multiple similarities between the CD4+ PLZF+ MAIT-like 
cells we find in Itk-deficient mice and MAIT cells, we did not see the requirement 
of MR1 for the development of CD4+ PLZF+ MAIT-like cells. Although this was a 
puzzling result, it is possible that CD4+ PLZF+ MAIT-like cells and MAIT cells still 
have some commonalities in their development and/or maintenance. For 
instance, MAIT cells require B cells for their peripheral maintenance and 
expansion (Treiner et al., 2003). Therefore, MAIT-like cells may also require help 
from B cells. We could test this by crossing Itk KO mice to a B cell-deficient 
mouse, such as a CD19 KO or µMT KO. Potentially, if we deplete B cells from Itk 
KO mice, we may also be able to see a change in the presence of MAIT-like cells 
in the periphery. In addition to the requirement of B cells in the maintenance of 
MAIT cells, these cells are not found in germ-free mice (Treiner et al., 2003). 
Thus, if the CD4+ PLZF+ MAIT-like cells that develop in the absence of Itk are 
similar to MAIT cells, we may also see a difference in this population in the 
absence of commensal flora. This hypothesis appears to be likely since we have 
seen correlations between the gut-homing receptors α4β7, CD103, and CCR6 
and the frequencies of Eomes+ innate CD8+ T cells or CD4+ PLZF+ MAIT-like 
cells. While it would be hard to obtain Itk-deficient mice that are germ-free, we 
can utilize a protocol worked out by Dipti Karmarkar from Dr. Kenneth Rock’s lab 
in which a strong course of antibiotics is provided to mice neonatally. This 
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removes the majority of commensal flora from these mice and will allow us to 
study the development of MAIT-like cells in these “germ-free” mice.  
Although B cells and commensal flora may be involved in the peripheral 
maintenance of itk-/- MAIT-like cells (Treiner et al., 2003), a potential mechanism 
for the development of these cells in the thymus may be due to disregulation of 
Lin28b. Recently, this protein was described to inhibit the let-7 family of 
microRNAs (miRNAs) during fetal ontogeny (Yuan et al., 2012). This inhibition of 
let-7 promoted the pluripotency of hematopoietic stem cells (HSCs) and the 
development of PLZF+ innate T cells during fetal ontogeny (Yuan et al., 2012). It 
has recently been proposed that the majority of γδ NKT cells develop during fetal 
ontogeny (Grigoriadou et al., 2003). However, in the absence of Itk, γδ NKT cells 
are able to develop both pre- and post-natally (Yin et al., 2013). Further, post-
natal bone marrow had decreased expression Lin28b (Yuan et al., 2012), which 
may explain why WT γδ NKT cells fail to develop post-natally. Additionally, this 
group overexpressed Lin28b using a retroviral vector transduced into human 
hematopoietic stem/progenitor cells (HSPCs) (Yuan et al., 2012). These 
transduced cells were transferred into a Rag-deficient mouse and lymphocyte 
development was examined. Remarkably, an abundance of PLZF+ innate T cells 
developed in lymphocytes overexpressing Lin28b (Yuan et al., 2012). Although 
there was an increase in iNKT and γδ NKT cells, there was also a population of 
CD3+ PLZF+ cells that did not bind CD1d tetramer or antibodies against 
TCRδ (Yuan et al., 2012). Therefore, we can imagine that, in the absence of Itk, 
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Lin28b may not be downregulated in postnatal bone marrow, which would 
promote the development of PLZF+ innate T cells.  
These PLZF+ innate T cells have previously been shown to influence the 
development of conventional CD8+ T cells (Figure 6.5). These PLZF+ innate T 
cells produce copious amounts of IL-4 that converts conventional CD8+ T cells 
into Eomes+ innate T cells (Gordon et al., 2011; Verykokakis et al., 2010b; 
Weinreich et al., 2010). A novel finding of this study is that Itk-deficient 
conventional CD4+ T cells also appear to be affected by this abundance of IL-4. 
In our studies we found a population of Eomes+ innate CD4+ T cells that develop 
in the absence of Itk. Like Eomes+ innate CD8+ T cells, these Eomes+ innate 
CD4+ T cells highly express CD44, CD62L, CD122, CD124, and CXCR3 (Atherly 
et al., 2006a; Broussard et al., 2006; Weinreich et al., 2010). Additionally, these 
cells were able to produce IFNγ upon ex vivo stimulation. Further, Eomes+ innate 
CD4+ T cells required MHC class II for their development, which exemplifies the 
conversion of conventional CD4+ T cells into Eomes+ innate CD4+ T cells. The 
finding of this subset provides further evidence that this balance between TCR 
signaling and IL-4/Type I IFN signaling is critical for the lineage decision between 
innate versus conventional lymphocytes. During positive selection, thymocytes 
that receive strong TCR signals differentiate into CD4+ T cells while thymocytes 
receiving weak TCR signals differentiate into CD8+ T cells (Singer et al., 2008; 
Starr et al., 2003). Therefore, in the absence of Itk, CD8+ T cells seem to be 
more susceptible to the induction of Eomes by IL-4 due to weakened TCR 
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Figure 6.5: Eomes+ Innate CD8+ and CD4+ T Cells are Regulated by Distinct 
Pathways. Novel CD4+ PLZF+ MAIT-like cells that develop in the absence of Itk 
regulate the development of Eomes+ innate CD8+ T cells through IL-4. These 
cells are also able to influence the development of Eomes+ innate CD4+ T cells. 
However, iNKT cells are able to regulate the development of Eomes+ innate 
CD4+ T cells although the mechanism is unknown. Itk-deficient iNKT cells 
produce IL-4, which may regulate the development of Eomes+ innate CD4+ T 
cells. iNKT cell regulation of Eomes+ innate CD4+ T cells may also be due to 
location within the thymus. Eomes+ innate CD4+ T cells are selected by MHC 
class II expression on the thymic epithelium. However, Eomes+ innate CD8+ T 
cells can be selected on hematopoietic cells. Thus, the regulation of these two 
subsets may occur in separate areas of the thymus.   
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signaling (Weinreich et al., 2010). This would also explain why only a small 
population CD4+ T cells have this Eomes+ innate phenotype. I would hypothesize 
that these Eomes+ innate CD4+ T cells receive weaker TCR signaling during 
development, which would allow IL-4 to induce Eomes in these cells. 
Surprisingly, we saw different requirements for the development of 
Eomes+ innate CD4+ and CD8+ T cells. For instance, although the absence of 
iNKT cells slightly affected the development of Eomes+ innate CD8+ T cells, the 
majority of these cells were still present in the absence of iNKT cells. Conversely, 
the absence of iNKT cells severely affected the development of Eomes+ innate 
CD4+ T cells (Figure 6.5). We have previously seen that Itk-deficient iNKT cells 
are arrested at an early stage of development, which would allow them to 
produce plentiful amounts of IL-4. Therefore, it is possible that Eomes+ innate 
CD4+ T cells are more sensitive to IL-4 in their environment, and thus, would be 
more affected by a slight reduction of IL-4 in their environment. However, this 
seems unlikely since we saw little difference in the expression of CD124 between 
Itk KO and Itk/CD1d DKO Eomes+ innate T cells. Additionally, if Eomes+ innate 
CD4+ T cells were influenced by small changes in IL-4, we would expect to see a 
decrease in this population in the absence of γδ T cells. However, this was not 
the case, and surprisingly, we saw no influence of γδ T cells on the development 
of Eomes+ innate T cells. Another possibility to explain this differential regulation 
of Eomes+ innate T cells by iNKT cells is proximity. Within the thymus, different 
cell populations may reside in distinct compartments, which would limit the 
access of cytokines to cells in the immediate environment. Thus, Eomes+ innate 
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CD4 T cells in itk-/- mice might be co-localized with iNKT cells to a greater extent 
than Eomes+ innate CD8+ T cells, which could explain why Eomes+ innate CD4+ 
T cells are more influenced by the absence of iNKT cells. 
As mentioned briefly, an unexpected finding from our studies was the lack 
of importance of γδ NKT cells in the development of Eomes+ innate CD4+ and 
CD8+ T cells in itk-/- mice.  As this cell population is greatly expanded in numbers 
in itk-/- mice and is a significant producer of IL-4 that induces hyper-IgE syndrome 
(Felices et al., 2009; Qi et al., 2009), it was reasonable to propose that these 
cells would contribute to, or be completely responsible for, the IL-4 production 
that generates Eomes+ innate T cells. Yet, we observed no detectable change in 
either innate CD4+ or CD8+ T cells in itk-/- mice lacking γδ T cells. Instead, our 
data demonstrate that the CD3+ PLZF+ T cells responsible for converting 
conventional itk-/- CD4+ and CD8+ thymocytes into innate Eomes-expressing 
innate T cells are actually αβ TCR+ cells. Furthermore, for the development of itk-
/- CD8+ innate T cells, our data rule out the other known subsets of PLZF+ T cells, 
iNKT cells and MAIT cells. Thus, these findings argue for a novel PLZF+ CD4+ T 
cell subset capable of producing IL-4 that is likely to be expanded in itk-/- mice, 
similar to the situation for γδ NKT cells. 
Significance  
One interesting possibility is that the population of itk-/- PLZF+ CD4+ MAIT-
like T cells responsible for inducing Eomes+ innate T cell development is related 
to the ‘T-CD4’ cells found in the thymus of mice engineered to express MHC 
class II proteins on their thymocytes (Lee et al., 2010). These T-CD4 cells 
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develop as a result of SAP-dependent thymocyte-thymocyte interactions that 
lead to upregulation of PLZF and an innate capacity to secrete IL-4 (Lee et al., 
2010).  In addition, similar to the innate CD8+ T cells seen in mice deficient in Itk, 
KLF2, Id3, CBP, and SLP-76 signaling (Atherly et al., 2006b; Dubois et al., 2006; 
Gordon et al., 2011; Verykokakis et al., 2010b; Weinreich et al., 2010), the 
CD8SP thymocytes in T-CD4 mice develop as innate cells expressing high levels 
of Eomes (Min et al., 2011). Intriguingly, unlike mouse thymocytes, human 
thymocytes express MHC class II molecules, and studies from Chang and 
colleagues have found a substantial number of Eomes+ CD8+ T cells in human 
fetal thymus and spleen (Min et al., 2011).  Based on these findings, Min et. al. 
have suggested that these innate T cells may function in protective immunity 
during the perinatal period (Min et al., 2011). Thus, it is possible that a normal 
developmental pathway for human T cells has been revealed by the genetic 
ablation of key T cell signaling proteins and transcription factors in mice. 
In addition to Itk-deficient mice potentially mimicking a human immune 
system, recent data involving Itk null patients has revealed a role for Itk in the 
suppression of EBV (Huck et al., 2009; Linka et al., 2012; Stepensky et al., 
2011). These patients succumb to EBV-LPD, and the only known treatment is a 
bone marrow transplant (Linka et al., 2012; Stepensky et al., 2011). Remarkably, 
the CD8+ T cells of these patients express high levels of Eomes, similarly to what 
we see in Itk-deficient mice (Huck et al., 2009). Additionally, these patients have 
reduced iNKT cells, which is also similar to Itk-deficient mice (Huck et al., 2009). 
However, the inability of these Itk null patients to control EBV suggests a role for 
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Itk in the generation of protective memory responses. Indeed, when Itk-deficient 
mice are infected with LCMV, we see that protective memory responses are lost 
and that there is a higher frequency of antigen-specific T cells expressing Eomes 
rather than T-bet. The data presented here may provide us with insight into how 
CD8+ T cells are differentially regulated in response to an acute infection 
producing effector cells and in response to a chronic infection that results in 
exhausted cells. Thus, Itk-deficient mice may be a good animal model for 
examining the development and function of the human immune system.     
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